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A PHYLOGENOMIC- AND PROTEOMIC INVESTIGATION INTO THE EVOLUTION 
AND BIOLOGICAL CHARACTERISTICS OF THE MEMBERS OF THE GROUP 2 
LATIN-AMERICAN MEDITERRANEAN (LAM) GENOTYPE OF MYCOBACTERIUM 
TUBERCULOSIS 
Mycobacterium tuberculosis (M. tuberculosis) is the causative agent of tuberculosis (TB), a disease 
that affects millions of people world-wide. The species M. tuberculosis consists of a large number of 
different strains that can be grouped into at least 40 different known strain families. Many of the strains 
present with different pathogenic characteristics and host adaptations. The F11 LAM strains and 
Beijing strains currently have a nearly equal representation in the population of Cape Town, making up 
a total of 45% of all strains in this setting. The Latin-American Mediterranean (LAM) family of M. 
tuberculosis is proved to be the cause of a large percentage of TB cases worldwide and it is the 
predominant strain in high-prevalence regions such as the Western Cape and KwaZulu-Natal regions 
of South Africa, Zambia, Zimbabwe, and South America.  
This project aimed to investigate the evolution and biological characteristics of the members of the 
principle genetic group (PGG) 2 Latin-American Mediterranean (LAM) genotype of M. tuberculosis 
using a combination of whole genomic and proteomic analyses, coupled to mycobacterial molecular 
epidemiological techniques. 
The evolution of M. tuberculosis strain families from the Western Cape Province of South Africa 
proved to be consistent with previous evolutionary scenarios for M. tuberculosis isolated from other 
parts of the world. This genome-wide SNP-based phylogeny for the evolution of M. tuberculosis offers 
novel insight into the unique global representation of the M. tuberculosis isolates from the Western 
Cape, South Africa. The evolutionary scenario presented confirms six LAM sub-lineages, namely 
IS6110 RFLP families F9, F11, F13, F14, F15, and F26. A subset of sub-lineage defining SNPs was 
determined for each of the six LAM sub-lineages. 
The genomic changes in the LAM genotype strains observed through the SNP analysis presented 
here mostly occur in the genes involved in the cell wall, cell processes, intermediary metabolism and 
respiration. The same phenomenon was observed when the non-redundant SNPs of the non-LAM 
isolates were functionally annotated. The functional classification of the regulated proteins in the 
representative of the LAM RDRio lineage of M. tuberculosis suggests that proteins involved in the lipid 
metabolism, intermediary metabolism and respiration may be the key to the pathogenic effectiveness 
of the RDRio LAM lineage. A combination of the LAM SNP analysis and the LAM RDRio/non-RDRio 
comparison showed that the overall genomic- and proteomic features involved in the cell wall and cell 
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processes of the LAM genotype differ to a large extent from what is seen in the reference strain, M. 
tuberculosis H37Rv. This genome wide phylogenetic study is the first of its kind in a South African 
context, and not only presents a robust phylogeny of the M. tuberculosis strain families, and 
specifically the LAM lineage, but also gives the first ever insight into the protein differences which 
distinguishes RDRio and non-RDRio M. tuberculosis strains from each other.   
 
 




‗N FILOGENOMIESE EN –PROTEOMIESE ONDERSOEK IN DIE EVOLUSIE EN 
BIOLOGIESE EIENSKAPPE VAN LEDE VAN DIE GROEP 2 LATYNS-
AMERIKAANS MEDITERREENSE (LAM) GENOTIPE VAN MYCOBACTERIUM 
TUBERCULOSIS 
Mycobacterium tuberculosis (M. tuberculosis) is die mikrobiese agent wat tuberkulose (TB), 'n siekte 
wat miljoene mense wêreldwyd affekteer, veroorsaak. Die spesie M. tuberculosis bestaan uit 'n groot 
aantal verskillende stamme wat in ten minste 40 verskillende bekende stam-families gegroepeer word. 
Baie van die stamme toon verskillende patogeniese eienskappe en gasheer aanpassings. Die F11 
LAM stam en Beijing stam het tans 'n byna gelyke verteenwoordiging in die bevolking van Kaapstad, 
wat 'n totaal opmaak van 45% van stamme wat in hierdie gebied gevind word. Die Latyns-
Amerikaanse Meditereense (LAM) familie van M. tuberculosis is bewys om die oorsaak van 'n groot 
persentasie van TB-gevalle wêreldwyd te wees, en dit is die oorheersende stam in hoë voorkoms 
streke soos die Wes-Kaap en KwaZulu-Natal streke van Suid-Afrika, Zambië, Zimbabwe en Suid-
Amerika. 
Hierdie projek het ten doel gehad om die evolusie en biologiese eienskappe van die lede van die 
basiese genetiese groep (BGG) 2 Latyns-Amerikaanse Meditereense (LAM) genotipe van M. 
tuberculosis te ondersoek deur gebruik te maak van 'n kombinasie van heel genoom en proteoom 
analise, gekoppel aan mikobakteriële molekulêre epidemiologiese tegnieke. 
Die evolusie van M. tuberculosis stam families van die Wes-Kaap Provinsie van Suid-Afrika blyk om in 
ooreenstemming te wees met vorige evolusionêre scenario's vir M. tuberculosis wat in ander dele van 
die wêreld geïsoleer is. Die genoom-wye enkelnukleotied polimorfisme-gebaseerde filogenetiese 
hipotese vir die evolusie van M. tuberculosis bied nuwe insig in die unieke wêreldwye 
verteenwoordiging van die M. tuberculosis isolate van die Wes-Kaap, Suid-Afrika. Die evolusionêre 
scenario wat hier aangetoon word bevestig ses LAM sub-lyne, naamlik IS6110 RFLP families F9, F11, 
F13, F14, F15, en F26. 'n Versameling sub-lyn definiërende enkelnukleotied polimorfismes was 
bepaal vir elk van die ses LAM sub-afstammelinge. 
Die genomiese veranderinge wat waargeneem is in die LAM-genotipe isolate deur die enkelnukleotied 
polimorfisme analise wat hier aangebied word, is meestal in die gene wat betrokke is in die selwand, 
selprosesse, intermediêre metabolisme en respirasie. Dieselfde verskynsel is waargeneem wanneer 
die nie-oorbodige enkelnukleotied polimorfismes van die nie-LAM isolate funksioneel geannoteer is. 
Die funksionele klassifikasie van die gereguleerde proteïene in die verteenwoordiger van die LAM 
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RDRio-lyn van M. tuberculosis dui daarop dat die proteïene wat betrokke is in die lipiedmetabolisme, 
intermediêre metabolisme en respirasie die sleutel tot die patogene doeltreffendheid van die RDRio-
LAM-lyn kan wees. 'n Kombinasie van die LAM enkelnukleotied polimorfisme analise en die LAM-
RDRio/nie-RDRio vergelyking het getoon dat die totale genomiese- en proteomiese kenmerke wat 
verwant is aan selwand en selprosesse van die LAM genotipe tot ŉ groot mate verskil van wat gesien 
word in die verwysing stam, M. tuberculosis H37Rv. Hierdie genoom-wye filogenetiese studie is die 
eerste van sy soort in 'n Suid-Afrikaanse konteks, en bied nie net ‗n robuuste filogenie van die M. 
tuberculosis stam families, en spesifiek die LAM genotipe van M. tuberculosis nie, maar gee ook die 
eerste keer ooit insig in die proteïen verskille wat RDRio en nie-RDRio M. tuberculosis stamme van 
mekaar onderskei.  
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CHAPTER 1  
INTRODUCTION 
1.1 BACKGROUND 
Mycobacterium tuberculosis (M. tuberculosis) is the causative agent of tuberculosis (TB), a disease 
which is a major threat to the health of millions of people worldwide (WHO, 2011). The species M. 
tuberculosis is part of the M. tuberculosis complex (MTC), and consists of a large number of different 
strains falling into at least 40 different known strain families, with many presenting with different 
pathogenic characteristics and host adaptations (Brudey et al., 2006).  
The different species and strains of the MTC is thought to have evolved from a common mycobacterial 
ancestor (Brosch et al., 2002). The evolution of the MTC has been hypothesized to have occurred in 
parallel with the evolution of anatomically modern humans and the expansion of the pathogen is 
ascribed to the increased human population density in the Neolithic period (Comas et al., 2013). The 
global spread of human-adapted M. tuberculosis strains coincides with modern human migration 
patterns out of Africa (Wirth et al., 2008). During the evolutionary process, members of the M. 
tuberculosis complex are thought to have lost the ability to undergo horizontal gene transfer, and as 
such, the only genetic changes that can still take place in these organisms are deletions, duplications, 
genetic rearrangements, transposon insertions and single nucleotide polymorphisms. Notwithstanding 
the high clonality of these MTC members, different lineages, sub-lineages and strains have evolved 
over time through the mechanisms mentioned above (Brosch et al., 2002).  
The different strains of M. tuberculosis vary greatly in pathogenicity and fitness and are found 
historically associated with different human host populations from different regions of the world (Brown 
et al., 2010; Comas et al., 2013; Gagneux et al., 2006). Due to the fact that South Africa was located 
in a geographically central position in the historical trade route between East and West for hundreds of 
years, we observe a spectrum of strains from both European and Eastern origin as the dominant strain 
types in this country (Mokrousov et al., 2005). Over time and in association with different host 
populations, different strains of M. tuberculosis have acquired different phenotypic properties through 
evolution, resulting in strains which are, for example, hyper- or hypovirulent (de Souza et al., 2010). 
Furthermore, it was observed that specific strain families seem to outcompete others in a certain 
setting, suggesting host-pathogen compatibility (Gagneux et al., 2006). Co-evolutionary events 
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between the host and pathogen are further supported by the association between human leukocyte 
antigen types and specific M. tuberculosis strain genotypes (Salie et al., 2013).  
The Latin-American Mediterranean (LAM) lineage of M. tuberculosis is prevalent in Latin-America and 
the Mediterranean region. More recently, the LAM lineage has been shown to be the predominant 
cause of TB in Russia and in high-prevalence African regions such as the Western Cape and 
KwaZulu-Natal regions of South Africa, Zambia, and Zimbabwe (Chihota et al., 2012; Mulenga et al., 
2010). The RDRio subset of LAM genotype strains shows effective transmissibility and are thought to 
be hyper-virulent, compared to non-RDRio strains (Gibson et al., 2008; Lazzarini et al., 2007, 2008). 
The LAM genotype is responsible for approximately 15% of TB cases globally (Brudey et al., 2006). 
The F11 LAM strains and Beijing strains currently have a nearly equal representation in the population 
of Cape Town, making up a total of 45% of all strains in this setting (Victor et al., 2004). We observe 
changing M. tuberculosis population patterns, largely due to the increase in the incidence of cases 
caused by specific strains of M. tuberculosis in a local South African setting. This highlights the ability 
of strains to acquire genotype-specific pathogenic characteristics (van der Spuy et al., 2009).  
The fact that LAM strains are a common cause of TB worldwide highlights the importance of the LAM 
genotype and suggests that this strain lineage is a global threat that should be specifically targeted by 
public health resources. 
1.2. PROBLEM IDENTIFICATION 
In order to control the TB epidemic, it is essential to understand the dynamics of the epidemic. We 
need to be able to accurately identify the lineages, clusters and strains to which M. tuberculosis 
isolates belong in order to identify their genomic background, to understand the changing population 
patterns, and track outbreaks. Furthermore, we need to understand the biological grounds for these 
strain differences in order to efficiently design drugs and vaccines to combat the disease.  
The Beijing and LAM genotypes of M. tuberculosis have been recognized as the major clades to 
cause TB globally (Brudey et al., 2006). The Beijing genotype has been the subject of various in vivo 
and in vitro studies over the last decade, due to its apparent hyper-virulence leading to increased 
transmissibility and ability to cause disease (Hanekom et al., 2011). Even though the LAM family of M. 
tuberculosis has been shown to be the cause of a large percentage of TB cases worldwide, it has not 
been as extensively studied and much remains to be uncovered about the mechanisms of 
pathogenicity of this strain family. We hypothesize that the epidemiological success of this strain 
family reflects physiological changes through evolution of the proteome as a result of altered gene 
expression (which may be derived from genomic mutations). As such, an understanding of the 
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evolution and diversification of these strains, as well as the biological reasons underlying their fitness, 
are crucial to the combat of this disease.  
1.3. AIMS 
This project aims to investigate the evolution and biological characteristics of the members of the 
principle genetic group (PGG) 2 Latin-American Mediterranean (LAM) genotype of M. tuberculosis 
using a combination of whole genomic and proteomic analyses, coupled to mycobacterial molecular 
epidemiological techniques.  
 
Whole genome sequencing and high throughput mass spectrometry will be employed in conjunction 
with a large set of molecular markers (which includes spoligotyping, IS6110-RFLP, deletions, and 
single nucleotide polymorphisms selected from previous studies in our department, from literature, and 
from the results of publicly-available whole genome sequencing) to screen all LAM strains available to 
the study. The results will be used to generate a robust phylogenetic reconstruction of the evolutionary 
history of the M. tuberculosis LAM genotype. A set of markers will be identified that could be used for 
the rapid screening, delineation and identification of lineages, sublineages and strains of LAM M. 
tuberculosis, and identify the biological basis for their variation in fitness and pathogenicity.  
 
Overall aim of this study: 
To use whole genome sequencing in association with highly sensitive mass spectrometry techniques 
to describe the genomes and proteomes of strains representative of the different sub-lineages of the 
M. tuberculosis LAM genotype. 
1.4. OBJECTIVES 
• To culture strains representative of the different strain families of the M. tuberculosis LAM 
genotype. 
• To extract genomic DNA from strains representative of the different strain families of the M. 
tuberculosis LAM genotype for whole genome sequencing. 
• To establish a pipeline for the bioinformatic analysis of next generation sequencing (NGS) data.  
• To do bioinformatic analyses of the whole genome sequence data to identify changes that 
have occurred during the evolution of the LAM genotype. 
• To generate a comprehensive phylogenetic tree of the LAM genotype. 
• To extract whole cell lysate proteins from strains representative of different strain families of 
the M. tuberculosis LAM genotype for protein mass spectrometry analysis. 
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• To identify proteins that have changed in abundance that may be involved in the development 
of the high virulence phenotypes of M. tuberculosis. 
• To develop a ‗map‘ of the changes in the genomes and proteomes to correlate mutation with 
protein abundance. 
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CHAPTER 2   
L ITERATURE REVIEW 
M. TUBERCULOSIS  EVOLUTION: THE GROUP II LATIN-AMERICAN 
MEDITERRANEAN (LAM) GENOTYPE    
2.1. THE CURRENT SITUATION OF TUBERCULOSIS GLOBALLY 
Mycobacterium tuberculosis (M. tuberculosis) is the causative agent of tuberculosis (TB) – an 
infectious disease that has pestered human-kind for centuries. Robert Koch was awarded the Nobel 
Prize for his discovery of M. tuberculosis at the turn of the 19th century. However, the pathogen is still 
responsible for a worldwide TB epidemic, which reached an all-time high in 2009 when the total 
number of tuberculosis cases worldwide was estimated at 9.4 million (WHO, 2011). Suggested factors 
that contribute to the extremely high global TB burden include HIV co-infection, the emergence of drug 
resistant (DR)-, multidrug resistant (MDR)-, extremely drug resistant (XDR)- and recently reported, 
totally drug resistant (TDR) TB (Chiang et al., 2010; Devaux et al., 2009; Migliori et al., 2009; Schaaf 
et al., 2009).  
The TB burden in Africa, which also largely applies to South Africa, is extremely high compared to 
other parts of the world. This is striking when it is considered that the population size is smaller than 
e.g. South East Asia, yet the incidence (cases arising during a certain period), prevalence (new and 
existing cases at a given point in time) and mortality due to tubercle disease is second highest in the 
world in all three categories. The mortality rate due to TB in Africa (excluding HIV) was 50 per 100 000 
during 2009. HIV contributes greatly to the increase in incidence of tuberculosis all over the world, 
especially in Africa. Among HIV-negative TB patients, 1.3 million deaths were reported worldwide in 
2009 amongst HIV negative TB patients (WHO, 2012).  
2.2. EARLY ORIGINS OF M. TUBERCULOSIS  
The Mycobacterium tuberculosis complex (MTC) is comprised of a number of Mycobacterium species 
that cause tubercle disease in mammals. Members include M. tuberculosis, Mycobacterium africanum 
(M. africanum), Mycobacterium canettii (M. canettii), Mycobacterium microti, Mycobacterium bovis (M. 
bovis) and Mycobacterium bovis Bacillus Calmette-Guérin (BCG), Mycobacterium pinnipedi, 
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Mycobacterium caprae, Mycobacterium suricattae, the dassie bacillus and the oryx bacillus, recently 
named Mycobacterium orygis (Brosch et al., 2001; Parsons et al., 2002, 2013; van Ingen et al., 2012; 
Walker et al., 2013). These species are all able to cause disease in mammals, including humans but 
tend to favour disease in a certain host (e.g. dassie bacillus is mostly found in Cape Hyrax and M. 
pinnipedi in seals) (Smith, 1898). Members of the MTC are highly clonal, are said to share 99.9% 
similarity in their nucleotide sequence. Little evidence of horizontal or lateral gene transfer has been 
observed (Baker et al., 2004). The 16s RNA sequences of the various members are highly conserved, 
except in the ancestral M. canettii (Dos Vultos et al., 2008).  
Studies performed during the last decade prove that the ancestor of M. tuberculosis is M. canettii, and 
not M. bovis as previously assumed (Brosch et al., 2002; Sreevatsan et al., 1997). The different 
mycobacterial species comprising the MTC are thought to have evolved from this common ancestor. 
Some controversy exists as to the exact age of mycobacteria and when it evolved into the different 
mycobacterial species that are known to date (Wirth et al., 2008). A recent coalescent study estimated 
that the MTC emerged roughly 70 000 years ago and was spread by anatomically modern humans 
migrating out of Africa (Comas et al., 2013). Epidemiologic and phylogenetic studies have shown that 
tubercle bacilli emerged in Africa, and consequently underwent initial diversification (Comas et al., 
2013; Walker et al., 2013). A successful pathogenic clone of the MTC, M. tuberculosis, expanded and 
spread to the rest of the world, most likely with the early human migration patterns driven by the 
historical trade route to and from Africa (Walker et al., 2013). 
Comparative genomics have revealed that even the most distantly related Mycobacterium species 
(non-MTC members) share 60% DNA homology and that the loss of genetic material in particular 
contributes towards the continuous evolution of the slow-growing pathogenic species of mycobacteria 
(Brosch et al., 2001). It is commonly accepted that M. tuberculosis do not undergo horizontal gene 
transfer, although available data suggest that lateral genetic exchange has occurred in the precursor 
of the MTC, commonly referred to as M. prototuberculosis (Brisse et al., 2006; Supply et al., 2003; 
Walker et al., 2013). It is said that modern mycobacteria are continuously and rapidly evolving as 
apparently successful pathogens after the evolutionary ancestral bottleneck that gave rise to the 
different members of the MTC known to date (Namouchi et al., 2012). 
Variations in M. tuberculosis were already described in 1982 (Collins et al., 1982) when five variants 
where identified on the basis of differences in oxygen requirement (aerobic or microaerophilic), nitrate 
reductase activity, susceptibility to pyrazinamide and susceptibility to thiophene-2-carboxylic acid 
hydrazide. These variants were then termed classical human, Asian human, bovine, African I and 
African II, and this terminology was used in early epidemiological studies of M. tuberculosis infection 
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(Collins et al., 1982). Current strain classification is based on various genetic markers (elaborated 
upon in Section 2.3).  
Evolution may refer to change in the genetic properties and/or physical appearance of an organism 
over time. A clear distinction can be made between micro- and macro-evolution, where micro-
evolution refers to small changes that occur in a shorter period of time and is undergone in one or 
more small events. Macro-evolution is achieved through rare, but large events and usually over a 
longer period of time (Behe, 1998). Genetic variation in a population makes it possible for that 
population to evolve when certain selective pressures are applied. The diversity among M. 
tuberculosis strains has largely been attributed to genetic drift, whilst the influence of natural selection 
on the development of diversity patterns is still poorly understood (Pepperell et al., 2013).  
2.3. M. TUBERCULOSIS  STRAIN DIVERSITY 
Genetic divergence between the different M. tuberculosis strains underlies the variation in phenotype 
and disease presentation (Sarkar et al., 2012). M. tuberculosis lineages cause varying disease 
phenotypes that include duration and extent of disease, anatomic dispersal of tubercle lesions and 
response to treatment (Caws et al., 2008; Click et al., 2012; Hanekom et al., 2011; Hirsh et al., 2004). 
However, as a routine practice, the same drug regimen is administered to patients to treat tuberculosis 
regardless of the strain(s) of M. tuberculosis responsible for the infection, even though it has been 
shown that strains respond to treatment differently (Richardson et al., 2002; WHO, 2011). Even more 
alarming is the fact that tuberculosis treatment is often started even before any genetic 
characterisation (genotyping) of the disease-causing strain is performed, leading to a situation where 
patients with tuberculosis caused by DR-, MDR-, XDR strains together with drug sensitive (DS) strains 
are subjected to the same initial treatment. This may lead to the selection of DR-, MDR- or XDR 
strains in favour of the DS strain in the host. Alternatively, selective drug pressure may contribute to 
the development of a DR (or worse) strain if such a strain has a genetic predisposition to acquire 
resistance to a specific drug (Davies and Davies, 2010; Nachega and Chaisson, 2003). The on-going 
TB epidemic, the emergence of drug resistance and the consequent complications thereof have lead 
scientists to explore the genetic basis of M. tuberculosis variability in order to understand the 
underlying mechanisms of pathogenicity.  
Strains of pathogens that cause severe disease in the host and cause rapid mortality are thought to 
undergo negative selection due to the reduction transmission time (de Souza et al., 2010; Mostowy 
and Behr, 2005). This common perception in the evolution of pathogens is challenged by the fact that 
natural selection may favour hyper-virulent strains (causing severe disease and rapid mortality) if 
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these strains carry a remunerative advantage such as increased immediate rates of transmission, or 
high resistance to host defence-mechanisms (Lipsitch and Moxon, 1997). The perfect pathogen 
maintains a fine balance between virulence and a prolonged disease process in order to promote 
transmissibility through the host (Mostowy and Behr, 2005). 
Several studies have shown that a small number of strains are frequently responsible for a large 
number of TB cases in a defined area (Chihota et al., 2007; van Soolingen et al., 1995). It can be 
speculated that inherent increased transmissibility of certain strains compared to others may favour 
the spread of that particular strain in an area. Inherent transmissibility may be due to smear positive 
disease caused by the strain in question, which is more prone to transmission, delayed onset of 
disease symptoms which cause patients to be infectious for a longer period of time, or increased 
virulence compared to other strains (Chihota et al., 2011).  
It is evident that M. tuberculosis is more genetically diverse than previously assumed. In general, 
changes in the M. tuberculosis genome are caused by single nucleotide polymorphisms (SNPs), 
deletions, duplications, genetic rearrangements, and transposon insertions. The more recent changes 
may have occurred as a result of aberrant DNA repair, recombination and replication (3R); the M. 
tuberculosis genome contains no genes encoding components involved in the miss match DNA repair 
pathway (MMR) and as such, M. tuberculosis can be regarded as a natural mutator to some extent 
(Dos Vultos et al., 2008; Mestre et al., 2011).  
2.4. GENETIC CHARACTERIZATION OF M. TUBERCULOSIS  
Genetic markers are used to identify and distinguish different strains of M. tuberculosis, or to 
differentiate strains from the same lineage from one another to study the molecular epidemiology and 
the spread of disease, as well as to study the evolutionary history of M. tuberculosis. The strain-
specific markers have different levels of discriminatory power and stability and various genetic typing 
methods are used to characterise clinical isolates of M. tuberculosis (Brosch et al., 2002; Brudey et al., 
2006; Filliol et al., 2006; Frothingham and Meeker-O‘Connell, 1998; Groenen et al., 1993; Gutacker et 
al., 2002; Moström et al., 2002; Sreevatsan et al., 1997). These typing methods rely on the 
characteristics of a small section of the genome of M. tuberculosis to make assumptions to identify 
clinical isolates in terms of lineage, family, or strain. The markers used in the different typing methods 
are diverse and vary in discriminatory power, and thus; the results obtained by different typing 
methods do not always agree (Filliol et al., 2006; Ford et al., 2012; Hanekom et al., 2008).  
Various molecular epidemiologic genetic markers are used to characterise the MTC. These include 
IS6110 – an insertion sequence unique to members of the MTC, guanine- and cytosine-rich elements 
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present in the genome, spacer oligonucleotide typing (spoligotyping) of the direct repeat locus, 
mycobacterial interspersed repetitive units and variable-number tandem repeats (MIRU-VNTR) 
(Aranaz et al., 1996; Frothingham and Meeker-O‘Connell, 1998; Hermans et al., 1991; Kamerbeek et 
al., 1997; Mazars et al., 2001; Ross et al., 1992; Van Embden et al., 1993).   
The genetic typing method known as spoligotyping is based on determining the presence or absence 
of specific spacer sequences in the direct repeat (DR) locus of members of the MTC (Kamerbeek et 
al., 1997). The DR locus consists of directly repeated DNA sequences, 36 bases in length, 
interspersed by 34 - 40 bp non-repetitive spacer sequences (Kamerbeek et al., 1997).  
It is hypothesised that the evolution of the DR locus of M. tuberculosis is unidirectional; spacers in this 
region are lost rather than gained (Van Embden et al., 1993). Spoligotype families are defined by 
certain spacer patterns which may evolve autonomous from each other in different strains causing 
homoplasy. This could be problematic as an epidemiologic tool, as it is possible that the spoligotype 
pattern that a strain presents with, may not represent the true identity of that strain (Warren et al., 
2002). Spoligotyping is thus not a reliable typing method on its own, due to it being limited to a small 
portion of the genome. It is becoming clear that with the rise of convergent spoligotype patterns, one 
typing method is not sufficient to determine the true strain identity of M. tuberculosis isolates (Comas 
et al., 2009; Flores et al., 2007; Gibson et al., 2008; Reed et al., 2009; Schürch and van Soolingen, 
2011). 
2.5. LINEAGE-SPECIFIC GENETIC MARKERS OF M. TUBERCULOSIS  
Single nucleotide polymorphisms (SNPs) are single nucleotide changes that occur in the genome and 
can be synonymous (polymorphisms that do not change the amino acid sequence) or non-
synonymous (polymorphisms that alter amino acid sequence of the encoded protein). Some of the first 
classification systems of the MTC were based on SNPs. Members of the MTC are classified in three 
principle genetic groups based on different combinations of SNPs in the katG and gyrA genes at the 
following positions; katG463 and gyrA95. Although katG and gyrA genes are both associated with 
drug-resistance, the abovementioned specific SNPs do not confer resistance (Sola et al., 2001; 
Sreevatsan et al., 1997).  
Large sequence polymorphisms (LSPs), better known as regions of difference (RDs), are commonly 
detected in species of mycobacteria and are mostly genomic deletions, although insertions or genetic 
duplications also occur (Alland et al., 2007). TbD1 is an LSP in the genome of some Mycobacterium 
species that distinguishes ancient mycobacterial species and strains from their modern counterparts 
(Brosch et al., 2002). The TbD1 region is present in the genomes of all animal-adapted strains and 
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some of the ancient human-adapted strains (M. africanum type 1 isolates, MANU and EAI) but deleted 
from most modern strains of M. tuberculosis (Baker et al., 2004). The TbD1 deletion of 2.1 Kb thus 
pre-dates the katG G1388T and rpoB T3243C mutations, and is estimated to have been deleted from the 
ancestral M. tuberculosis lineage before the 18th century (Baker et al., 2004; Brosch et al., 2002). 
Genes present in the TbD1 region (which include mmpS6 and mmpL6, both encoding membrane 
proteins), are thus not present in modern M. tuberculosis strains (Cole, 2002).  
Lineage-specific polymorphisms are unlikely to occur simultaneously, and can thus be used to infer 
phylogeny or an order of evolutionary informative events. SNP-based phylogenies of the MTC groups 
the members of the complex into multiple lineages that separate the animal- and human-adapted 
strains from each other and further subdivide the M. tuberculosis strains (Baker et al., 2004; Gutacker 
et al., 2002). Genome wide polymorphisms in genes including oxyR, katG and rpoB, have been used 
to subdivide M. tuberculosis strains in four lineages or phylogenetic groups, in a study by Baker et al. 
(2004) - M. bovis strains accounted for a fifth lineage (Baker et al., 2004). These phylogenetic groups, 
based on polymorphisms at multiple loci, gave similar groupings to the principle genetic groups 
distinguished by the katG463 and gyrA95 polymorphisms, IS6110 RFLP patterns and spoligotype data 
(Bhanu et al., 2002; Filliol et al., 2003; van Soolingen et al., 1995).  
M. tuberculosis strains causing disease in South Eastern Asia are mostly restricted to lineage I, whilst 
TB in Europe is mainly caused by members of lineage II, whereas lineage III is strongly associated 
with the Indian subcontinent. However, lineage IV is globally distributed with the exception of Europe. 
African-born TB patients however, do not show an association with a single lineage of M. tuberculosis, 
but a wide array of M. tuberculosis strains cause disease in this high incidence setting (Baker et al., 
2004). The mixed bag of M. tuberculosis strains is partly explained by the African continent's central 
position in the historical trade routes between East and West. Although the most ancient members of 
the MTC traces back to Africa, this continent and its people were also exposed to various strains of M. 
tuberculosis from across the world (Baker et al., 2004).  
LSPs may be located in regions of the M. tuberculosis genome that are likely to undergo insertion or 
deletion events (so-called hotspot regions) and are often flanked by the IS6110 insertion element 
(Alland et al., 2007; Tsolaki et al., 2004). These LSPs have the potential to be somewhat inexpedient 
for the pathogen, but in some cases they are speculated to be advantageous. Possible beneficial 
effects of large deletions include the ability of the pathogen to escape the host immune system, 
reducing the load of microbial mobile genetic elements, or even to promote drug resistance. Deletions 
can also render a state of latency in the microbe to promote long term illness and thus increased 
opportunity for transmission (Tsolaki et al., 2004). LSPs have been shown to provide considerable 
diversity within mycobacteria and are considered to be more stable genetic markers than point 
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mutations as the latter are subject to reversion (Alland et al., 2007; Brosch et al., 2002). These LSPs 
are often used to infer the phylogeny of M. tuberculosis strains and can thus differentiate between 
certain groups of strains if the LSP is a result of a unique event polymorphism (UEP) (Alland et al., 
2007; Gagneux et al., 2006; Hirsh et al., 2004; Huard et al., 2003). UEPs are polymorphisms that are 
irreversible and do not display homoplasy (convergent evolution) (Hirsh et al., 2004). LSPs are very 
useful for defining robust phylogenetic groups, and are particularly informative and discriminatory for 
ancient M. tuberculosis strains and W-Beijing strains that present with a spoligotype profile where 
nearly all spacers are absent (Flores et al., 2007).   
A significant association was shown in several studies between the patients' origin (country of birth) 
and the lineage of the disease-causing strain of M. tuberculosis (Brown et al., 2010; Gagneux et al., 
2006). Host-pathogen compatibility was inferred from the fact that different lineages of M. tuberculosis 
have been associated with the continent of birth of the patients in which TB is caused (Gagneux et al., 
2006). Regardless of the differences in naming convention and strain distribution of M. tuberculosis 
lineages described in different studies, certain strains show predominance in specific geographical 
areas of the world. SNPs were used to infer four lineages of M. tuberculosis (see Table 2.5.1) (Baker 
et al., 2004). The various lineages of M. tuberculosis have consequently been named in conjunction 
with the geographical location in which a specific strain was first isolated and where it is thought to 
have originated. It has been shown that certain lineages prevail as the dominant strain responsible for 
causing disease in a specific geographical setting and the associated host population (Gagneux et al., 
2006).  
A subsequent study grouped the MTC into six phylogenetic lineages (one to six) and one lineage 
consisting of animal-adapted strains of mycobacteria on the basis of a phylogenetic analysis of over 
300 SNPs (Hershberg et al., 2008). The study performed by Hershberg et al. (2008) referred to the M. 
tuberculosis complex as MTBC as they did not include M. canetti in their analysis since it is more 
distantly related to any species or strain within the complex than any two members of the MTC from 
each other (Hershberg et al., 2008). This phylogenetic grouping was more comprehensive than the 
initial SNP-based lineages and was also concordant with that obtained with LSPs, including the 
presence and absence of the TbD1 deletion, and spoligotype family groupings (Baker et al., 2004; 
Gagneux et al., 2006). Lineage one includes the East-African-Indian (EAI) or the Indo-Oceanic strains. 
The well-described Beijing genotype of M. tuberculosis correlates with lineage two, Central-Asian 
(CAS) and Delhi strains belong to lineage three, Haarlem-, Latin-American Mediterranean (LAM)-, X- 
and U families segregated to form several sublineages of lineage four, better known as the Euro-
American lineage. The widely used reference strain; M. tuberculosis H37Rv is a member of lineage 
four, and is thus a member of PGG3. Mycobacterium africanum AFR2 correspond to lineage five and 
Stellenbosch University  http://scholar.sun.ac.za
12 
 
Mycobacterium africanum AFR1, to lineage six (Chuang et al., 2010; Comas et al., 2009). A summary 
of the SNP- and LSP-based lineages of M. tuberculosis are shown in Table 2.5.1. Data mining 
approaches have identified seven basal/primary strain groups of M. tuberculosis, which include Beijing, 
LAM, EAI, Haarlem, CAS, X, and T, which can all be assigned to one of the major lineages as 
described above (Brudey et al., 2006; Filliol et al., 2002; Sebban et al., 2002; Sola et al., 2001). Strong 
evidence also suggests that geographic structuring in M. tuberculosis populations could play a role in 
the evident global variation in success of the M. bovis BCG vaccine (Baker et al., 2004; Brown et al., 
2010; Gagneux et al., 2006).  
SNP-typing of mycobacteria has been extensively used in phylogenetic studies to determine the 
evolutionary structure of the MTC and, more specifically, M. tuberculosis and its large array of strains 
(Baker et al., 2004; Filliol et al., 2006; Gutacker et al., 2006, 2002). Hence, various SNP clusters and 
SNP based phylogenies have been published to date, the groupings mostly coincide with each other 
but due to the non-uniform naming scheme of these clusters or phylogenetic groupings, some 
confusion may exist (Baker et al., 2004; Chuang et al., 2010; Filliol et al., 2006; Gutacker et al., 2006, 
2002). Table 2.5.1 shows a summary of the lineages of M. tuberculosis as defined by SNPs, LSPs, 
and spoligotyping.  
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Table 2.5.1. A summary of the lineages of Mycobacterium tuberculosis and Mycobacterium 
africanum as determined by various genetic markers in different studies 
Markers used 
(Study) 
Lineage 1 Lineage 2 Lineage 3 Lineage 4 Lineage 5 Lineage 6 
SNPs (Sreevatsan 
et al., 1997) 
PGG1 PGG1 PGG1 PGG2, 3 PGG1 PGG1 
SNPs (Baker et al., 
2004) 
Lineage IV Lineage I Lineage III Lineage II Not done Not done 



















SNPs (Gutacker et 
al., 2006) 




Not done Not done 










Not done Not done 
Spoligotyping 
(Brudey et al., 
2006) 
EAI Beijing CAS Haarlem, 
LAM, T, X, U 
AFRI2 AFRI1 
LSP marker RD239 RD105 RD750 Pks15/1 - 
7bp 
RD711 RD702 








Not known Not known 
Geographical 
association 

























Other information Ancestral 
strains 
(TBD1 +) 




PGG: principle genetic group, LAM: Latin-American Mediterranean, LCC: low copy clade, CAS: Central Asian 
strains, EAI: East African Indian, AFRI1: M. africanum type 1, AFRI2: M. africanum type 2. Table adapted from 
Gagneux and Small 2007 (Gagneux and Small, 2007).  
2.6. WHOLE GENOME SEQUENCING OF M. TUBERCULOSIS  
With the rapid advances in next generation sequencing techniques and the decrease in its cost, 
several of the MTC members, various strains of M. tuberculosis and other Mycobacterium species 
have been subjected to whole genome sequencing (WGS), which provides genetic information with a 
much greater resolution than previous methods (Bentley et al., 2012; Chan et al., 2012; Cole et al., 
1998; Fleischmann et al., 2002; Gardy et al., 2011; Pan et al., 2011).  
When the first whole genome sequence of M. tuberculosis (of the laboratory strain H37Rv) was first 
published in 1998, it was envisaged that phenotypic variation would be readily explained by the 
underlying genetic features. However, the genome sequence of M. tuberculosis in combination with 
various genetic typing techniques has not provided an unambiguous understanding of the underlying 
mechanisms of pathogenicity. Recent advances in the field of TB research together with the rapid 
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decline in the cost of WGS technologies made genetic characterisation of different strains much more 
accessible, plausible and feasible in a research and diagnostic environment (Ford et al., 2012). These 
advances have also brought about the characterisation of various strains of M. tuberculosis and the 
differences on multiple biological levels between these strains are currently being extensively explored. 
The biological grounds of pathogenicity and disease presentation due to M. tuberculosis infection are 
largely unknown, therefore research on both bacterial and host level continues.  
The tools that are currently employed to monitor and control TB outbreaks do not provide sufficient 
evidence about the directionality and the sequence of transmission events for cases arising over a 
short period of time and fail to capture the true dynamics of an outbreak (Roetzer et al., 2013). The 
unprecedented resolution that WGS offers, enables the study of molecular epidemiology over short 
periods of time as well as the micro-evolutionary events observable during transmission (Walker et al., 
2013). WGS permits the assessment of the aptitude of M. tuberculosis to mutate over the course of an 
infection in its natural host context with minimum bias and optimum sensitivity (Bryant et al., 2013; 
Ford et al., 2012). Whole genome sequencing of MTC members is quickly becoming the gold standard 
for various research applications for the simple reason that it provides an unparalleled means to detect 
genetic diversity between isolates. 
To date, whole genome sequencing has been applied to evolutionary studies, transmission 
investigations and preliminary studies to observe the dynamics of host-pathogen co-evolution. The 
potential of whole genome sequencing as a molecular epidemiology tool has been recognised due to 
its sensitivity to detect intermittent genetic events, and the comprehensive ability to detect several 
forms of genetic variation. It has been demonstrated that whole genome sequencing has the capability 
to replace current genotyping methods used in molecular epidemiology. Future technologies aim to 
improve the chemistry in order to produce longer read lengths with the aim to resolve these repeat 
elements and decrease the cost involved. 
2.7. THE LATIN AMERICAN-MEDITERRANEAN GENOTYPE 
2.7.1. INTRODUCTION  
Epidemiological studies have revealed two major families of M. tuberculosis to be the cause of TB 
globally, the Beijing- and the LAM family. The Beijing family of M. tuberculosis has been extensively 
reviewed and is the topic of many TB-related studies – present and past. The LAM-genotype is clearly 
of great importance due to its high prevalence, not only in South-Africa but also in other African 
countries such as Zambia and Zimbabwe as well as Latin-America and the Mediterranean regions 
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(Chihota et al., 2007; Lazzarini et al., 2007), and the need for an in-depth investigation of this 
genotype is apparent.  
The LAM family of strains has been the subject of many studies during the last decade due to its 
world-wide prevalence. Its position in the evolution of M. tuberculosis is shown in Figure 2.6.1, which 
represents a summary of the general evolution of M. tuberculosis as previously reported (Baker et al., 
2004; Gutacker et al., 2002; Hershberg et al., 2008). A wide range of phenotypic and genetic 
















Figure 2.6.1. A summary of the evolution of M. tuberculosis, showing the evolutionary position of lineage 
4 (to which the LAM genotype belongs) 
2.7.2 EPIDEMIOLOGY 
The LAM lineage is endemic to Latin-America and the Mediterranean region, which includes coastal 
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(Fanning, 1994; Lazzarini et al., 2007). Worldwide, the group 2 LAM genotype strains of M. 
tuberculosis are the cause of approximately 15% of all TB cases (Brudey et al., 2006). Tuberculosis 
caused by a subset of the LAM genotype of M. tuberculosis, termed RDRio M. tuberculosis was found 
in four continents out of five examined and is thus not confined to a specific area (Gibson et al., 2008). 
LAM and Beijing genotypes of M. tuberculosis commonly cause tuberculosis in Russian prisons 
(Drobniewski et al., 2002; Shemyakin et al., 2004; Ignatova et al., 2006). The majority of LAM strains 
have been shown to contain an IS6110 in a unique position in the plcA gene. This specific IS6110 
insertion site serves as a genetic marker for the LAM-RUS family (Dubiley et al., 2007).  
It has recently been shown that the Euro-American lineage, which includes the LAM lineage, is largely 
accountable for MDR-TB outbreaks in Latin-America and Spain (Ritacco et al., 2011). The LAM 
genotype is a prevalent cause of tuberculosis in South Africa, especially in the Western Cape and 
KwaZulu-Natal provinces of the country (Streicher, 2007; Victor et al., 2004). In Cape Town, Western 
Cape, South Africa, the strain responsible for causing the highest number of TB cases is LAM strain 
family F11. A 2004 study reported that 21.4% of TB cases in this area are attributed to this strain 
(Victor et al., 2004). F11 was also shown to cause TB in several other countries around the world, on 
various continents (Victor et al., 2004). The LAM3 lineage was only first observed to cause 
tuberculosis in Asia in 2008, therefore it was accepted that LAM strains were not a very common 
cause of TB in Asia (Chuang et al., 2008).  
2.7.3. GENETIC CHARACTERISTICS 
A 7-bp region of difference in the pks15/1 (polyketide synthase) gene was shown to differentiate the 
major Euro-American lineage of M. tuberculosis (Gagneux et al., 2006; Gibson et al., 2008; 
Marmiesse et al., 2004). Interestingly, the Euro-American lineage consists of both members of PGG2 
and PGG3 of M. tuberculosis, but not ancestral strains (i.e. members of PGG1) (Huard et al., 2006; 
Marmiesse et al., 2004). Furthermore, it was shown that the 7-bp deletion in the pks15/1 gene is 
associated with the katG463 SNP, CGG (Gibson et al., 2008).  
Genome-wide SNP analysis has been used to infer phylogeny of the strains of M. tuberculosis (Baker 
et al., 2004; Filliol et al., 2006; Gutacker et al., 2006). Nine phylogenetic lineages were distinguished 
by Gutacker et al. (2006), SNP cluster VI consists of ~ 80% LAM strains and a subset of T strains 
(Gutacker et al., 2006). Large sequence polymorphisms (LSPs) were used by Gagneux et al. (2006) to 
create a global phylogenetic tree, which gave similar results. A SNP has been identified that is 
situated in the mgtC gene that distinguishes Haarlem strains from non-Haarlem strains, which are 
closely related to the LAM genotype of M. tuberculosis (Alix et al., 2006; Gagneux et al., 2006). A sub-
group of the LAM lineage, designated the LAM-RUS family, are characterised by a unique IS6110 
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insertion in the plcA gene, that encodes a phospholipase C protein (Dubiley et al., 2007). The LAM-
RUS family has been associated with multidrug-resistance and is a prevalent cause of disease in 
prisons in Tula and Moscow in Russia (Ignatova et al., 2006; Shemyakin et al., 2004). A LAM lineage 
specific SNP was identified in the gene encoding Ag85C (Rv0129c) at position 103 (Musser et al., 
2000). This SNP was later shown to be present in most LAM strains tested, as well as in a small 
number of non-LAM strains, the specificity and sensitivity of the Ag85C103 polymorphism in a global 
collection of strains are relatively high (Gibson et al., 2008). A study investigating SNP markers for 
antibiotic resistance has shown that a SNP in the thyA gene (Thr202Ala) does not confer resistance to 
para-aminosalicylic acid as hypothesized, but instead serves as a marker for the LAM lineage of M. 
tuberculosis (Feuerriegel et al., 2010). A synonymous LAM-specific SNP in ligB1212 was reported in a 
lineage assignation study employing high-throughput SNP typing of the 3R genes (Abadia et al., 2010). 
Recently cell wall biosynthesis-associated genes were screened for SNPs to further uncover the 
phylogeny of M. tuberculosis strains. A SNP in fbpC codon 103 (synonymous SNP, GAG to GAA) was 
identified in all LAM isolates and correlated with the findings of Gibson et al. (2008) (Chuang et al., 
2010; Gibson et al., 2008). A SNP in codon 107 (synonymous SNP, GGC to GGT) of the pimB gene 
was identified as a robust marker for lineage IV, which includes LAM, Haarlem and T strains of M. 
tuberculosis (Chuang et al., 2010).  
In 2007, a sublineage of LAM strains was identified that is the major cause of TB in Rio de Janeiro, 
Brazil. These strains are distinguished by a 26-kb deletion, the largest genomic deletion described in 
M. tuberculosis to date (Lazzarini et al., 2007). Ten genes are affected by the RDRio deletion, including 
PPE55 and PPE56. Recently RDRio LAM genotype strains of M. tuberculosis have been associated 
with MDR-TB in Ibero-America as well as in Portugal (Ritacco et al., 2011). RDRio is associated with 
the West African sub-lineage of the major Euro-American lineage of M. tuberculosis (Gibson et al., 
2008). 
RD174 is associated with the RDRio genetic marker found in a subset of members of the LAM family of 
M. tuberculosis, and is not present in any other (non-RDRio) LAM strains (Gagneux et al., 2006; Gibson 
et al., 2008). The 3 650-bp region that is deleted in RD174 includes genes involved in the hypoxia-
induced regulon (Tsolaki et al., 2004). RD174 was identified prior to the massive RDRio deletion and 
was shown to be associated with RD149 in a study characterising a collection of strains from San 
Francisco. RD149 includes the open reading frames (ORFs) Rv1572c – Rv1586c (Kato-Maeda et al., 
2001; Musser et al., 2000; Tsolaki et al., 2004). The RDRio subset of LAM genotype strains is 
commonly associated with LAM9 and LAM1 (Lazzarini et al., 2007). Furthermore, LAM1 strains 
exclusively possess the RDRio deletion (Gibson et al., 2008). These were concordant with the South 
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African F9 and F13 families (respectively LAM11 and LAM1) also commonly associated with the RDRio 
genetic marker (Gibson et al., 2008).  
The transmission and evolution of an XDR (previously MDR) F15/LAM4/KZN strain of M. tuberculosis 
in a South African setting were described in a study by Pillay and Sturm (2007). The rapid evolution 
from MDR to XDR and persistence of the strain was attributed to its effective transmission ability and 
the selective pressure of the standard TB treatment received by patients presenting with pulmonary 
TB symptoms (Pillay and Sturm, 2007).  
A group of strains, named the South Africa 1 (SAF1) family, was identified, and proved to be the 
predominant cause of TB in Zimbabwe (it caused 47.2% of TB cases included in the study) and 
Zambia (65%) (Chihota et al., 2007). These strains belong to the South African F9 family of LAM 
strains and are thus part of the RDRio sublineage of the LAM lineage of M. tuberculosis (Chihota et al., 
2007; Gibson et al., 2008). Gagneux et al. (2006) proposed that certain strains of M. tuberculosis are 
adapted to cause disease in a specific human population which may in part explain the selection and 
dissemination of SAF1 in Zambia and Zimbabwe (Chihota et al., 2007; Gagneux et al., 2006). This 
again suggests that there is some level of host-pathogen compatibility contributing to the 
predominance of a specific strain of M. tuberculosis largely causing disease in a geographically 
related community (Gagneux et al., 2006).  
In 2010, a large duplication of 350-kb was reported in two strains of the Beijing family of M. 
tuberculosis. This duplication event spans Rv3128c to Rv3427c and includes the dosR regulon 
(Domenech et al., 2010). A subsequent study found that this duplication is also present in lineage two 
and four of M. tuberculosis, and is thus not limited to the Beijing family. The large duplication has 
different boundaries in different strains, which indicates that it originated from distinct duplication 
events (Weiner et al., 2012).  
In summary, the LAM lineage of M. tuberculosis possess the following genetic characteristics: i) LAM 
strains are members of PGG2 as defined by the katG and gyrA polymorphisms, and phylogenetic 
cluster VI as defined by Gutacker et al. (2002), ii) contain a 7-bp deletion in the pks15/1 gene, iii) the 
Ag85C103 SNP, iv) the site-specific IS6110 insertion element, and v) a typical spoligotype pattern 
where spacers 21 to 24 and -33 to 36 are deleted (Brudey et al., 2006; Gibson et al., 2008; Gutacker 
et al., 2006, 2002; Sreevatsan et al., 1997). However, in a lineage assignation study utilising a high-
throughput 3R SNP typing method and spoligotypes for lineage calling ability, it was shown that 
spacers 21 and 22 are not as definitively informative for LAM strains as the deleted spacer 23 (Abadia 
et al., 2010).   
The genetic markers (SNPs, RDs and IS6110 elements) associated with the group 2 LAM genotype of 
M. tuberculosis are summarised Table 2.7.1. 
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Table 2.7.1. Summary of the genetic characteristics of the group 2 LAM genotype. 
Characteristic Details Position Start Stop Size Gene/genes involved Reference 
RD115 M. tuberculosis KZN 4207, 
1435,605, V2475, R506; 98-
R604 (LAM5); F11 (LAM3) 
n.a 453364 455971 2 607 
bp 
Rv0376c - Rv0378 (Kato-Maeda et al., 2001; 
Tsolaki et al., 2004) 
RD761 Unique to a South African 
strain from the Euro-
American lineage 
n.a 1502787 1503881 1094 bp Rv1334-Rv1336 (Gagneux et al., 2006) 
RD149 RD174 is associated with the 
presence of RD 149, 
subgroup of LAM strains 
n.a 1779264 1788512 9248 bp Rv1572c-Rv1578c (Kato-Maeda et al., 2001; 
Tsolaki et al., 2004) 
RD174 Associated with the RDRio 
deletion 
n.a 2237049 2240699 3650 bp Rv1992c-Rv1997 (Gibson et al., 2008) 
Deletion in 
pks15/1 
Micro deletion specific Euro-
American lineage 
n.a - - 7 bp Rv2946c - Rv2947c (Marmiesse et al., 2004) 






Rv3352c, Rv3353c, Rv3355c 
(Lazzarini et al., 2007) 
Deletion in 
gidB 
KZN MDR and XDR    130 bp gidB (Ioerger et al., 2009) 
IS6110 in 
plcA 
IS6110 in plcA gene, specific 
to LAM-RUS family 
n.a - n.a n.a plcA (Dubiley et al., 2007) 
SNP in katG PGG2 defining SNP codon 
95 
n.a n.a n.a   
SNP in mgtC Distinguishes Haarlem 
strains from non-Haarlem 
strains (GCG to CAC) 
Codon 
182 
n.a n.a n.a MgtC (Alix et al., 2006) 
SNP in fbpC LAM lineage specific, GAG 




n.a n.a n.a FbpC (Chuang et al., 2010; Gibson et 
al., 2008; Musser et al., 2000) 
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Table 2.7.1. Summary of the genetic characteristics of the group 2 LAM genotype. (Continues from previous page) 
Characteristic Details Position Start Stop Size Gene/genes involved Reference 
SNP in rrs C-to-T transition, 491 of the 
rrs gene Specific to F11 
491 (nt n.a n.a n.a rrs (Victor et al., 2001) 
SNP in ligB TCC (ser) to TCG (ser) 1212 
(nt) 
n.a n.a n.a LigB (Abadia et al., 2010) 
SNP in 
Rv0129c 
LAM lineage specific SNP codon 
103 
n.a n.a n.a Ag85C (Rv0129c) (Gibson et al., 2008; Musser 
et al., 2000) 




   pimB (Chuang et al., 2010) 
SNP in thyA Thr202Ala Phylogenetic 
marker for LAM genotype 
codon 
20 




Duplication in various M. 
tuberculosis lineages 
- - - 350 Kb Rv3128c – Rv3427c (Weiner et al., 2012) 
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2.7.4. PHENOTYPIC INFORMATION 
It has been shown that the genetic diversity observed in M. tuberculosis strains has important clinical 
relevance, in that different strains may present with differing disease phenotypes (Thwaites et al., 
2008). In addition to causing a severe form of pulmonary disease, the LAM family of strains exhibits a 
fitness advantage over non-LAM strains when growth rates were compared in vitro, emphasising the 
success of this group of strains (Von Groll et al., 2010). 
It was shown that different lineages of M. tuberculosis have specific patterns of cytokine induction and 
growth. Lineage four strains induce a more severe immune response in the host shown by high levels 
of interleukin (IL) 12p40 and tumour necrosis factor (TNF), in comparison with lineage 2 and 3. This 
suggests that strains have differing in vivo capabilities to optimally utilise the host milieus in different 
human populations (Sarkar et al., 2012).  
An association was shown between M. tuberculosis RDRio infection and pulmonary cavitation, 
indicating that the severity of disease caused by the RDRio LAM genotype of M. tuberculosis was 
increased in a certain setting. The phenomenon was attributed to a strategy of the strain to increase 
transmission (Lazzarini et al., 2007; Weisenberg et al., 2011). In an HIV co-infected population it was 
concluded that TB caused by SAF1/RDRio M. tuberculosis strains is associated with smoking, but 
strangely not with cavitary lung disease (Chihota et al., 2011). 
A description of the transmission and evolution of an XDR (previously MDR) F15/LAM4/KZN strain of 
M. tuberculosis in a South African setting showed rapid evolution from MDR to XDR. Persistence of 
the strain was attributed to its effective transmission ability and the selective pressure of the standard 
TB treatment received by patients presenting with pulmonary TB symptoms (Pillay and Sturm, 2007).  
LAM10 has shown a strong association with isoniazid resistance (Brown et al., 2010). The LAM F11 
strain has been identified as the most successful TB-causing strain in communities of the Western 
Cape Province in South Africa (Warren et al., 1999, 2002). LAM F11 drug-resistant isolates were 
described in a study setting in the Western Cape of South Africa (Victor et al., 2004). 
2.8. CONCLUSION 
Decades of research on tuberculosis and the etiologic agent of the disease (M. tuberculosis), its 
mechanisms of pathogenesis and persistence, have shown it to be an extremely successful pathogen 
of both humans and animals. In order to combat a disease of any sort, the biological means in which 
the agent exhibits pathogenicity has to be understood. Research on the evolution and the biological 
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grounds that account for strain differences and varying disease phenotypes of different strains of M. 
tuberculosis is thus potentially of great public health benefit.  
The LAM lineage of M. tuberculosis does not only pose a world-wide threat, but is also extremely 
prevalent in local settings, including central southern Africa (Zambia and Zimbabwe) and the Western 
Cape and KwaZulu-Natal provinces of South-Africa (Chihota et al., 2007; Mulenga et al., 2010; Viegas 
et al., 2010). A significant knowledge gap remains in the understanding of the evolution and 
diversification of the LAM lineage of M. tuberculosis strains, and the genetic and proteomic traits 
underlying its fitness advantage. Further delineating the strains of M. tuberculosis will aid in the 
comprehension of host-pathogen compatibility, population patterns, and the evolution of drug 
resistance and could ultimately advance drug- and vaccine development to combat the disease.  
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CHAPTER 3  
MATERIALS & METHODS  
3.1. INTRODUCTION 
All procedures involving the handling of live M. tuberculosis cultures were done in the Biosafety level 3 
(BSL3) laboratory in the Division of Molecular Biology and Human Genetics, 4th floor, FISAN building, 
Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg, South Africa. Strict 
BSL3 safety procedures were followed as described in the in-house departmental BSL3 safety manual. 
Care was taken to prevent any contamination of the bacterial cultures or human exposure to 
pathogenic mycobacterial cultures.  
The work described in the present study forms part of a large on-going project which received ethical 
approval from the Stellenbosch University Health Research Ethics Committee under the title: ―An 
investigation into the evolutionary history and biological characteristics of the members of genus 
Mycobacterium, with specific focus on the different strains of M. tuberculosis, other members of the M. 
tuberculosis complex and non-tuberculosis Mycobacteria (NTM)‖,  ethics reference number: 
N10/04/126.  
Methods for preparing buffers and reagents used in the experiments described in this chapter are 
included in Appendix A. All oligonucleotide sequences used to verify nucleotide variants identified by 
whole genome analysis are listed in Appendix B.  
The whole genome sequencing data analysis pipeline described in this dissertation was developed by 
the candidate to analyse the data generated for this project, as well as other ongoing research 
projects. All bioinformatics was done by the candidate unless stated otherwise (e.g. scripts written by 
colleagues).  
Sputum specimens from all new and retreatment tuberculosis cases were collected from patients who 
attended primary healthcare clinics and who resided in an epidemiological field site in Cape Town, 
Western Cape, South Africa, from January 1993 to December 2004.  These samples were subjected 
to sputum smear microscopy (fluorescent staining) and culturing in a BACTEC 460, MGIT 960 and 
Löwenstein-Jensen (LJ) medium by the National Health Laboratory Service (NHLS) or Stellenbosch 
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University laboratories to confirm the presence of M. tuberculosis. Confirmed M. tuberculosis isolates 
were subject to standard genetic characterisation by IS6110 RFLP analysis and spoligotyping 
(Kamerbeek et al., 1997; Van Embden et al., 1993). Well characterized drug susceptible M. 
tuberculosis isolates (n=50) were selected from this established sample bank for the present study. 
This isolate panel represents a mixture of different genotypes found in the Western Cape setting.  
3.2. SAMPLE SELECTION 
M. tuberculosis strains representative of the three principle genetic groups (PGG) were selected from 
the longitudinal sample bank. These strains were cultured for DNA extraction and the DNA was 
subjected to whole genome sequencing. The genetic population structure of this sample set is 
summarised in Table 3.2.1. 
Table 3.2.1 Summary of the M. tuberculosis strains subjected to whole genome sequencing.  








Strain ID Spoligotype pattern 
PGG 1 


















25 3385* Cas1/Delhi/Kili 
33 3740 Cas/Kili 














32 1123* - 
28 1595 Quebec 
9 1955 LAM 11/ZWE 
30 2005* - 
24 2026* Pre-Haarlem/X1 
26 2262 U 
2 2282 Haarlem 3 
140 2336* LCC, 4 bander 
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13 2511* LAM 1 
15 2576* LAM 4, KZN 










1 3448* Haarlem 1 





26 3656* U 
110 3933* 







160 4336* LCC, 6 bander 
11 4498 LAM 3 
150 4972* LCC, 5 bander 
7 4978* Haarlem-like T1 
11 5165 LAM 3 
26 5260* U 
13 5276* LAM 1 
4 6680 Haarlem 3 
10 7367 Haarlem 1 
22 337* T1 
PGG 3 
5 478* T2 
17 1397* T1 
16 1543* - 
18 3839* T1 
8 4302 U 
23 4472* T 
21 5330* T5 
12 5440* - 
An asterisk (*) next to the SAWC number of an isolate indicates that the spoligotype signature was not 
derived from traditional spoligotyping, but was determined using the WGS data for that isolate using 
SpolPred (Coll et al., 2012).    
3.3. MYCOBACTERIAL CULTURING FOR DNA EXTRACTION 
Clinical isolates of M. tuberculosis that were genetically characterised by IS6110 DNA fingerprinting 
and spoligotyping using the internationally standardised methods, were used. The selected isolates 
were initially cultured in BACTEC 460 tubes (12B media) or mycobacterial growth indicator tubes 
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(MGITs) at 37°C from frozen stock cultures until positive growth was detected by means of the 
BACTEC 460, 960 instruments (BD Biosciences, USA), respectively.  
Upon detection of growth the isolates were allowed to incubate until visible growth was observed. The 
BACTEC 460 or MGIT tubes were briefly centrifuged to collect bacterial growth. Two LJ slants were 
prepared for each isolate, by adding 100 µl of the bacterial growth collected from the bottom of the 
tube to each of two clearly marked LJ slants. The LJ slants were incubated at 37˚C with regular 
aeration for approximately three weeks or until sufficient growth was observed.  
3.4. EXTRACTION OF DNA 
DNA was extracted as previously described (Warren et al., 2006). In summary, after sufficient growth 
was observed, the outer surface of the LJ slants were decontaminated with Incidin Plus (Ecolab, 
Minnesota, USA) and placed in a biosafety autoclave bag and transferred to a pre-warmed fan oven at 
80°C for 1 hour to ensure heat killing. Colonies were gently scraped with a disposable 10 µl loop from 
the surface of the media and transferred to a 50 ml tube containing approximately 20 glass beads 
(4mm in diameter) and 6 millilitres of extraction buffer (5% sodium glutamate, 50 mM Tris-HCl (pH 7.4) 
and 25mM EDTA)). The 50 ml tubes containing the extraction buffer cell suspension were vortexed to 
disrupt the colonies. Lysozyme (25 mg, Roche, Germany) and RNAse A (25 µg, Roche, Germany) 
were then added and incubated after gentle mixing for 2 hours at 37°C to degrade the cell wall and to 
digest RNA. Thereafter, 600 µl of 10x proteinase K buffer (5% sodium dodecyl sulphate, 100nM Tris-
HCl (pH 7.8), 50mM EDTA) and 1.5 mg proteinase K (150 µl of a 10 mg/ml stock solution) were added 
and the suspension was incubated for a further 16 hours at 45°C to digest all bacterial proteins. An 
equal volume of phenol/chloroform/isoamyl alcohol (24:23:1) was added and mixed intermittently over 
a period of 2 hours at room temperature. After centrifugation at 3000 x g for 20 minutes, the aqueous 
phase was aspirated and an equal volume of chloroform/isoamyl alcohol (24:1) was added. After 
centrifugation at 3000 g for 20 minutes, the extracted DNA was precipitated with the addition of 600 µl 
3 M sodium acetate (pH 5.2) and an equal volume of isopropanol, and the precipitate immediately 
collected on a glass rod. The DNA was washed with 70% ethanoland was left to dry on the glass rod.  
The air-dried DNA was re-dissolved in 300 µl TE (10 mM Tris-HCl (pH 8.0), 1mM EDTA) and stored at 
-20°C. The concentration of the extracted DNA was measured using a NanoDrop spectrophotometer 
(Thermo Fisher Scientific, Waltham, Massachusetts, USA). 
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3.5. NEXT GENERATION SEQUENCING (NGS) OF ISOLATES3.5.1. NGS 
INTRODUCTION  
Sequencing and library preparation was done in collaboration with Dr Arnab Pain and Dr Abdallah M. 
Abdallah from the King Abdullah University of Technology (KAUST), Saudi Arabia, and Dr Ruth 
McNerney and Dr Taane Clark from the London School of Hygiene and Tropical Medicine (LSHTM), 
UK. The DNA isolated from the M. tuberculosis isolates selected for the present study were subjected 
to whole genome sequencing on the Illumina HiSeq2000 (Illumina, California, USA) platform using a 
paired-end approach, with 500 base fragment sizes which resulted in insert sizes between 350 and 
550 bases. The depth of coverage for all the isolates was estimated to be at least above 100 times. 
This, together with the excellent quality of the sequencing data, ensured a high level of confidence for 
identifying variation in the genomes of interest.  
3.5.2. DATA SOURCES 
The fastq whole genome sequence data files of the sequenced M. tuberculosis isolates were provided 
by KAUST and were shared via a secure file transfer protocol (FTP). The reference genomes (M. 
tuberculosis H37Rv and M. tuberculosis F11) in fasta format, genome summary information and 
summary of gene sequences were downloaded from the TB database (TBDB) at 
http://genome.tbdb.org/annotation/genome/tbdb/MultiDownloads.html. Other previously published 
Mycobacterium sp. genome sequences that were included in the analyses were downloaded from 
publically available databases and are summarised in Table 3.5.1  
 
Table 3.5.1 Published Mycobacterium sp. genomes included in the present study  
Strain name Reference Source 
M. tuberculosis 
KZN 4207 (DS) 
 ―M. tuberculosis Comparative 
Sequencing Project, Broad Institute 





KZN 1435 (MDR) 
 ―M. tuberculosis Comparative 
Sequencing Project, Broad Institute 





KZN 605 (XDR) 
 ―M. tuberculosis Comparative 
Sequencing Project, Broad Institute 





africanum lineage 5 
(5444) 
(Comas et al., 2010) ftp://ftp.broad.mit.edu/pub/annotation/mtu
berculosis/diversity 
M. tuberculosis (Comas et al., 2010) ftp://ftp.broad.mit.edu/pub/annotation/mtu
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(LAM) 1503 berculosis/diversity 
Mycobacterium 
africanum lineage 5 
(11821_03) 
(Comas et al., 2010) ftp://ftp.broad.mit.edu/pub/annotation/mtu
berculosis/diversity 
Mycobacterium 
africanum lineage 6 
(0981) 








(Miyoshi-Akiyama et al., 2012) ftp://ftp.ddbj.nig.ac.jp/ddbj_database/dra/f
astq/SRA008/SRA008875/SRX005707/ 
M. tuberculosis 
lineage 7 (Mt256) 
(Blouin et al., 2012) http://www.ebi.ac.uk/ena/data/view/ERP0
01885 
3.5.3. BIOINFORMATICS ANALYSIS OF WGS DATA  
Computational analysis was done in collaboration with Professor Alan Christoffels and Ms 
Mmakamohelo Direko (South African National Bioinformatics Institute (SANBI), University of the 
Western Cape, South Africa), (initial Linux training and advice on software packages to use for NGS 
data analysis), Dr Margaretha de Vos, Dr Ruben van der Merwe, and Mrs Michelle Daya (Department 
of Molecular Biology and Human Genetics, Stellenbosch University), (writing of scripts for data 
processing and annotation). Due to the large amounts of data included in the present study and the 
lack of feasibility to verify the magnitude of variants present in the array of isolates analysed with PCR-
Sanger sequencing, a multi-software approach was used to minimise the identification of false positive 
variants. Only variants (polymorphisms) called by all software packages employed were regarded as 
high-confidence polymorphisms.  
The workflow for the analysis of the whole genome sequences produced on the Illumina platform is 
summarised in Figure 3.5.1.  




Figure 3.5.1. The summarised workflow of the computational analysis of whole genome 
sequencing data. 
3.5.4. FASTQ FILE FORMAT 
The fastq format (Figure 3.5.2) is a text-based format for the storing of biological sequences and the 
corresponding quality information as it is recorded from the sequencer (Cock et al., 2010). 
 
Figure 3.5.2. A representative of a typical read from a fastq file produced by the Illumina 
sequencing platform version 1.5. 
The data contained in these files begin with an ‗@‘ character, which is followed by the sequence 
identifier. On the second line, the sequence is listed in raw sequence letters. The end of the sequence 
is indicated by a new line and the third line starts with a ‗+‘ character and is optionally followed by the 
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3.5.5. PHRED-SCALED QUALITY VALUES 
Phred quality scores are assigned to each base called during an automated sequencing run, such as 
those produced by NGS sequencing technologies (Cock et al., 2010). A phred score is a log value of 
the probability that a base is called incorrectly by the sequencer, such that: 
Q = -10 log10 P 
Where:  
Q = phred score  
P= error probability 
Illumina 1.5 and Sanger phred quality scores are depicted as ASCII (American standard code for 
informational change) characters with an offset of +33. The system correlates a character with a 
number. For example, the character ―=‖ represents a phred quality score of 28, that correlates to an 
error probability of 0.00158. Table 3.5.2 contains some of the quality scores and their corresponding 
ASCII characters found in the datasets analysed in the present study.  
Table 3.5.2. Examples of phred quality scores and the corresponding ASCII characters 
Phred quality score (Q) Error probability (P) 
Corresponding ASCII 
character 
02 0.63096 # 
10 0.10000 + 
15 0.03162 0 
20 0.01000 5 
25 0.00316 : 
28 0.00158 = 
30 0.00100 > 
3.5.6. NGS DATA ANALYSIS PIPELINE 
An extensive selection of specialised software is freely available to analyse high through-put next 
generation sequencing (NGS) data. However, the software available is often generic and publicly 
available pipelines do not take organism-specific genomic traits into account. These traits include 
genome size, GC-content, and characteristic repeat regions. A combination of software packages was 
used with optimised parameters, together with in-house developed scripts to compile a customised 
pipeline for the analysis of mycobacterial genomes.  
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3.5.6.1. QUALITY CONTROL 
The raw sequencing data for each isolate analysed was subject to quality control. The quality of the 
Illumina reads was assessed with FastQC and Prinseq-lite to validate the quality of the reads and to 
determine whether the data included any factors that would influence the subsequent analysis. 
FastQC is a java-based program that takes fastq files as input and the results obtained are produced 
in HTML format. FastQC analyses the raw data through a 7 step module that includes the following:  
1. The general statistics, including a description of the platform used, input file type, the amount of 
reads processed, read length and percentage GC content. 
2. Calculating the per read quality score using the mean scores of all the reads. 
3. Calculating the per base sequence content to determine the distribution of the four nucleotides 
throughout the reads. 
4. Calculating the GC content throughout the reads and comparing it to a theoretical normal 
distribution and mean value. 
5. Calculating the possibility of contamination in the reads. 
6. Calculating the number of uncalled bases throughout the reads (number of ―N‖s). 
7. Calculating the amount of duplicate sequences. 
PRINSEQ is a rapid quality control and data pre-processing tool that also produces summarised 
statistics of fastq files in tabular and graphical format (Schmieder and Edwards, 2011). A locally 
installed version of PRINSEQ, PRINSEQ-lite, was used to generate graphs presented in Chapter 4 
(Section 4.1.). The data generated by PRINSEQ include information on read length, GC content, read 
quality, sequence complexity, duplicated sequences, the presence of Ns (uncalled bases) and poly-A 
tails.  
3.5.6.2. TRIMMING OF THE READS: 
Appropriate trimming of the 3‘ ends of the reads was carried out with a simple clipper function in 
FASTX-Toolkit. While it is important to maintain good quality (phred score > 28) bases in the reads, 
read length must remain sufficient.  A balance should thus be maintained between good quality 
bases in reads (phred score > 28) and read length. These trimmed, high quality fastq files were used 
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Table 3.5.3.  Read length before and after trimming 
Read 
Read length before 
trimming (bases) 
Number of bases 
trimmed from 3’ 
end 
Resulting length of 
read (bases) 
Forward (R1) 105 35 70 
Reverse (R2) 105 35 70 
3.5.6.3. ALIGNMENT AND MAPPING 
Three independent mapping software packages were used that utilise different algorithms for mapping 
short sequencing reads to a reference genome, in this case M.tuberculosis H37Rv or M. tuberculosis 
F11. The mapping software packages that were used included BWA, which uses a Burrows-Wheeler 
transform algorithm (Li and Durbin, 2009), Novoalign release 2. 07.18 (Needleman-Wunsch algorithm) 
(Novocraft Technologies http://www.novocraft.com), and Blat-like Fast Accurate Search Tool (BFAST) 
which employs a hash table- based algorithm (Homer et al., 2009). Various free software packages 
were used to post-process the alignment files and perform quality control. 
Using three different aligners minimised the identification of false positive variants since the aligners 
use different algorithms. All the aligners employed produced an output in the Sequence 
Alignment/Map (SAM) format. This format is compact in size and allows for most operations on the 
alignment to work on a stream without loading the entire alignment into the memory. This format can 
also be indexed, allowing the efficient and fast retrieval of all reads at a specific chromosomal locus. 
BURROWS-WHEELER ALIGNER (BWA) 
BWA aligns relatively short reads to a reference genome by implementing two algorithms: BWA-short 
(for reads shorter than 200bp) and BWA-SW (for longer reads around 100kbp). BWA-short was used 
for the analyses in the present study since it does gapped global alignment, supports paired-end reads 
and produces results with a low error rate (< 3%). The program requires an indexed reference 
genome for the alignment step. This was done by using the ―faidx‖ command from SAMTools (Li et al., 
2009) and the ―index‖ command in BWA. BWA takes fastq reads as input and uses the ―aln‖ command 
to find suffix array (SA) coordinates of good hits for every read. The BWA ―aln‖ command was run 
separately for the forward and reverse reads. Subsequently the ―sampe‖ command was used to 
convert the SA coordinates into chromosomal coordinates, combining the forward and reverse read 
alignments, and thereby producing a SAM file. Default command line parameters were used for this 
alignment procedure. 
 




Novoalign aims to produce fast and accurate alignments of short reads in fastq format to a reference 
genome in fasta format. This software also requires the reference genome to be indexed. This was 
done by the ―novoindex‖ command, using a k-mer indexing size of 13 and an indexing step size of 1. 
Novoalign takes fastq reads as input and uses the Needleman-Wunsch algorithm to compute the 
alignment. The software does global gapped alignment and for this analysis the default value of 6 was 
used, thus allowing six mismatches per alignment, producing a SAM file as output. 
BFAST 
BFAST is optimised to rapidly align DNA sequencing reads with a length of between 25 and 100 
bases, to a reference genome. This algorithm creates flexible and efficient whole genome indexes to 
map reads to candidate alignment locations. Firstly, the reference genome in fasta format was made 
compatible with BFAST by running the ―bfast fasta2brg‖ command. Ten arbitrary multiple independent 
indexes were created for each reference genome used (M. tuberculosis F11 and M. tuberculosis 
H37Rv), which allows robust alignment to guard against erroneous mapping of low quality reads and 
sequence variants. The pair of fastq files for each isolate was merged with the use of a python script 
that interleaves two fastq files by writing a read and its corresponding mate one after the other 
together with the corresponding quality information in a new fastq file ([CSL STYLE ERROR: 
reference with no printed form.]). The indexes are searched by using the ―bfast match‖ command. The 
final local alignment uses a Smith-Waterman method that allows for gapped alignment, and is 
employed by using the command; ―bfast localalign‖. Finally, the alignment is converted to SAM format 
with the ―bfast postprocess‖ command. The alignment produced by the series of commands in BFAST 
does not contain read groups that are necessary for downstream analysis. Therefore the Picard tool 
―AddReadGroups‖ (http://picard.sourceforge.net/) were used to add read groups to the SAM file.  
3.5.6.4. SAM FILE VALIDATION 
The ―ValidateSamFile‖ command from Picard (http://picard.sourceforge.net) was used to report on the 
validity of the SAM file. This tool verifies the presence of read groups within the SAM file and provides 
a verification of the primary step in the genomic analysis pipeline.   
3.5.6.5. CONVERTING THE SAM FILE TO A BAM FILE  
SAMTools (http://samtools.sourceforge.net) provides a set of various utilities for manipulating and 
post-processing of SAM files (Li et al., 2009). The software package includes tools to sort, merge, and 
index SAM files. The SAMTools commands ―view‖ and ―sort‖ was used to convert the SAM alignment 
files into a sorted binary alignment (BAM) format. 
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3.5.6.6. ALIGNMENT STATISTICS   
SAMTOOLS 
SAMTools was used to compute statistics about the alignment process. The ―flagstat‖ command 
calculates the total number of reads used as input in the mapping software. Additionally it also 
calculates: the number of duplicate reads; the number of reads that mapped to the reference genome 
and the number of reads that properly paired with its mate in the opposite direction when aligned to 
the reference genome. 
QUALIMAP 
Qualimap was used to generate more comprehensive alignment statistics for the isolates analysed in 
Chapter 4, Section 4.1.  The program inspects the sequence alignment in an input SAM or BAM file 
and provides a holistic report of the data with regards, to depth of coverage of the reference genome, 
nucleotide distributions and mean and median values of the insert size (García-Alcalde et al., 2012). 
3.5.6.7. POST ALIGNMENT PROCESSING OF BAM FILES 
BAM files were subsequently processed to correct for errors incorporated during the alignment step. 
COORDINATE SORTING AND INDEXING OF BAM FILES 
The SAMTools functions ―sort‖ and ―index‖ were used to convert the BAM file in a format that is easy 
to manage and read. The BAM file is sorted by coordinate to avoid loading extra alignments into the 
computational memory. 
LOCAL REALIGNMENT AROUND IN/DELS (INSERTIONS AND DELETIONS)  
Insertions and deletions might influence the alignment of reads to the reference genome, which may 
result in many bases mismatching the reference near the misalignment (which could be misinterpreted 
as single nucleotide polymorphisms (SNPs). To minimize the number of mismatching bases across all 
reads, the Genome Analysis Toolkit (GATK) was used to locally realign misaligned sequencing reads 
(DePristo et al., 2011; McKenna et al., 2010). The first step in this process includes the identification of 
small intervals which were misaligned, by using the ―RealignerTargetCreator‖ tool. Subsequently, the 
―IndelRealigner‖ tool was used to realign the suspicious intervals to the reference genome, and 
thereby correcting the misaligned reads. 
CO-ORDINATE SORTING AND INDEXING OF REALIGNED BAM FILES 
The realigned BAM files were sorted with Picard‘s ―sortsam‖ function and indexed with the ―index‖ 
function of the SAMTools software package. 
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REMOVAL OF PCR DUPLICATES 
Duplicate reads may be produced by PCR amplification during library construction. To lessen the bias 
introduced by PCR amplification, the Picard command ―MarkDuplicates‖ was used to locate duplicate 
reads in the BAM file, which was then flagged in the output BAM file. 
3.5.6.8. VARIANT CALLING 
Two independent variant callers were used to identify SNPs and short insertions and deletions (in/dels) 
with regards to the reference genome used for the alignment. The three different mapping files 
obtained from the previous step were analysed with two SNP callers – SAMTools and GATK (Li et al, 
2009; McKenna et al, 2010; DePristo et al, 2011). The resulting variants are contained in six variant 
call format (vcf) files. The GATK was also used to identify small insertions and deletions from each of 
the mappings, resulting in three vcf files containing possible in/dels for each isolate analysed. The use 
of three mapping algorithms with two variant callers minimised the identification of false positive 
variants. 
GATK 
The ―UnifiedGenotyper‖ tool from the GATK was used for SNP and indel calling and produced an 
output in the variant call format (vcf) format. The Stand_call_conf value was set to 50. This allows a 
minimum phred-scaled confidence threshold of 50, variants with a confidence value greater than or 
equal to 50 are reported as polymorphic sites. The Stand_emit_conf value was set to 10. Variants with 
a phred-scale confidence value greater than or equal to 10 but less than the calling threshold of 50 are 
reported but marked as filtered. The output vcf file contains information about the position, the 
alternative sequence and the phred scaled probability that the polymorphism exists at this position. 
The phred scale (Q) is defined as a property which is logarithmically related to the probability that 
there might be an error in the actual base-calling. Q = -10log10, a value of 10 indicates that there is a 1 
in 10 chance of error. The vcf file also contains information specific to the alternative base, including 
the number of reads bridging that position, as well as the number of reads that contained the 
reference and alternative base at that position. 
SAMTOOLS 
The SAMTools function; ―mpileup‖ was used to create a pileup of the reads relative to the reference 
genome and subsequently identifies SNPs relative to the reference sequence. Default parameters 
were employed. In/dels called by SAMTools were excluded from the subsequent analysis. The vcf file 
produced by SAMTools contains information about the position, the alternative sequence and quality 
score in phred scale of each variant. The file also contains specific information about the variant, 
including the number of reads aligning to that position. 
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3.5.6.9. EXTRACTION OF OVERLAPPING SNPS GENERATED BY THE VARIOUS 
PIPELINES 
The SNPs called by the combination of all the mappers and variant callers that overlap in both position 
and base identity were written to a high-confidence vcf file with the use of an in-house script, for each 
reference strain used. The in-house script is called run_snp_overlap.sh and was written by Mrs. 
Michelle Daya. This script makes use of the R statistical package to compare the SNPs identified by 
each pipeline (R Development Core Team, 2005). These high confidence SNPs were then used in 
subsequent analyses.   
As discussed previously, three different aligners (BWA, Novoalign and BFAST) and two different 
variant callers (GATK and SAMTools) were used to minimize the identification of false positive 
variants (see Figure 3.1). Therefore, six strategies (pipelines) where used to identify SNPs, these were 
BWA-GATK, BWA-SAMTools, Novoalign-GATK, Novoalign-SAMTools, BFAST-GATK and BFAST-
SAMTools. For indel calling, only three pipelines were used: BWA-GATK, Novoalign-GATK and 
BFAST-GATK. Thus variants were only considered in further analysis if identified with all pipelines 
used. In-house script run_snp_overlap.sh was used to extract overlapping SNPs generated by all six 
pipelines. For this purpose, SNPs present in both vcf files created by BWA-GATK and BWA-
SAMTools were first extracted and written to a new vcf file containing all SNPs identified in the BWA-
mapping with high confidence. Likewise, SNPs present in both of the vcf files created by Novoalign-
GATK and Novoalign-SAMTools were also extracted, and the same procedure was followed for vcf 
files created by BFAST-GATK and BFAST-SAMTools. SNPs present in all three of these newly 
created vcf files were extracted to create a final vcf file that contains high confidence SNPs identified 
by all six pipelines. A similar approach was followed to extract in/dels present in three vcf files created 
by BWA-GATK, Novoalign-GATK and BFAST-GATK. The statistical package R (http://www.r-
project.org) was used to create Venn diagrams to illustrate the distribution of variants created with the 
respective pipelines.  
3.5.6.10. ANNOTATION AND FUNCTIONAL CLASSIFICATION OF SNPS/IN/DELS 
Perl scripts written by Mrs Margaretha de Vos were used to: 1) annotate the identified high confidence 
SNPs, 2) calculate the consequent amino acid change caused by SNPs located within genes (if any), 
3) annotate the identified in/dels 4) calculate the effect of in/dels on the reading frame of the 
corresponding genes. The genes in which the variants occur were classified according to its cellular 
function as described on the TubercuList knowledge base (Cole et al., 1998; Lew et al., 2011). The 
scripts are included in Appendix E.  
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3.5.6.11. CONSTRUCTION OF A PHYLOGENETIC TREE 
A python script (see Appendix E) written by Mrs. Michelle Daya was used to create a concatenated 
sequence of all high confidence SNPs identified for each isolate. The principle of this method is 
illustrated by the following example: 
 
Reference strain partial genome sequence:  ATGCAGTTGCGCACAGCTGCGGAT 
Strain A partial genome sequence:   ATCCAGTACCGCACCGCTGCGGAT 
Strain B partial genome sequence:   ACGCAGTTCCGCACAGGTGCGCTT 
 
Concatenated SNP strings: 
Reference:      TGTGACGAT 
Strain A:      TCACCCGAT 
Strain B:      CGTCAGCTT 
 
The concatenated sequences containing informative sites were saved in multi-fasta format and 
aligned using ClustalW (Larkin et al., 2007). The alignment was saved in the Phylip format (.phy) and 
was used as input in Modelgenerator to determine the optimal substitution model that fits the data 
structure (Felsenstein, 1989; Keane et al., 2006). The general time reversal (GTR) model scored the 
lowest in the hierarchical likelihood ration test; Bayesian information criterion (BIC), and thus 
described the substitution pattern occurring in the dataset most accurately. The GTR model of 
substitution was subsequently applied to construct a maximum likelihood phylogeny of the isolates 
included in this analysis with MEGA 5.2, RaxML and PhyML with 1000 bootstrap replicates (Guindon 
and Gascuel, 2003; Stamatakis, 2006). The phylogenetic trees produced by the different algorithms 
were compared for similarity of the nodes.  
3.5.6.12. IDENTIFICATION OF LARGE DELETIONS 
Genome-wide depth of coverage was determined with a specialised function in the BEDTools software 
package, for each BAM file produced by BWA, Novoalign and BFAST, respectively (Quinlan and Hall, 
2010). The depth of coverage files were searched for regions that have zero depth of coverage, i.e. no 
reads mapped to these regions on the reference genome used during mapping. This step outputs a 
file with a list of positions that indicate possible deletions. However, visual inspection of every region 
was required in order to determine if the region indicated is a true deletion, since false deletions are 
commonly picked up with this approach. Sequencing in highly repetitive regions or regions with a high 
GC content may present some difficulty and are often erroneous. Mapping stringency may contribute 
to the fact that these regions are often flagged as deletions in this approach, which is why visual 
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inspection is of the essence. Again, large deletions present in at least two of the three mapping files, 
were considered as high confidence deletions and were subjected to PCR verification and sequencing 
to determine the exact loci of the deletion boundaries.   
3.5.6.13. VALIDATION OF HIGH CONFIDENCE VARIANTS 
High confidence variants (large deletions) identified in the analysis of sequenced genomes were first 
validated by visualisation using Artemis (Carver et al., 2011; Rutherford et al., 2000). Subsequently 
primers were designed to amplify and/or sequence the surrounding regions of the variants as 
described in Section 3.7. 
3.6. POLYMERASE CHAIN REACTION (PCR) 
PCR reactions were performed using the HotStar-Taq system (Qiagen, Venlo, Limburg, Netherlands) 
in 25 µl reaction volumes. The PCR master-mix consisted of 1x Q-solution, 1x reaction buffer, 2mM 
MgCl2, 200µM of each deoxyribonucleotide triphospate (dNTP), 50 µM forward primer, 50µM internal 
reverse primer, 50µM reverse primer, 1.25 U Hotstar Taq polymerase, 1 µl of the DNA template (50 
ƞg/µl), and H2O to make up the reaction to a final volume of 25 µl. PCR reactions took place in a 
thermal cycler (GeneAmp PCR System 2400, Applied Biosystems, Foster City, CA, USA) under the 
following thermo-cycling conditions: an initial denaturing step at 95ºC for 15 minutes, followed by 35 
cycles of: (a) a denaturing step at 94ºC for 1 minute, (b) an annealing step at the Tm of the primers 
included in the specific reaction for 1 minute, (c) an extension step at 72ºC for 1 minute (depending on 
the expected size of the PCR products, allocating 1 minute per 1000 bp), and a final extension step at 
72ºC for 15 minutes. All PCR experiments included a negative control containing no DNA template 
and a positive control (M. tuberculosis H37Rv genomic DNA) which does not contain the deletion 
being tested for. 
3.7. GEL ELECTROPHORESIS 
A 1.5% agarose solution was prepared by dissolving 1.5 g of agarose in 100 ml 1x sodium borate (SB) 
buffer (pH 8.3) and heating the solution in a microwave until fully disolved. Once the mixture has 
cooled, 5 µl ethidiumbromide (10 mg/ml) was added and the agarose was cast into a gel tray and 
allowed to cool to room temperature. The PCR product (25 µl) was mixed with 5 µl of blue loading dye 
(0.25% Xylene Cyanol, 30% glycerol) and a 5 µl aliquot wasloaded onto the gel. A 100 bp Plus DNA 
ladder (GeneRuler, Thermo Scientific, USA) was loaded into a well adjacent to the samples to allow 
for the determination of the size of the amplified DNA samples. The gel was run at 120 V for 
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approximately 3-4 hours in 1x SB buffer and visualized under ultra violet light using the Kodak Digital 
Science Electrophoresis Documentation and Analysis System 120 (VilberLourmat, France).  
3.8. PREPARATION OF MTB.  CULTURES FOR PROTEIN EXTRACTION 
Clinical isolates of M. tuberculosis that were genetically characterised by IS6110 DNA fingerprinting 
and spoligotyping using the internationally standardised methods, were used. The selected isolates 
were initially cultured in mycobacterial growth indicator tubes (MGITs) at 37°C from frozen stock 
cultures until positive growth was detected by means of the BACTEC 960 instrument (BD Biosciences, 
USA).  
MGIT tubes were briefly centrifuged to collect bacterial growth at the bottom of the MGIT tube. A 
dilution series of the bacterial suspension was prepared in Middlebrook 7H9 (Becton, Dickinson and 
Company, Sparks, USA) liquid medium, supplemented with 0.2% glycerol, 10% albumin, dextrose, 
catalase (ADC) (Merck Laboratories, Saarchem, Gauteng, SA) and 0.1% Tween 80 (Becton, 
Dickinson and Company, Sparks, USA). For a ten times dilution, 100 µl of the bacterial suspension 
was added to 900 µl of supplemented 7H9 liquid medium. From this dilution, 100 µl was added to 900 
µl supplemented 7H9 liquid medium in order to obtain a 100 times dilution. For each isolate included in 
this study, 100 µl of concentrated bacterial suspension from the MGIT culturing tube was spread out 
on a Middlebrook 7H10 (Becton, Dickinson and Company, Sparks, USA) agar plate, supplemented 
with 0,5% Glycerol and 10% ADC aseptically. Also, 100 µl of the ten- and 100 times dilution were 
spread out on supplemented Middlebrook 7H10 plates, respectively, for each isolate. The culturing 
plates were incubated at 37°C for approximately seven days. The duration of the incubation period 
varied slightly between strains/isolates, as fitness vary amongst the members of different strains 
included for investigation in this study. The period of incubation was extended until single colonies 
were easily visible on the surface of the media, if necessary. Five single colonies were picked for each 
isolate under investigation. Single colonies were carefully removed from the culturing media with a 
disposable pipette tip and inoculated in 5 ml of supplemented 7H9 liquid media, in 25 cm2 culturing 
flasks (Greiner Bio-one, Maybachstreet, Germany). The culturing flasks were incubated at 37˚C 
without shaking. Cultures were incubated until an optical density (OD) reading of between 0.6 and 1.0, 
measured as arbitrary units, was reached at the wavelength of 600 ƞm. Multiple glycerol freezer 
stocks were made by adding 500 µl of the bacterial culture to 500 µl 50% glycerol. These glycerol 
stock cultures were stored at -80°C until needed for inoculation of cultures for protein extraction.  
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3.9. ZIEHL-NEELSEN STAINING 
In order to ensure that the rest of the experiments proceed successfully, Ziehl-Neelsen (ZN) staining 
was performed on each isolate, every isolate was also plated on a blood agar plate to confirm the 
absence of contamination. Blood agar plates with mycobacterial culture were incubated at 37°C for 
two to three days. If no growth was present on the blood agar plates, and the Ziehl-Neelsen procedure 
confirmed the absence of non-acid fast bacteria, cultures were considered to be pure and free of 
contamination. For ZN staining, a small amount of liquid culture from each isolate was fixed 
individually on a microscope slide. The microscope slides with bacterial culture were heat fixed at 
85°C for two hours after which the slides were flooded with carbolfuchsin. Flooded slides were heated 
with a flame until the liquid on the slides was steaming. Slides were flooded with carbolfuchsin again if 
necessary and left for 5 minutes. The slides were subsequently rinsed with water and drained of 
excess liquid. Slides were flooded with 1% acid alcohol and left to destain for approximately 2 minutes. 
The acid alcohol was removed by rinsing the slides with running water and draining the slides of 
excess liquid. Slides were flooded with methylene blue and left to stand for roughly 2 minutes, after 
which the slides were rinsed with running water and drained of excess water. Slides were left to dry 
completely before analysing the slides with a light microscope under an oil immersion objective lens. 
The absence of non-acid fast bacteria was confirmed.  
3.10. MYCOBACTERIAL CULTURING FOR PROTEIN EXTRACTION 
M. tuberculosis cultures selected for proteomic analysis were cultured from the glycerol stocks 
prepared as described above in Section 3.9. The analysis for each strain selected was performed in 
duplicate on biological level. For this purpose, two of the glycerol stock cultures (prepared from one 
single colony inoculated in liquid culture) were used to obtain two separate starter cultures, from each 
of which a final volume of 50 ml was inoculated for whole cell lysate protein extraction. Each 1 ml 
glycerol stock culture was inoculated into 10 ml 7H9 Middlebrook growth medium supplemented with 
0.2% glycerol, 0.1% Tween 80 and 10% dextrose, catalase and incubated at 37°C until it reached an 
A600 (absorbance or optical density reading at 600 ηm) of between 0.6 and 0.8. (Note that no albumin 
was included in the growth media used to culture isolates subjected to proteomic investigation as the 
added protein may have an influence on the protein fingerprint obtained for each isolate via mass 
spectrometry.)  One millilitre of the starter culture was inoculated into 50 ml albumin-free 
supplemented 7H9 Middlebrook medium and subsequently incubated at 37°C until the culture reached 
an OD of between 0.6 and 0.7 at 600 ƞm. A growth curve experiment was performed for all strains 
cultured for whole cell lysate protein extraction by measuring the OD at regular time intervals for a 
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period of 20 days. It was determined that the M. tuberculosis cultures used in the present study 
reached a mid-log (middle logarithmic) growth phase at an OD (A600) of between 0.6 and 0.7. Care 
was taken to ensure that all cultured isolates used for whole cell lysate protein extractions and 
subsequent protein analysis were at a similar OD at the time of harvesting to ensure comparability 
between different strains evaluated by mass spectrometry.  
3.11. PREPARATION OF CRUDE MYCOBACTERIAL EXTRACTS 
The mycobacterial cells were cultured as described in Section 3.3 and harvested by means of 
centrifugation for 10 minutes, at 2500 g and 4°C. The supernatant was decanted into sterile 50 ml 
tubes and the cell pellet was resuspended in 1 ml of cold lysis buffer containing 10 mM Tris-HCl , pH 
7.4 (Merck Laboratories, New Jersey, USA), 0.1% Tween 80 (Sigma-Aldrich, Missouri, USA), 200 μl of 
protease inhibitor cocktail (Roche Applied Bioscience, Penzburg, Germany). Resuspended cells were 
transferred into 2 ml cryogenic tubes with O-rings. The resuspension was centrifuged at 13 000 g for 1 
minute, followed by one minute on ice, and the process was repeated. The supernatant was removed 
by pipetting and discarded. An equal volume of 0.1 mm glass beads (Biospec Products Inc, 
Bartlesville, OK) was added to the pellet of cells together with 300 µl of cold lysis buffer and 10 µl of 
RNase-free DNase I (Thermo Scientific, Massachusetts, USA). The cells were subsequently lysed 
mechanically by ribolysing 6 times for 20 seconds at a speed of 4.0, after each ribolysing step the cells 
were cooled on ice for 1 minute. The crude lysate was centrifuged at 13 000 g for one minute, kept on 
ice for one minute, and centrifugation was repeated. The supernatant was retained and filter-sterilised 
twice through a 0.22 micron Acrodisc 25mm PF syringe filter (Millipore, Massachusetts, USA), 
aliquoted in 100 µl aliquots and stored at -80˚C until further analysis. The culture media was filter 
sterilised in the same manner and stored at -80˚C for future analysis.  
3.12. PROTEIN FRACTIONATION AND IN-GEL TRYPSIN DIGEST 
The protein concentration was determined by using the commercial RC-DC Protein assay (Bio-Rad 
Laboratories, California, USA), following the manufacturer‘s instructions. A total of 60 µg of whole cell 
lysate protein extract made up to a total volume of 20 µl was mixed with 6 × Laemmli buffer and 
heated for 5 minutes at 95 ˚C. The total volume of protein extract and sample buffer was loaded on a 
1.0 mm NuPAGE gel (Invitrogen, Carlsbad, CA, USA) with a gradient of 4 – 12%. For each biological 
replicate, the proteins were fractionated in duplicate by running the SDS-PAGE at 150 V for 
approximately 1 hour, or until the dye has reached the bottom of the gel. After electrophoresis, the gel 
was stained for one hour with Imperial™ Protein Stain (Thermo Scientific, Massachusetts, USA), 
whilst shaking. The gel was destained in double distilled water overnight to remove excess stain and 
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the gel was inspected to make sure that the lanes were uniform and that proteins were not degraded 
in the previous steps.  
Each lane of the gel was divided into 10 approximately equal fractions and each fraction was cut into 
1mm2 sized cubes and added to a sterile 1.5 ml centrifuge tube. Fractions were washed with 300 µl 
HPLC grade water for 10 minutes at room temperature, after which the water was removed by 
pipetting. A volume of 300 µl 50% acetonitrile (ACN) (Sigma-Aldrich, Misourri, USA) was added to the 
fractions for 10 minutes at room temperature, after which the ACN was removed by pipetting. This was 
followed by 300 µl of 50 mM ammonium bicarbonate (ABC) (Sigma-Aldrich, Misourri, USA) and a 
further incubation step at room temperature for 10 minutes, after which the ABC was also removed. 
The wash cycle was repeated 3 times to remove excess dye from the gel pieces. Three hundred µl of 
100% ACN was added to each fraction and was removed after 10 minutes. The fractions were dried in 
a centrifugal evaporator for approximately one hour. After the fractions were dried, 120 µl of 10 mM 
dithiothreitol (DTT) (Sigma-Aldrich, Misourri, USA) was added to each fraction to reduce the disulphide 
bonds in the proteins. The fractions were incubated at 56 ˚C and the DTT was removed after 1 hour, 
after which 120 µl of 55 mM iodacetamide (IAA) (Sigma-Aldrich, Misourri, USA) was added to each 
fraction and incubated in the dark at room temperature for 1 hour. IAA alkylates catalytic cysteine 
residues. The IAA was removed when the incubation time was over and the fractions were washed by 
adding 300 µl of 55 mM ABC and incubating the fractions at room temperature for 10 minutes. The 
ABC was removed and 300 µl of 50% ACN was added to each fraction. After 10 minutes of incubation 
at room temperature, the ACN was removed and the fractions were dried in a centrifugal evaporator 
for approximately 1 hour to remove the ACN. The reduced and alkylated proteins were digested with 
sequencing grade modified trypsin (Promega, Fitchburg, Wisconsin) by adding 80 µl of 10 ng/µl 
trypsin solution to each fraction, and incubating the mixture at 37˚C for 17 hours. To quench the 
reaction, 80 µl 70% ACN, 0.1% formic acid (FA) (Sigma-Aldrich, Misourri, USA) was added to each 
fraction. After 30 minutes, the supernatant of each fraction was removed and added to a sterile 1.5 ml 
centrifuge tube. The peptide mixtures were desalted using STAGE-tips packed with C18 resin and 
dried in a centrifugal evaporator for one hour. 
3.13. MASS SPECTROMETRY 
The dried peptides obtained from the previous step were submitted to the Stellenbosch University 
Central Analytical Facility (CAF) for analysis by means of Mass Spectrometry by Dr. S. Smit. Dried 
peptides were dissolved in 5% acetonitrile in 0.1% formic acid and 10 µl injections were made for 
nano-LC chromatography. All experiments were done on a Thermo Scientific EASY-nLC II connected 
to a LTQ Orbitrap Velos mass spectrometer (Thermo Scientific, Germany) equipped with a nano-
Stellenbosch University  http://scholar.sun.ac.za
43 
 
electropsray source. For liquid chromatography, separation was performed on an EASY-Column (2 cm, 
ID 100µm, 5 µm, C18) pre-column followed by XBridge BEH130 NanoEase column (15 cm, ID 75 µm, 
3.5 µm, C18) with a flow rate of 300 ƞl/min. The gradient used was from 5-17% B in 5 min, 17-25% B 
in 90 min, 25-60% B in 10 min, and 60-80% B in 5 min and kept at 80% B for 10 min. Solvent A was 
100% water in 0.1% formic acid, and solvent B was 100% acetonitrile in 0.1% formic acid. The mass 
spectrometer was operated in data-dependent mode to automatically switch between Orbitrap-MS and 
LTQ-MS/MS acquisition. Data were acquired using the Xcaliber software package (Thermo Scientific, 
Germany). The precursor ion scan MS spectra (m/z 400 – 2000) were acquired in the Orbitrap with 
resolution R = 60000 with the number of accumulated ions being 1 x 106. The 20 most intense ions 
were isolated and fragmented in linear ion trap (number of accumulated ions 1.5 x 104) using collision 
induced dissociation. The lock mass option (polydimethylcyclosiloxane; m/z 445.120025) enabled 
accurate mass measurement in both the MS and MS/MS modes. In data-dependent LC-MS/MS 
experiments, dynamic exclusion was used with 60 s exclusion duration. Mass spectrometry conditions 
were 1.8 kV, capillary temperature of 250°C, with no sheath and auxiliary gas flow. The ion selection 
threshold was 500 counts for MS/MS and an activation Q-value of 0.25 and activation time of 10 ms 
were also applied for MS/MS.  
3.14. PROTEIN IDENTIFICATION 
All acquired data was processed and analysed using MaxQuant 1.2.2.5 (Cox and Mann, 2008) as part 
of the service provided by CAF. MaxQuant is a united suite of algorithms that were specifically 
developed for the analysis of high-resolution, quantitative mass spectrometry data. The algorithms 
employ correlation analysis and graph theory to detect peaks, isotope clusters and labelled peptide 
pairs as three-dimensional objects in mass to charge ratio (m/z). It uses elution time and signal 
intensity space (area) to determine peptide sequences. The statistical plugin, Perseus, is used to do 
all downstream statistical analysis on the MaxQuant data files and peak intensity is used to infer 
relative abundance. The elution profiles of the peaks detected in the first mass spectrometry scan 
(MS1) is used to determine the area under the curve as a measure of abundance in order to compare 
peaks in samples that are being compared (Cox and Mann, 2008). 
A total of 120 RAW files which accounted for a total of 240 hours of acquisition time were submitted 
for protein identification using the TbDB H37Rv (GB:AL123456) and custom database as previously 
reported (de Souza et al., 2011, 2010). Carbamidomethyl cysteine was set as fixed modification, and 
oxidized methionine, N-terminal acetylation (protein), deamidation (NQ), pyro-Glu(Gln) and pyro-
Glu(Glu) as variable modifications. The precursor mass tolerance was set to 20 ppm, and fragment 
mass tolerance set to 0.8 Da. Two missed tryptic cleavages were allowed. The following criteria were 
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applied: peptide and protein false discovery rate of 1% (0.01), minimal peptide length of six, and a 
protein posterior error probability (PEP) of 0.01 and peptide PEP of 0.15. These extremely strict 
parameters guarantee that proteins are identified with high confidence. Each protein identified was 
assigned to a functional category of proteins as defined by Cole et al. (1998) and summarised on the 
TubercuList knowledge base (Lew et al., 2011).    
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CHAPTER 4  
RESULTS & DISCUSSION           
4.1. QUALITY CONTROL  
4.1.1. INTRODUCTION 
Whole genome sequencing of clinical isolates from the Western Cape region in South Africa was done 
in collaboration with the King Abdullah University of Science and Technology (KAUST), and the 
sequencing process and data analysis pipeline are explained in detail in Chapter 3 (Section 3.8). 
Several measures were taken to ensure high quality sequencing and mapping of data in order to call 
variants with high confidence. In order to control for the quality of the sequencing technology and 
alignment strategies employed to analyse the large amounts of data generated during the present 
study, two clinical isolates from the local setting (SAWC 4498 and SAWC 5165) were used as controls 
to validate the NGS data analysis pipeline. These isolates were identified as fully drug susceptible M. 
tuberculosis F11 LAM strains by standard genotyping methods, and were selected based on the fact 
that they are members of the same M. tuberculosis strain family as the fully sequenced M. 
tuberculosis F11 strain. These isolates were subjected to whole genome sequencing on the Illumina 
HiSeq 2000 platform and the customised pipeline was used to analyse the WGS data. The reads 
obtained for these strains were aligned to the completed sequence of M. tuberculosis F11 (Section 
4.1.1), sequenced by the Broad Institute (M. tuberculosis Diversity Sequencing Project, Broad Institute 
of Harvard and MIT (http://www.broadinstitute.org/)), as well as the completed genome sequence of 
the M. tuberculosis H37Rv laboratory strain (Section 4.1.2). The M. tuberculosis F11 strain was the 
first drug resistant strain to be sequenced and the second clinical isolate of M. tuberculosis of which 
the completed sequence was produced (Victor, 2005). The F11 strain has been isolated from TB 
patients around the world and is particularly prevalent in the Western Cape Province, South Africa. 
The genome sequence of the F11 strain revealed that it had multi-drug resistance conferring 
mutations in katG315 (AGC to ACC) and rpoB531 (TCG to TTG).  
The M. tuberculosis F11 strain family lack spoligotype spacers 9 to 11, 21 to 24, and 33 to 36 (Warren 
et al., 1999), which is consistent with the spoligotype patterns of SAWC 4498 and SAWC 5165 (Table 
3.1). F11 isolates are members of PGG2 based on the SNPs in the katG463 (CGG) and gyrA95 (ACC) 
genes. The evolution of the PGG-defining SNPs in katG and gyrA is shown in Figure 4.1.1. 
























Figure 4.1.1. PGG-defining SNPs in gyrA and katG. 
All members of F11 have a C – T polymorphism in rrs491 (Victor et al., 2001). From the published 
sequence of the M. tuberculosis F11 sequence, a 1094 bp deletion with respect to M. tuberculosis 
H37Rv was revealed. This region contains the genes Rv1334 – Rv1336, and is known as RD761 
(Gagneux et al., 2006; Victor et al., 2004). Other LAM specific, and F11 genetic markers with respect 
to the reference genome, M. tuberculosis H37Rv, are listed in Table 2.1.4, Chapter 2. All of these 
genetic markers characteristic to M. tuberculosis F11 were confirmed in the two M. tuberculosis F11 
isolates (SAWC 4498 and SAWC 5165) analysed in this chapter of the present study.   
 
Mycobacterium prototuberculosis 
katG463 CTG (Leu) 
gyrA95 ACC (Thr) 
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4.1.2 READ ASSESSMENT AND TRIMMING 
The quality of the raw sequencing reads in the forward and the reverse orientation were assessed for 
both of the M. tuberculosis F11 LAM strains using open-access quality control tools. FastQC and 
PRINSEQ-lite, were used to assess the quality of the reads and the consequent mapping steps 
(―Babraham Bioinformatics - FastQC A Quality Control tool for High Throughput Sequence Data,‖ n.d.; 
Schmieder and Edwards, 2011). The quality of the raw sequencing data was considered and trimming 
of the reads were done accordingly. Figure 4.1.2.A and 4.1.2.B shows quality scores for the raw reads 
obtained for SAWC 4498 in the forward and the reverse orientation, respectively. The reads were 105 
bases long and the quality scores in phred scale deteriorated towards the ends of the reads, 
consistent with previous observations (Claesson et al., 2010). The average and mean values of the 
quality scores at the base position in the read indicated that 35 bases should be trimmed from the 5`-
ends of the sequencing reads. Trimming resulted in reads that were 70 bases long with average phred 
scaled quality values above 28, which translates to a sequencing error probability of 0.00158. The 
quality of the trimmed reads in the forward and reverse orientation is depicted in Figure 4.1.2.C and 
4.1.2.D, respectively.  
 
Figure 4.1.2. The per base quality of the sequencing reads for SAWC 4498.   
A. The per base quality graph for the forward reads (R1) of SAWC 4498 before trimming.   
B. The per base quality graph for the reverse reads (R2) of SAWC 4498 before trimming.   
C. The per base quality graph for the forward reads (R1) of SAWC 4498 after trimming.   
D. The per base quality graph for the reverse reads (R2) of SAWC 4498 after trimming.   
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Similarly, Figure 4.1.3.A and 4.1.3.B illustrates the quality of the raw sequencing reads respectively in 
the forward and reverse direction obtained for SAWC 5165. The average and mean values of the 
quality scores at the base position in the read were used to indicate that 35 bases should be trimmed 
from the 5`-ends of the sequencing reads. The trimming procedure resulted in reads that were 70 
bases long with average phred scaled quality values above 28. The quality of the trimmed reads in the 
forward and reverse orientation is shown in Figure 4.1.2.C and 4.1.2.D respectively. 
 
Figure 4.1.3. The per base quality of the sequencing reads for SAWC 5165.   
A. The per base quality graph for the forward reads (R1) of SAWC 5165 before trimming.   
B. The per base quality graph for the reverse reads (R2) of SAWC 5165 before trimming.   
C. The per base quality graph for the forward reads (R1) of SAWC 5165 after trimming.   
D. The per base quality graph for the reverse reads (R2) of SAWC 5165 after trimming.   
 
The pre-processing and quality control of raw sequencing data is the first crucial in silico step to 
ensure that high quality data is used as input in the next generation sequencing (NGS) analysis 
pipeline. Table 4.1.1 summarises the number of sequencing reads obtained for SAWC 4498 and 
SAWC 5165, the read lengths before and after trimming, as well as the GC content of the reads. The 
number of reads can provide an approximate indication of the coverage of the genome of interest by 
multiplying the total number of reads (in the forward and reverse orientation) with the original read 
length to obtain the total number of bases generated by the sequencing run for a specific isolate. The 
expected size of the genome of interest divided by the total number of bases generated gives an 
estimated indication of the average coverage of the entire genome. This estimate can be used as a 
preliminary screen to evaluate whether enough data has been generated; however more 
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comprehensive and reliable coverage statistics can be obtained after the pre-processed reads have 
been mapped to a reference genome. When members of a species with a high GC content is 
sequenced GC content of the reads should reflect the expected genomic GC content, as PCR- and 
sequencing errors can occur and may lead to sequencing bias where GC-rich areas of the genome of 
interest are not covered sufficiently.  
Table 4.1.1. Summary of sequencing reads for SAWC 4498 and SAWC 5165 
  SAWC 4498 SAWC 5165 












Number of reads 2 976 575 2 976 575 4 000 000 4 000 000 
Read length 105 105 105 105 
GC content 64% 65% 65% 65% 











Number of reads 2 976 575 2 976 575 4 000 000 4 000 000 
Read length 70 70 70 70 
GC content 64% 64% 64% 64% 
4.1.3. READ ALIGNMENT AND MAPPING STATISTICS 
Three autonomous mapping software packages were used that employ different algorithms for 
mapping short sequencing reads to the reference genomes used for the analysis in this chapter, i.e. M. 
tuberculosis F11 and M. tuberculosis H37Rv, respectively 
(http://genome.tbdb.org/annotation/genome/tbdb/MultiDownloads.html). The mapping software 
packages that were used included BWA that uses a Burrows-Wheeler transform algorithm (Li and 
Durbin, 2009), Novoalign release 2.07.18 (Needleman-Wunsch algorithm) (Novocraft Technologies 
http://www.novocraft.com), and Blat-like Fast Accurate Search Tool (BFAST) which employs a hash 
table-based algorithm (Homer et al., 2009), as described in Chapter 3, Section 3.8.6. 
All the aligners used for mapping sequencing reads to a reference genome produced an output in the 
Sequence Alignment/Map (SAM) format. Qualimap, a Java application that considers sequence 
features and their genomic properties to provide graphical and statistical evaluation of the data in SAM 
or BAM format, was used to obtain mapping statistics for the M. tuberculosis F11 strains pertaining to 
the present analysis (García-Alcalde et al., 2012). Selected mapping statistics obtained with Qualimap 
for the alignments of SAWC 4498 and SAWC 5165, to the reference genomes M. tuberculosis F11 
and M. tuberculosis H37Rv, are summarised in Table 4.1.2. The range of values obtained for each of 
the parameters listed in Table 4.1.2 reflects the divergent algorithms employed by the mapping 
software packages used. The repetitive nature of sections of the M. tuberculosis genome provides 
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challenges for whole genome sequencing and the bioinformatics analysis of the data generated. 
Aligning algorithms may map a read to the wrong location in the reference genome, especially around 
repetitive areas of other low-complexity regions. Using multiple aligners thus minimises the 
identification of false positive variants called for each isolate, since different algorithms were used to 
map sequencing reads to the reference genome.  
Table 4.1.2. Summary of alignment statistics for SAWC 4498 and SAWC 5165 
  
SAWC 4498 SAWC 5165 
  
















96.05% 95.85% 97.72% 96.51% 96.18% 98.22% 
Mean coverage 
89.01   
(+/- 23.87) 
89.26   
(+/- 21.07) 










47.52 56.74 69.61 48.17 57.16 69.68 
Mean insert size - 252.07 252.08 - 220.35 220.41 
Number of 
mapped bases 
393817300 394935034 350853342 551051003 552049399 488927395 
  




















95.79% 95.37% 97.23% 96.25% 95.72% 97.77% 
Mean coverage 
88.97   
(+/- 24.2) 
89.09   
(+/- 21.74) 










47.47 56.72 69.59 48.12 57.14 69.66 
Mean insert size - 252.01 252.03 - 220.32 220.37 
Number of 
mapped bases 
392515657 392754834 348621137 549169463 549108114 486392010 
4.1.4. HIGH CONFIDENCE VARIANTS 
4.1.4.1. M. TUBERCULOSIS F11 AS REFERENCE GENOME 
Three different aligners (BWA, Novoalign and BFAST) and two independent variant callers (GATK and 
SAMTools) were used to minimize the identification of false positive SNPs. Therefore, six pipelines 
where used to identify SNPs, these were BWA-GATK, BWA-SAMTools, Novoalign-GATK, Novoalign-
SAMTools, BFAST-GATK and BFAST-SAMTools. For in/del calling, only three pipelines were used: 
BWA-GATK, Novoalign-GATK and BFAST-GATK. SNPs present in both vcf files created by BWA-
GATK and BWA-SAMTools were first extracted and written to a new vcf file containing all SNPs 
identified in the BWA-mapping with high confidence. Likewise, SNPs present in both of the vcf files 
created by Novoalign-GATK and Novoalign-SAMTools were also extracted, and the same procedure 
was followed for vcf files created by BFAST-GATK and BFAST-SAMTools. SNPs present in all three 
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of these newly created vcf files were extracted to create a final vcf file that contains high confidence 
SNPs identified by all six pipelines. A similar approach was followed to extract in/dels present in three 
vcf files created by BWA-GATK, Novoalign-GATK and BFAST-GATK. The statistical package R 
(http://www.r-project.org) was used to create Venn diagrams to illustrate the distribution of variants 
identified with the respective pipelines. The Venn diagrams shown in Figure 4.1.4.A and -B depicts the 
number of SNPs that are identical in position and base identity and which overlap between the 
pipelines for SAWC 4498 and SAWC 5165 respectively. A total number of 79 high confidence SNPs 
were identified in SAWC 4498 compared to the M. tuberculosis F11 reference genome (Figure 
4.1.4.A). The SNPs identified by only one or two of the three pipelines were not regarded as true 
variants. Upon further inspection it was shown that mapping quality at the positions of these SNPs 
only identified by one or two of the pipelines was low. The M. tuberculosis SAWC 5165 isolate differed 
from the M. tuberculosis F11 reference genome by 65 high confidence SNPs (Figure 4.1.4.B).  
 
 
Figure 4.1.4. SNPs in SAWC 4498 and SAWC 5165. A. SNPs called with SAMTools and GATK using the 
alignments obtained from different mapping algorithms for SAWC 4498, employing M. tuberculosis F11 as a 
reference genome. B. SNPs called with SAMTools and GATK using the alignments obtained from different 
mapping algorithms for SAWC 5165, employing M. tuberculosis F11 as a reference genome. 
The Venn diagrams shown in Figure 4.1.5.A and -B depicts the number of high confidence in/dels that 
overlap, and are unique to SAWC 4498 and SAWC 5165, respectively. A total number of 14 high 
confidence in/dels were identified in SAWC 4498 compared to the M. tuberculosis F11 reference 
genome (Figure 4.1.5.A). The in/dels identified by only one or two of the three pipelines were not 
regarded as true variants, upon further inspection it was shown that the alignment algorithms often did 
not agree on the start and end positions of the in/dels, despite realignment around in/dels being done. 
A B 
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Mapping quality around the positions of these in/dels only identified by one or two of the pipelines was 
low. The M. tuberculosis SAWC 5165 isolate differed from the M. tuberculosis F11 reference genome 
by 10 high confidence in/dels (Figure 4.1.5.B).  
Fig
ure 4.1.5. In/dels in SAWC 4498 and SAWC 5165. A. In/dels called with GATK using the alignments obtained 
from different mapping algorithms for SAWC 4498, employing M. tuberculosis F11 as a reference genome. B. 
In/dels called with GATK using the alignments obtained from different mapping algorithms for SAWC 5165, 
employing M. tuberculosis F11 as a reference genome. 
The M. tuberculosis clinical isolates, SAWC 4498 and SAWC 5165, which were analysed for the 
purpose of this chapter were both confirmed to be members of the LAM family of strains, more 
specifically the F11 subfamily, as determined by their spoligotype patterns and characteristic IS6110 
RFLP fingerprints, and thus belong to the same family as the reference strain, M. tuberculosis F11. 
Even though these isolates are members of the same family as the reference strain and seemingly 
closely related to one another, a relatively large number of variants were identified between the 
isolates and the reference strain used in the mapping steps of the bioinformatics analysis. The 
diversity of the strains highlights the diversity of the pool of strains present in the high TB incidence 
setting from which these strains were isolated. Also, the extent to which whole genome sequencing 
provides an unparalleled means to detect genetic diversity between isolates is emphasised. Figure 
4.1.6.A shows a Venn diagram of the SNPs that overlap and are unique to SAWC 4498 and SAWC 
5165 with regards to the M. tuberculosis F11 reference strain. SAWC 4498 and SAWC 5165 share 33 
common SNPs and have 46 and 32 SNPs respectively that are unique to the two strains (in position 
and base identity). SAWC 4498 and SAWC 5165 share six in/dels with respect to M. tuberculosis F11 
and have eight and four unique in/dels, respectively (Figure 4.1.6.B). 
A B 




Figure 4.1.6. Overlapping variants between SAWC 4498 and SAWC 5165. A. SNPs that overlap in position 
and base identity between, or unique to, SAWC 4498 and SAWC 5165, employing M. tuberculosis F11 as a 
reference genome. B. In/dels that overlap in length, start- and end position and base identity between, or unique 
to, SAWC 4498 and SAWC 5165, employing M. tuberculosis F11 as a reference genome. 
SNPs unique to SAWC 4498 and SAWC 5165 respectively, with regards to the M. tuberculosis F11 
reference strain, and overlapping between these two isolates, were annotated. Annotation includes 
determining whether the SNP falls in between two coding regions (i.e. is situated in an intergenic 
region) or if it falls within a gene (i.e. it is intragenic). SNPs that occur intragenically were further 
assessed for being either non-synonymous (resulting in an amino acid change in the translated protein 
product) or synonymous (not resulting in an amino acid change in the translated protein product). 
Furthermore, the genes in which the SNPs occur were assigned to functional categories according to 
the TubercuList knowledge base as first described by Cole et al., 1998 (Lew et al., 2011). Table 4.1.3, 
4.1.4 and 4.1.5 summarises the annotated SNPs unique to, and shared between SAWC 4498 and 
SAWC 5165. The in/dels unique to, and shared between SAWC 4498 and SAWC 5165 are 
summarised in Table 1, Appendix C.  
Of the 46 high confidence unique SNPs identified in SAWC 4498 (not identified in SAWC 5165), five 
were intergenic. Of the remaining 41 SNPs, 27 led to non-synonymous changes whilst 14 were 
synonymous. A large proportion (roughly one third) of the genes of M. tuberculosis has an unknown 
function, as can be seen by the number of SNPs found in genes that are annotated as ―conserved 
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Table 4.1.3 Analysis of SNPs unique to SAWC 4498 




































Cell wall and cell 
processes 
4 Cell wall and cell 
processes 
























Lipid metabolism 5 Lipid metabolism 4 Lipid metabolism 1 
PE/PPE protein 
families 
1 PE/PPE protein 
families 





3 Insertion sequences 
and phages 
3 Insertion sequences 
and phages 
0 
Hypothetical 4 Hypothetical 3 Hypothetical 1 
Intergenic 5 -  -  
Total 46 Total 27 Total 14 
 
Table 4.1.4 shows that one SNP of the total number of 32 high confidence SNPs that were identified 
uniquely for SAWC 5165 (not found in SAWC 4498) with respect to the M. tuberculosis F11 reference 
strain was intergenic. Of the remaining 31 SNPs, 20 led to non-synonymous changes and 11 were 
synonymous. A total number of 11 and 5 SNPs were annotated as ―conserved hypothetical‖ and 
―hypothetical‖, respectively.  
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Table 4.1.4 Analysis of SNPs unique to SAWC 5165 
 
Annotation of SNPs overlapping between SAWC 4498 and SAWC 5165 revealed that five common 
SNPs were intergenic, whilst 18 of the total number of 33 common SNPs led to non-synonymous 
changes. Ten of the overlapping SNPs were synonymous (Table 4.1.5). The reference strain of M. 
tuberculosis F11 used for alignment in this section is multi-drug resistant and contains the drug 
resistance conferring mutations; katG315 (AGC to ACC) and rpoB531 (TCG to TTG), with respect to 
the drug-susceptible reference strain M. tuberculosis H37Rv. The two clinical isolates studied in the 
present section are drug susceptible and are thus not expected to harbour these mutations. Due to the 
approach of this quality control exercise, it is expected that the two isolates should have SNPs at 
katG315 (ACC to AGC) and rpoB531 (TTG to TCG), since the drug resistant strain is used as a 
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and phages 
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Hypothetical 5 Hypothetical 3 Hypothetical 2 
Intergenic 1 -  -  
Total 32 Total 20 Total 11 
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reference in this section. The nucleotide sequence corresponding to katG315 and rpoB531 were 
indeed AGC and TCG respectively, thus indicating that the strains are susceptible to the first line anti-
tuberculosis drugs isoniazid and rifampicin and the validity of the quality of the analysis. 
Table 4.1.5 Analysis of overlapping SNPs between SAWC 4498 and SAWC 5165 
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4.1.4.2. M. TUBERCULOSIS H37RV AS A REFERENCE GENOME 
The pre-processing and quality control of raw sequencing data was repeated for SAWC 4498 and 
SAWC 5165 with M. tuberculosis H37Rv as the reference genome, as described in Section 4.1.1.2. 
The high quality trimmed reads were used as input in the NGS analysis pipeline as reported in Section 
4.1.1.3, with the exception that M. tuberculosis H37Rv was used as the reference genome during the 
read alignment step, and consequent high confidence variants are reported with respect to M. 
tuberculosis H37Rv.  
The multi-software approach described in Chapter 3, Section 3.8.6 was used to identify variants in 
SAWC 4498 and SAWC 5165, with respect to M. tuberculosis H37Rv. Figure 4.1.7.A and -B show the 
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number of SNPs that are identical in position and base identity that overlap between the pipelines for 
SAWC 4498 and SAWC 5165, respectively. A total number of 789 high confidence SNPs were 
identified in SAWC 4498 compared to the M. tuberculosis H37Rv reference genome (Figure 4.1.7.A). 
The SNPs identified by only one or two of the three pipelines were not regarded as true variants. The 
M. tuberculosis SAWC 5165 isolate diverged from the M. tuberculosis H37Rv reference genome by 
816 high confidence SNPs (Figure 4.1.6.B). 
 
Figure 4.1.7. SNPs in SAWC 4498 and SAWC 5165. A. SNPs called with SAMTools and GATK using the 
alignments obtained from different mapping algorithms for SAWC 4498, employing M. tuberculosis H37Rv as a 
reference genome. B. SNPs called with SAMTools and GATK using the alignments obtained from different 
mapping algorithms for SAWC 5165, employing M. tuberculosis H37Rv as a reference genome. 
The Venn diagrams shown in Figure 4.1.8.A and -B portrays the number of in/dels that are identical in 
start- and end position (length) for SAWC 4498 and SAWC 5165 respectively, in comparison with the 
M. tuberculosis H37Rv reference genome. A total number of 62 high confidence in/dels were identified 
in SAWC 4498 compared to the M. tuberculosis H37Rv reference genome (Figure 4.1.8.A). The 
in/dels identified by only one or two of the three pipelines were not regarded as true variants, upon 
further inspection it was shown that the alignment algorithms often did not agree on the start and end 
positions of the in/dels, despite realignment around in/dels being done. Mapping quality around the 
positions of these in/dels only identified by one or two of the pipelines was low. The M. tuberculosis 
SAWC 5165 isolate differed from the M. tuberculosis H37Rv reference genome by 64 high confidence 
in/dels (Figure 4.1.8.B). 
 




Figure 4.1.8. In/dels in SAWC 4498 and SAWC 5165. A. In/dels called with GATK using the alignments 
obtained from different mapping algorithms for SAWC 4498, employing M. tuberculosis H37Rv as a reference 
genome. B. In/dels called with GATK using the alignments obtained from different mapping algorithms for SAWC 
5165, employing M. tuberculosis H37Rv as a reference genome.  
The heterogeneity of the strains again highlights the diverse pool of strains present in the high TB 
incidence setting from which these strains were isolated. Figure 4.1.9.A shows a Venn diagram of the 
SNPs that overlap and are unique to SAWC 4498 and SAWC 5165 with respect to the M. tuberculosis 
H37Rv reference genome used in the analyses. SAWC 4498 and SAWC 5165 share 728 mutual 
SNPs and have 88 and 61 SNPs respectively that are unique to the strain (both in position and base 
identity). SAWC 4498 and SAWC 5165 share 56 in/dels with regards to M. tuberculosis H37Rv and 
have eight and six unique in/dels, respectively (Figure 4.1.9.B). 
 




Figure 4.1.9. Overlapping variants between SAWC 4498 and SAWC 5165. A. SNPs that overlap in position 
and base identity between, or unique to, SAWC 4498 and SAWC 5165, employing M. tuberculosis H37Rv as a 
reference genome. B. In/dels that overlap in length, start- and end position and base identity between, or unique 
to, SAWC 4498 and SAWC 5165, employing M. tuberculosis H37Rv as a reference genome. 
When the M. tuberculosis F11 strain was first sequenced and published, a 1094 bp deletion with 
respect to M. tuberculosis H37Rv was identified. This region contains the genes encoding Rv1334 – 
Rv1336 (Gagneux et al., 2006; Victor et al., 2004). The deletion named RD761 is thought to be 
characteristic to the M. tuberculosis F11 strain family. The approach followed in this study allowed for 
the identification of the deletion in SAWC 4498 and SAWC 5165, as shown in Figure 4.1.10 and 
Figure 4.1.11, respectively, confirming the identity of SAWC 4498 and SAWC 5165.  
The alignments of a small genomic section done with the three different alignment algorithms; BFAST, 
BWA and Novoalign, for SAWC 4498, using M. tuberculosis H37Rv as reference genome, is shown in 
Figure 4.1.9.A, -B, and C, respectively. The section of the M. tuberculosis H37Rv genome shown 
includes Rv1334 – Rv1336, the genes deleted in M. tuberculosis F11 strain family (Gagneux et al., 
2006; Victor et al., 2004). In the BFAST alignment (Figure 4.1.10.A) there are no reads mapping to the 
genomic region from position 1 502 787 to 1 503 881, whilst there are spurious reads mapping to this 
region in the BWA- and Novoalign alignments (Figures 4.1.10.B and –C). The spurious reads are in all 
probability erroneously mapped to this region in these two alignments. The M. tuberculosis F11 clinical 
isolate SAWC 4498 visibly harbours RD761.  




Figure 4.1.9. Alignment of reads across the genomic region containing Rv1334 – Rv1336 in SAWC 4498. 
A. A screenshot of the visualisation of the BFAST alignment of the raw sequencing reads of SAWC 4498 to the 
M. tuberculosis H37Rv reference genome, indicating the presence of RD761. B. A screenshot of the 
visualisation of the BWA alignment of the raw sequencing reads of SAWC 4498 to the M. tuberculosis H37Rv 
reference genome, indicating the presence of RD761. C. A screenshot of the visualisation of the Novoalign 
alignment of the raw sequencing reads of SAWC 4498 to the M. tuberculosis H37Rv reference genome, 
indicating the presence of RD761. 
The alignments across the genomic section spanning Rv1334, Rv1335, and Rv1336, in the genome of 
SAWC 5165 is shown in Figure 4.1.11.A, -B, and -C, respectively. The alignments produced by the 
three different alignment algorithms show the expected read coverage of the region upstream from the 
genomic position 1 502 787 and downstream to position 1 503 881, whilst there are spurious reads 
mapping to the genomic region between 1 502 787 and 1 503 881, spanning Rv1334 – Rv1336. The 
spurious reads are in all likelihood incorrectly mapped to this region. The M. tuberculosis F11 clinical 
isolate SAWC 5165 evidently harbours RD761.  
 




Figure 4.1.11. Alignment of reads across the genomic region containing Rv1334 – Rv1336 in SAWC 5165. 
A. A screenshot of the visualisation of the BFAST alignment of the raw sequencing reads of SAWC 5165 to the 
M. tuberculosis H37Rv reference genome, indicating the presence of RD761. B. A screenshot of the 
visualisation of the BWA alignment of the raw sequencing reads of SAWC 5165 to the M. tuberculosis H37Rv 
reference genome, indicating the presence of RD761. C. A screenshot of the visualisation of the Novoalign 
alignment of the raw sequencing reads of SAWC 5165 to the M. tuberculosis H37Rv reference genome, 
indicating the presence of RD761. 
The M. tuberculosis F11 genotype isolates analysed here also contain RD 149 (see Table 2.4.1), 
which was accurately detected in the WGS analyses of both SAWC 4498 and SAWC 5186 (data not 
shown).  
4.1.5 SUB-CONCLUSIONS 
In Section 4.1, the accuracy and quality of the customised NGS data analysis pipeline was evaluated 
and it was shown to be highly accurate. The pre-processed paired end reads mapped nearly equally 
well to both reference genomes employed. In general, only 0.26 – 0.49% more reads mapped to the M. 
tuberculosis F11 reference genome than to the M. tuberculosis H37Rv reference genome. Expectedly, 
considerably fewer SNPs and small in/dels were identified when mapping the reads to the M. 
tuberculosis F11 reference genome, than mapping to –H37Rv. This was expected, as M. tuberculosis 
H37Rv (a member of PGG3) is situated much further from the clinical isolates than M. tuberculosis 
F11 (a member of PGG2). All known genetic features of the M. tuberculosis F11 strain family were 
successfully identified with the analysis pipeline, highlighting the accuracy of the pipeline and 
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providing more confidence in the ability of a multi-software approach to find distinct genetic variance in 
the isolates that were analysed in this section, as well as the rest of the isolates analysed in this study. 
However, the number of variations (SNPs and in/dels) between the alignments of the reads of the two 
isolates, SAWC 4498 and SAWC 5165, to the two reference genomes employed, did not agree. The 
read-alignment algorithms that were used in the multi-software approach are largely non-heuristic and 
thus aim to find the optimal alignment for each read. A combination of the repetitive nature of the M. 
tuberculosis genome and limited read length make some level of mapping error inevitable. This is 
especially true when aligning the sequencing reads of the M. tuberculosis F11 clinical isolates to the M. 
tuberculosis H37Rv reference genome, since M. tuberculosis H37Rv is phylogenetically further 
removed from the isolates than M. tuberculosis F11. Despite some discrepancies when using the 
different reference genomes as reference in the NGS data analysis pipeline, the known genetic 
features of the M. tuberculosis F11 clinical isolates was identified with high accuracy in the clinical 
isolates (using M. tuberculosis H37Rv as reference genome). The multi-software approach, using M. 
tuberculosis H37Rv, thus proves to be reliable for the identification of fixed genetic variation between 
different M. tuberculosis clinical isolates and strain families. This approach is particularly suitable for 
phylogenetic inference described in Section 4.2 and 4.3.    
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4.2. M. TUBERCULOSIS  PHYLOGENY 
4.2.1. INTRODUCTION 
This section focusses on the reconstruction of the phylogeny of drug susceptible M. tuberculosis 
isolates from a number of M. tuberculosis strain families representative of the TB epidemic in Cape 
Town, South Africa. Fifty clinical isolates from different strain families, based on IS6110 RFLP 
fingerprints, from the local setting that were identified as fully drug susceptible M. tuberculosis strains 
were included. These strains were subjected to whole genome sequencing on the Illumina HiSeq 2000 
platform and the customised pipeline was used to align the reads obtained for these strains to the 
completed sequence of M. tuberculosis H37Rv as a reference (Chapter 3, Section 3.8.3). Ten genome 
sequence datasets of different published M. tuberculosis strains were included in the analysis (Table 
3.2). The raw sequencing data for these strains were downloaded and were also subjected to analysis 
with the customised pipeline. Mycobacterium canettii was included as a closely related outgroup 
(Hershberg et al., 2008). High confidence variants for all isolates included in the analysis were taken 
into consideration and the strings of the concatenated variants in fasta format were aligned to each 
other with ClustalW (Larkin et al., 2007). The approach followed is similar to previous phylogenetic 
studies which investigated the evolution of M. tuberculosis strains using genome wide SNPs (Comas 
et al., 2013; Gutacker et al., 2002; Namouchi et al., 2012). The resulting alignment was used to 
construct the phylogeny discussed in this section. The different cladograms obtained by different 
phylogeny software packages were compared and major nodes proved to be similar in the trees 
produced.  
4.2.2. PHYLOGENY  
A total number of 27 530 variant positions were identified in the 61 isolates (50 clinical isolates, 10 
previously published sequences, M. tuberculosis H37Rv) that were included in the analyses. The 
concatenated sequence for every isolate included all possible SNP positions identified, if the isolate 
did not contain an SNP at a specific position, the reference (M. tuberculosis H37Rv) base at that 
position was recorded to ensure that the string of nucleotide sequences recorded for each isolate 
included all of the 27 530 bases being analysed.  
4.2.2.1. M. TUBERCULOSIS GENERAL PHYLOGENY 
A comprehensive phylogenetic reconstruction of the M. tuberculosis clinical isolates and selected 
published Mycobacterium sp. based on genome wide SNPs is shown in Figure 4.2.1. In agreement 
with previous studies, Mycobacterium canettii (indicated as M_canetti in Figure 4.2.1) proves to be 
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ancestral to the evolution of the human adapted Mycobacterium species – Mycobacterium africanum 
(indicated as Maf in Figure 4.2.1) and M. tuberculosis. Likewise, M. africanum is ancestral to M. 
tuberculosis. It is evident from the phylogeny that the M. africanum lineage five isolates (5444 and 
Maf_lin5) cluster together and can be distinguished from M. africanum lineage six (MAf_lin6). 
Furthermore, the ancestral human adapted M. tuberculosis strains, the East African Indian (EAI) strain 
(SAWC 1659) and the recently reported M. tuberculosis lineage seven strain (Mtb_l7), clearly 
precedes their modern descendants (Blouin et al., 2012; Flores et al., 2007; Tsolaki et al., 2004). 
These ancestral strains (M. canettii, M. africanum, M. tuberculosis EAI and M. tuberculosis lineage 7) 
all have the TBD1 region present, in contrast with their modern descendants in which this region is 
deleted, see Figure 4.2.1 (Brosch et al., 2002).  
The three principal genetic groups based on SNPs in the katG and gyrA genes noticeably cluster in 
the phylogeny summarised in the cladogram depicted in Figure 4.2.1. The clade forming PGG1 is 
comprised of CAS- (SAWC 995, SAWC 3385, SAWC 4370, SAWC 3740), typical Beijing- (SAWC 
2701, SAWC 1116, SAWC 4570, SAWC 1125, SAWC 4437), and atypical Beijing (SAWC 6519, 
SAWC 1453) strains. The clade containing all Beijing strains (typical and atypical) is nested within the 
PGG1 clade and the CAS clade forms its sister clade.   
The evolution of PGG2 is visibly more complex than that of PGG1. The combined clade forming PGG2 
and PGG3 is a sister clade to PGG1. PGG2 is comprised of one clade, made up of the Low copy 
clade (LCC)- (SAWC 2336, SAWC 4336, SAWC 4972, SAWC 3200), pre-Haarlem- (SAWC 2026), 
Haarlem-like- (SAWC 4046, SAWC 4978) and Haarlem strains (Erdmann, SAWC 3448, SAWC 2282, 
SAWC 7367, SAWC 6680), and an evolutionary grade that includes a possible intermediary LCC 
strain (SAWC 3933), Quebec strain (SAWC 1595), the LAM strains (SAWC 4498, SAWC 5165, 
SAWC 1955, SAWC 3517, LAM 1503, SAWC 2904, SAWC 2511, SAWC 5276, SAWC 5260, SAWC 
2262, SAWC 3656, SAWC 3388, SAWC 3100, SAWC 3651, KZN 605, SAWC 2576, KZN 4207, KZN 
1435), and a group of strains with similar but undesignated spoligotype names that belong to IS6110 
RFLP family 32 (SAWC 1123, SAWC 2005). These two strains are confirmed members of PGG2 
based on the gyrA95 ACC sequence and seem to be the precursors to PGG3. From this phylogenetic 
reconstruction, it is suggested that the Erdmann strain (Miyoshi-Akiyama et al., 2012) could be a 
Haarlem precursor. The Quebec strain (SAWC 1595) is basal to the clade including the LAM family of 
strains, F32 strains and PGG3. The evolution of the LAM family of strains is shown in Figure 4.2.1 and 
-4.2.2 and will be discussed in Section 4.2.2.2. The complexity of the evolutionary relationship among 
PGG2 strains found in Cape Town, South Africa is highlighted by the phylogenetic reconstruction 
shown in Figure 4.2.1. The predominant lineages within PGG2 have evolved independently from a 
common progenitor.  
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PGG3 is comprised of a number of strains that form a clade that is nested within the major clade that 
spans over PGG2 and PGG3. PGG3 has thus evolved from an ancestral PGG2 member. PGG3 also 
includes the M. tuberculosis H37Rv laboratory strain (Mtb_H37Rv) that is employed as the reference 
strain in the current study‘s bioinformatics analysis. PGG3 represents the most modern group of M. 
tuberculosis strains and includes T-strains (SAWC 5330, SAWC 3839, SAWC 1397, SAWC 478, 
SAWC 337, SAWC 4472) as well as strains with undesignated spoligotypes (SAWC 5440, SAWC 
1543, SAWC 4302).  
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Figure 4.2.1. Genome-wide SNP-based phylogeny of M. tuberculosis clinical isolates and selected 
published genomes of Mycobacterium species. The evolutionary history was inferred by using the Maximum 
Likelihood method based on the General Time Reversible model (Nei and Kumar, 2000). The bootstrap 
consensus tree inferred from 1000 replicates is taken to represent the evolutionary history of the taxa analysed. 
The percentage of replicate trees in which the associated taxa clustered together in the bootstrap test (1000 
replicates) is shown next to the branches (Felsenstein, 1989). Initial tree(s) for the heuristic search were 
obtained by applying the Neighbor-Joining method to a matrix of pairwise distances estimated using the 
Maximum Composite Likelihood (MCL) approach. The analysis involved 62 nucleotide sequences. All positions 
containing gaps and missing data were eliminated. There were a total of 27 530 positions in the final dataset. 
Evolutionary analyses were conducted in MEGA5 (Tamura et al., 2011). 
4.2.2.2. M. TUBERCULOSIS LAM PHYLOGENY 
The comprehensive phylogenetic reconstruction of the LAM subgroup of M. tuberculosis is shown in 
Figure 4.2.2. The position of the LAM strains in the overall evolution of M. tuberculosis can be seen in 
Figure 4.2.1. The LAM group of strains is evolutionarily complex and consists of six IS6110 RFLP 
families, namely F11, F9, F13, F26, F14 and F15, forming the six LAM sub-lineages. Strains belonging 
to the six IS6110 RFLP families cluster together without exception.  
Within the clade that forms the LAM family of strains are two major sister clades. One of these clades 
consists of the LAM3 (F11) strains, the LAM11/ZWE (F9) strains, including the previously published 
LAM 1503 strain, and the LAM1 strains (F13). Within this clade, the LAM11/ZWE (F9)- and LAM1 (F13) 
strains cluster together to form a sister clade to the LAM3 (F11) clade. The second clade is comprised 
of the strains with unknown (U) spoligotypes (F26), forming a sister clade to the T1, T1-Tusc, T5/Rus 
(F14) strains and the KZN (LAM4, F15) strains.  
From the phylogenetic reconstruction (Figure 4.2.2), the LAM4 KZN (F15) clinical isolate (SAWC 2576) 
included in this study clusters with the LAM4 KZN strains sequenced by the Broad Institute. The 
clinical isolate (SAWC 3517) clusters with the KZN 605 MDR isolate to form clade nested within the 
LAM4 KZN clade. Within this clade, the KZN drug sensitive isolate and KZN XDR isolate cluster 
together. 
 





Figure 4.2.2. Genome wide SNP-based phylogeny of the LAM family of strains of M. tuberculosis. The 
evolutionary history was inferred in the same manner as described for Figure 4.2.1. This phylogenetic tree is a 
sub-tree of the general M. tuberculosis and M. africanum tree shown in Figure 4.2.1.    
4.2.3. SUB-CONCLUSIONS 
In this part of the study, the unprecedented resolution provided by whole genome sequencing for 
investigating strain differentiation and evolution was exemplified by the robust phylogenetic data 
obtained. Previous studies have employed subsets of SNPs, sequences of subsets of genes and other 
informative genetic markers to infer phylogenetic relationships among the different strains of M. 
tuberculosis (Baker et al., 2004, Filliol et al., 2006, Gutacker et al., 2006). SNPs contribute to a large 
proportion of mycobacterial genome variation and have been proved to be able to delineate closely 
related isolates from each other (Gutacker et al., 2002). The present study employed genome wide 
SNPs of all isolates included in the analysis to reconstruct the phylogeny of selected M. tuberculosis 
and M. africanum strains. The same general groupings were found when different phylogenetic 
inference software packages were used (see Section 3.5.6.11). The data showed a clonal population 
structure of M. tuberculosis consisting of distinct lineages. IS6110 RFLP families and spoligotypes 
were specifically associated with defined SNP clusters, thereby confirming the robustness of the 
results. The general phylogenetic structure shows congruence with former genotypic groupings of M. 
tuberculosis (Baker et al., 2004, Filliol et al., 2006, Gutacker et al., 2006). The general lineages of M. 
tuberculosis as defined previously by both SNPs and RDs could be resolved by this phylogenetic 
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reconstruction of the evolution of M. tuberculosis (Baker et al., 2004; Gagneux et al., 2006). This SNP-
based phylogeny also mimics the phylogeny constructed using large deletion events, taking into 
account that in M. tuberculosis genetic material is more readily lost than gained (Pym and Brosch, 
2000). This similarity is emphasised by the mapping of the RDs and IS6110 insertion sites as depicted 
in Figure 4.3.11. It is evident that in this study setting tuberculosis is caused by an assortment of 
strains imported from around the globe. This genome-wide SNP-based phylogenetic reconstruction of 
the evolution of M. tuberculosis offers novel insights into the unique global representation of the M. 
tuberculosis isolates included in the analysis. Comprehensive phylogenetic studies such as the 
present one lay the foundation for studies that examine the relationship between genotype and 
disease phenotype in large, mixed-strain sample sets.     
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4.3. FUNCTIONAL ANALYSIS OF GENETIC VARIATION IN LAM ISOLATES 
4.3.1. INTRODUCTION 
This section examines the variants that are unique to all the LAM isolates included in the present 
study, and variants unique to the LAM sub-lineages. Figure 4.3.1 shows the evolutionary relationships 
among the LAM isolates included in the phylogenetic study, the different sub-lineages are indicated in 
grey boxes and named according to the IS6110 RFLP families. These IS6110 RFLP family names will 
be used to refer to certain LAM sub-lineages or groups of sub-lineages that can be differentiated by 
specific nucleotide variants.  
 
 
Figure 4.3.1. Genome wide SNP-based phylogeny of the LAM family of strains of M. tuberculosis 
indicating sub-lineages of the LAM genotype. The different LAM sub-lineages are separated by grey boxes 
and named according to the different IS6110 RFLP families.     
4.3.2. M. TUBERCULOSIS LAM SNP ANALYSIS  
The high confidence SNPs identified in a total of 56 isolates included in the present study were 
analysed and comparisons were made between different groups of strains. M. africanum isolates and 
the M. canetti isolate were excluded when doing the SNP analysis. SNPs in the LAM group of strains 
(n=18) were compared to all non-LAM strains included in the study to identify SNPs that are uniquely 
identified in all of the LAM strains included, or sub-groups of LAM strains included, but are not present 
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in any of the non-LAM strains (n=38) included in the analysis. This analysis was not restricted to the 
clinical isolates sequenced for the purpose of this study, but included the publically available M. 
tuberculosis data. All SNPs in specific genes are comprehensively listed in Appendix C.  
4.3.2.1. LAM SPECIFIC SNPS 
As shown in Table 4.3.1, a total of 55 SNPs were shown to be uniquely present in all LAM isolates 
included in the analysis (n=18), and can thus be considered as LAM-specific SNPs. Of these 55 SNPs, 
nine are found in non-coding regions (intergenic), and of the remaining 46 SNPs, 15 were 
synonymous and 31 were non-synonymous. The large proportion of non-synonymous SNPs observed, 
is consistent with previous findings and suggests that M. tuberculosis has not been under high 
purifying selective pressure (Hershberg et al., 2008). It is hypothesised that clonal organisms such as 
M. tuberculosis undergo random mutation events. In the absence of selective pressures, synonymous- 
and non-synonymous changes are expected to be equally prevalent. When purifying selection is 
taking place, synonymous nucleotide changes are overrepresented. An overrepresentation of non-
synonymous changes indicates the presence of positive selection (Hershberg et al., 2008). However, 
it has also been shown that large numbers of non-synonymous changes may be due to the close 
relatedness of the isolates under investigation. Somewhat deleterious non-synonymous genomic 
changes that are not fixed within populations may not yet have been removed by purifying selection.   
Table 4.3.1. Functional distribution of SNPs common to all LAM isolates 
Functional category Number of SNPs Non-synonymous Synonymous 
Information pathways 7 3 4 
Conserved hypothetical proteins 10 6 4 
Cell wall and cell processes 10 9 1 
Intermediary metabolism and respiration 7 3 4 
Regulatory proteins 1 0 1 
Virulence, detoxification and adaptation 2 2 0 
Lipid metabolism 5 4 1 
Insertion sequences and phages 2 2 0 
PE/PPE 2 2 0 
Intergenic 9 - - 
Total 55 31 15 
 
Figure 4.3.2 shows the functional distribution of genes containing the SNPs common to all LAM 
isolates included in this study, but absent from all the non-LAM isolates included. Due to the high 
number of protein coding sequences classified as ―conserved hypothetical‖ or ―unknown‖, it is 
expected that a high proportion of genome wide SNPs would be assigned to this category upon 
Stellenbosch University  http://scholar.sun.ac.za
72 
 
annotation and functional assignment (Camus et al., 2002; Cole et al., 1998). Of the total number of 
55 SNPs identified in all LAM isolates that were absent from their non-LAM counterparts, 10 SNPs 
occur in genes associated with the mycobacterial cell wall and cell processes. Proteins in this category 
include membrane associated proteins as well as secreted and trans-membrane proteins (Camus et 
al., 2002). Other functional categories that were highly represented among the genes harbouring LAM-
specific SNPs are ―intermediary metabolism and respiration‖ and ―information pathways‖. Four of the 
SNPs in genes that are functionally categorised in ―information pathways‖ were found in DNA 
replication, recombination and repair genes (3R-system). Three of these SNPs occur in the highly 
mutable genes recC, dnaG and ligB (Mestre et al., 2011; Dos Vultos et al., 2008). Genes involved in 
the 3R-system are said to play a significant role in the evolution of exceedingly clonal organisms such 
as M. tuberculosis (Dos Vultos et al., 2008). Other SNPs that are LAM-specific are found in the 
functional categories ―lipid metabolism‖, ―insertion sequences and phages‖, ―PE/PPE‖, ―virulence, 
detoxification and adaptation‖, and ―regulatory proteins‖, in order of descending prevalence. These 
functional categories are however very broad and cellular processes are inherently linked. It is clear 
from the changes observed within the LAM lineage that these strains are adapting to their human 
hosts in order to ensure its survival and possibly increase its dissemination, as is the case with the 
Beijing family (Hanekom et al., 2011).   
 
Figure 4.3.2. Functional distribution of genes in which LAM-specific SNPs occur. All SNPs that are 
common to 18 LAM isolates included in this analysis were functionally annotated. The SNPs listed are not found 
in any of the non-LAM isolates included in the analysis (n=38).   
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4.3.2.2. SNPS UNIQUE TO CLADES WITHIN THE LAM GENOTYPE 
The topology of the phylogenetic tree shown in Figure 4.3.1 is determined by SNPs that occur 
uniquely in certain clades. These SNPs define the nodes and can be used to distinguish certain sub-
lineages of the LAM family of strains from each other. SNPs that are responsible for the branching 
points in the phylogenetic hypothesis depicted in Figure 4.3.1 are summarised in Table 4.3.2.  



























































































































































Information pathways 5 5 1 2 0 2 1 0 2 0 4 0 1 0 6 0 3 3 
Conserved hypothetical proteins 14 10 9 5 2 3 4 3 4 0 11 11 1 1 14 6 8 4 
Cell wall and cell processes 19 6 8 5 8 2 1 5 6 3 11 8 0 2 10 8 8 2 
Intermediary metabolism and 
respiration 
25 10 5 4 6 2 3 1 5 4 16 17 1 0 8 7 5 3 
Regulatory proteins 5 1 0 0 0 1 0 0 1 1 2 0 1 0 3 0 0 0 
Virulence, detoxification and 
adaptation 
1 2 0 2 1 1 2 0 0 0 3 3 0 0 2 2 1 0 
Lipid metabolism 11 5 1 2 2 2 0 1 3 2 6 2 2 1 5 3 7 0 
Insertion sequences and phages 2 4 0 0 0 0 1 0 0 0 0 1 0 0 1 1 0 0 
PE/PPE 9 5 0 0 3 0 1 1 1 0 8 4 1 0 4 3 3 1 
Intergenic 25 4 0 6 5 12 2 7 9 
Total: syn + non-syn + intergenic 164 48 35 30 37 119 13 90 57 
 




Table 4.3.2. Summary of SNPs unique to clades of the LAM genotype 
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SNPS UNIQUE TO LAM3 (F11) 
The LAM3 (F11) genotype of M. tuberculosis is a prominent cause of TB in the Western Cape 
province of South Africa. This genotype shares many genetic characteristics with other members of 
the LAM family. This clade can be distinguished by 164 SNPs, of which 25 are in non-coding regions. 
Of the remaining SNPs, 91 are non-synonymous and 48 are synonymous (Table 4.3.2).  
The functional distribution of the genes in which SNPs uniquely identified in the LAM3 (F11) isolates 
occur is shown in Figure 4.3.3. A large number of SNPs are located in genes coding for proteins 
involved in the intermediary metabolism and respiration, in contrast with other clades where the 
majority of the single nucleotide variation occur in genes involved in cell wall and cell processes or are 
in conserved hypothetical genes. Other highly represented functional groups include ―cell wall and cell 
processes‖ and SNPs in conserved hypothetical genes. Ten percent of the variation is found in genes 
coding for proteins involved in the lipid metabolism.  
 
Figure 4.3.3. Functional distribution of genes harbouring SNPs common to LAM3 F11 (n=2). All SNPs that 
are common to LAM3 (F11) strains were functionally annotated. The SNPs listed are not found in any of the 
other LAM (LAM4 KZN (F15), T1, T1-Tusc, T5/Rus (F14), LAM U (F26), LAM11/ZWE (F9), LAM1 (F13)) or non-
LAM isolates included in the analysis. 
 
SNPS UNIQUE TO LAM11/ZWE (F9) AND LAM1 (F13) 
In this study, 48 SNPs were identified to be unique to the clade consisting of LAM11/ZWE (F9) and 
LAM1 (F13), and were thus not identified in any of the other LAM- or non-LAM isolates included in the 
present study. Of the total of 48 SNPs uniquely identified in this subgroup of LAM isolates, only 4 are 
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found in intergenic regions. Twenty four of the SNPs identified were non-synonymous and 20 were 
synonymous (Table 4.3.2).  
The graphical presentation of the functional distribution of the genes containing SNPs distinguishing 
this group from the rest of the M. tuberculosis isolates included in this study is shown in Figure 4.3.4. 
A large proportion of the SNPs are in genes classified as ―conserved hypothetical‖. Other functional 
categories that are highly represented include ―cell wall and cell processes‖ and ―intermediary 
metabolism and respiration‖.  
 
Figure 4.3.4. Functional distribution of genes containing SNPs common to LAM11/ZWE (F9) and LAM1 
(F13) (n=6). All SNPs that are common to LAM11/ZWE (F9)- and LAM1 (F13) strains were functionally 
annotated. The SNPs listed are not found in any of the other LAM (LAM4 KZN (F15), T1, T1-Tusc, T5/Rus (F14), 
LAM U (F26), LAM3 (F11)) or non-LAM isolates included in the analysis. 
 
SNPS UNIQUE TO LAM11/ZWE (F9) 
A total number of 35 SNPs were uniquely identified in the LAM 11/ZWE isolates included in this 
analysis (see Table 4.3.2). These SNPs were not found in any of the other isolates included in this 
study, besides the LAM11/ZWE (F9) isolates. Interestingly, none of these were intergenic, 22 were 
non-synonymous and the remaining 13 were synonymous.  
The functional distribution of genes harbouring SNPs that are common to all LAM 11/ZWE isolates 
included in this study is shown in Figure 4.3.5. The majority of the SNPs that define this clade are 
found in genes coding for proteins involved in the cell wall, cell processes, intermediary metabolism 
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and respiration. Other highly represented functional categories include ―lipid metabolism‖ and 
―PE/PPE‖ gene families.  
 
Figure 4.3.5. Functional distribution of genes containing SNPs common to LAM11/ZWE (F9) (n=3). All 
SNPs that are common to LAM11/ZWE (F9) strains were functionally annotated. The SNPs listed are not found 
in any of the other LAM (LAM4 KZN (F15), T1, T1-Tusc, T5/Rus (F14), LAM U (F26), LAM1 (F13), LAM3 (F11)) 
or non-LAM isolates included in the analysis. 
 
SNPS UNIQUE TO LAM1 (F13) 
A total number of 30 SNPs were identified to be unique to the LAM1 (F13) clade, of which six are 
intergenic, 13 cause amino acid substitutions and are thus non-synonymous, and 11 are synonymous 
(Table 4.3.2).   
Figure 4.3.6 shows the functional distribution of the genes in which the SNPs uniquely identified in the 
LAM1 (F13) isolates occur. A large proportion of SNPs were identified in conserved hypothetical 
genes. Other changes occur mostly in genes coding for proteins involved in the cell wall, cell 
processes, intermediary metabolism and respiration.  




Figure 4.3.6. Functional distribution of genes containing SNPs common to LAM1 (F13) (n=3). All SNPs 
that are common to LAM1 (F13) strains were functionally annotated. The SNPs listed are not found in any of the 
other LAM (LAM4 KZN (F15), T1, T1-Tusc, T5/Rus (F14), LAM U (F26), LAM11/ZWE (F9), LAM3 (F11)) or non-
LAM isolates included in the analysis. 
 
 
SNPS UNIQUE TO LAM U (F26) T1, T1-TUSC, T5/RUS (F14), LAM4 KZN (F15) 
Table 4.3.2 summarises the SNPs found in LAM U (F26) T1, T1-Tusc, T5/Rus (F14), LAM4 KZN (F15), 
but not in any of the other LAM isolates (F11, F9 or F13) or non-LAM isolates included in the analysis. 
Of the total number of 37 SNPs uniquely identified to this sub-group of LAM isolates, 22 are non-
synonymous, 10 are synonymous and five occur in intergenic regions.  
The functional distribution of the genes in which the 37 uniquely identified SNPs in this clade occur, 
are shown in Figure 4.3.7. The functional categories ―cell wall and cell processes‖ and ―intermediary 
metabolism and respiration‖ were equally represented, each containing 9 SNPs. Other highly 
represented functional groups include genes encoding for proteins involved in lipid metabolism and 
the ―conserved hypothetical proteins‖. The high frequency of non-synonymous changes seen in the 
genes encoding for proteins involved in the cell wall and cell processes, suggests a gradual change in 
the bacteria‘s first barrier of defence against the host immune system. It is likely that, in response to 
this change, the cellular processes inherently linked to the pathways and systems involved in the cell 
wall and other cell processes such as the lipid metabolism, intermediary metabolism and general 
respiration need to compensate and adjust.  




Figure 4.3.7. Functional distribution of genes containing SNPs common to LAM U (F26)-, T1, T1-Tusc, 
T5/Rus (F14)-, and LAM4 KZN (F15) (n=10). All SNPs that are common to LAM U (F26)-, T1, T1-Tusc, T5/Rus 
(F14)-, and LAM4 KZN (F15) strains were functionally annotated. The SNPs listed are not found in any of the 
other LAM (LAM11/ZWE (F9), LAM1 (F13), LAM3 (F11) or non-LAM isolates included in the analysis. 
 
SNPS UNIQUE TO LAM U (F26) 
The LAM U (F26) isolates included in this study were shown to have 119 unique SNPs in common, 
which were not found in any of the other LAM- or non-LAM isolates investigated here. Twelve of these 
SNPs are in non-coding regions, whilst 61 cause amino acid substitutions and 46 are synonymous 
(Table 4.3.2). LAM U (F26) isolates share a large number of SNPs that distinguishes them from the 
rest of the M. tuberculosis isolates included in this study.  
Figure 4.3.8 shows the functional distribution of the uniquely identified SNPs, in isolates belonging to 
LAM U (F26), within genes in the form of a pie chart. Interestingly, the functional category; 
‗intermediary metabolism and respiration‖ shows the most variation, with 28% of the SNPs present in 
genes involved in this functional group. Other functional categories that are highly represented are the 
diverse conserved hypothetical proteins and proteins involved in the cell wall and cell processes. This 
group of strains also shows variation in the PE/PPE family of genes. As mentioned previously, 
abundant variation in these genes has been reported in literature but the reliability of the variation 
identified with NGS technologies remains questionable. Interestingly, in contrast with the SNPs that 
distinguish other subgroups of the LAM genotype, only four SNPs are found in genes coding for 
proteins involved in the information pathways. Only one of these, namely dinP, is involved in the 3R 
system.  




Figure 4.3.8. Functional distribution of genes containing SNPs common to LAM U (F26) (n=3). All SNPs 
that are common to LAM U (F26) strains were functionally annotated. The SNPs listed are not found in any of 
the other LAM (LAM4 KZN (F15), T1, T1-Tusc, T5/Rus (F14), LAM11/ZWE (F9), LAM1 (F13), LAM3 (F11)) or 
non-LAM isolates included in the analysis. 
 
SNPS UNIQUE TO T1, T1-TUSC, T5/RUS (F14) AND LAM4 KZN (F15) 
Twelve SNPs were uniquely identified in the clade consisting of T1, T1-Tusc, T5/Rus (F14) and LAM4 
KZN (F15) strains, and were not found in any of the other LAM- or non-LAM isolates included in this 
study. Thirteen SNPs were unique to this clade and the functional categories of the genes in which 
these occur are shown in Figure 4.3.9. Of these unique SNPs, two occur in non-coding regions. Four 
SNPs are synonymous and the remaining seven cause non-synonymous changes. Three SNPs were 
found in genes coding for proteins involved in the lipid metabolism and two SNPs were found in genes 
coding for proteins in the functional category; ―cell wall and cell processes‖. One SNP was found in 
Rv3263, encoding a DNA methylase, which is one of the proteins involved in the 3R system.  




Figure 4.3.9. Functional distribution of genes containing SNPs common to T1, T1-Tusc, T5/Rus (F14) and 
LAM4 KZN (F15) (n=7). All SNPs that are common to T1, T1-Tusc, T5/Rus (F14)- and LAM4 KZN (F15)  
strains were functionally annotated. The SNPs listed are not found in any of the other, LAM U (F26), 
LAM11/ZWE (F9), LAM1 (F13), LAM3 (F11) or non-LAM isolates included in the analysis. 
 
SNPS UNIQUE TO T1, T1-TUSC, T5/RUS (F14) 
A total number of 90 SNPs were uniquely identified in the T1, T1-Tusc, T5/Rus (F14) isolates, of which 
seven occur in non-coding regions, 53 cause amino acid substitutions (non-synonymous), and 30 are 
synonymous (see Table 4.3.2). Again, the high frequency of non-synonymous SNPs points to the low 
influence that natural selection has on the evolution of M. tuberculosis    
The graphical presentation of the functional distribution of the genes, in which the uniquely identified 
SNPs for this clade occur, is shown in Figure 4.3.10. A large proportion of the SNPs are in genes 
coding for proteins involved in the cell wall, other cell processes, intermediary metabolism and 
respiration. SNPs in conserved hypothetical genes make up 20% of the total number of SNPs. Four of 
the SNPs in genes involved in the information pathways occur in genes of the 3R system, three of 
which are in the hyper mutable genes; polA, nei, and dnaQ. This sub-lineage of the LAM genotype 
clearly underwent a large number of evolutionary changes that distinguishes it from the rest of the 
LAM isolates included in this study, as well as from the non-LAM isolates included.   




Figure 4.3.10. Functional distribution of genes containing SNPs common to T1, T1-Tusc, T5/Rus (F14) 
(n=3). All SNPs that are common to T1, T1-Tusc, T5/Rus (F14) strains were functionally annotated. The SNPs 
listed are not found in any of the other LAM (LAM4 KZN (F15), LAM U (F26), LAM11/ZWE (F13), LAM1 (F13), 
LAM3 (F11)) or non-LAM isolates included in the analysis. 
 
SNPS UNIQUE TO LAM4 KZN (F15) 
The LAM4 KZN isolates included in this analysis share 57 SNPs, 34 of which cause non-synonymous 
changes and 14 SNPs do not lead to amino acid changes. Of the total number of 57 SNPs uniquely 
identified in this clade, nine proved to be in intergenic regions (see Table 4.3.2).  
The functional category distribution of the genes containing SNPs uniquely identified in all isolates of 
the LAM4 KZN clade is graphically presented in Figure 4.3.11. The functional categories that are 
highly represented include the genes coding for proteins involved in cell wall and cell processes and 
intermediary metabolism and respiration. Other highly represented categories are the intergenic SNPs 
and the SNPs located in conserved hypothetical genes. Conserved hypothetical proteins could 
potentially be involved in any of the mentioned functional categories, as their respective functions are 
not yet known. Furthermore, 10% of SNPs occur in genes coding for proteins involved in information 
pathways. Three of these genes are involved in the 3R system, one of which is the hyper-mutable 
dnaQ. The SNPs in the genes of the 3R system are non-synonymous and thus have the potential to 
alter protein function. Three SNPs unique to this clade are identified within the genes coding for the 
PE/PPE family of proteins. Studies have shown that PE and PPE genes have high sequence variation. 
However, the repetitive nature of these genes makes them problematic for NGS analysis and it is 
debatable whether or not to trust variants called by NGS analysis techniques in these areas, further 
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verification is needed to make conclusions regarding all nucleotide variants identified within these 
repetitive sections of the genome. Future NGS technologies aspire to better resolve genomic regions 
with a highly repetitive nature.   
 
Figure 4.3.11. Functional distribution of genes containing SNPs common to LAM4 KZN (F15) (n=4). All 
SNPs that are common to LAM4 KZN (F15) strains were functionally annotated. The SNPs listed are not found 
in any of the other LAM (T1, T1-Tusc, T5/Rus (F14), LAM U (F26), LAM11/ZWE (F13), LAM1 (F13), LAM3 (F11)) 
or non-LAM isolates included in the analysis. 
 
SNPS UNIQUE TO 17 OF 18 LAM ISOLATES ANALYSED 
The SNPs uniquely identified in all the LAM isolates included in this study, excluding any one of the 
LAM4 KZN isolates included (n=4), are summarised in Table 4.3.3. The SNPs are thus present in 17 
LAM isolates, but absent in any one isolate in clade consisting of LAM4 KZN isolates. A total number 
of 23 SNPs were identified in this group of strains consisting of 17 LAM isolates. Of these, six are in 
non-coding regions and 8 SNPs cause amino acid changes (non-synonymous), whilst 9 are 
synonymous. The fact that these single nucleotide changes are present in all but one of the LAM 
isolates included in the analysis may be due to sequencing errors or more likely due to erroneous 
mapping or SNP calling during the NGS data analysis pipeline. Alternatively, it could suggest that 
certain SNPs might have been fixed in the LAM family at one point in time but that LAM4 KZN isolates 
are systematically reverting some of the single nucleotide evolutionary events due to speculated 
selective pressure experienced by the bacteria within the host. A total number of 28 SNPs were 
identified that are present in 17 out of 18 LAM isolates included, 23 of these were present in all LAM 
isolates except one of 5 LAM4 KZN isolates (described above), whilst the other five SNPs occur in 17 
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LAM isolates except one random isolate, not forming a particular pattern of exclusion, and not limited 
to the LAM4 KZN (F15) clade. These were not included in Table 4.3.3.  
Table 4.3.3. SNPs common to all isolates, excluding any one of 5 LAM4 KZN isolates 




Information pathways 1 0 1 
Conserved hypothetical proteins 7 4 3 
Cell wall and cell processes 6 3 3 
Intermediary metabolism and 
respiration 
2 1 0 
Regulatory proteins 0 0 0 
Virulence, detoxification and 
adaptation 
1 0 1 
Lipid metabolism 0 0 1 
Insertion sequences and phages 0 0 0 
PE/PPE 0 0 0 
Intergenic 6 - - 
Total 23 8 9 
 
4.3.3. M. TUBERCULOSIS LAM LSP ANALYSIS  
In order to identify possible LSPs (more commonly known as RDs), the depth of coverage for all of the 
alignments for each of the LAM isolates analysed was considered and the alignments across the 
genomic regions that had zero coverage (no reads mapping to that region) were inspected visually. 
This technique is time consuming and it should be noted that this approach is dependent on the 
subjective interpretation of the alignment, the nature of the genomic region in which the LSP occurs 
(mapping in repetitive or high GC regions are often erroneous), and the coverage at which the target 
genome has been sequenced. Several previously reported LSPs were identified in subsets of the LAM 
isolates analysed. A number of these LSPs were confirmed by PCR in a small subset of LAM and non-
LAM M. tuberculosis clinical isolates. PCR confirmation of a selected subset of the deletions provided 
a level of confidence to which LSPs can be called by merely considering NGS data and the 
appropriate analysis approach, as described in Chapter 3, Section 3.5.6.13. The presence or absence 
of known- and newly identified LSPs detected in analysed the M. tuberculosis LAM isolates are 
summarised in Table 4.3.4. Interestingly, RD149 has been identified in all of the LAM isolates, RD149 
is however not LAM-specific as it has been identified in other lineages of M. tuberculosis, e.g. the 
Beijing genotype (Tsolaki et al., 2004). 
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RD115 RD149 RD150 RD152 RD174 RD
Rio













2511 0 1 0 0 1 1 0 1 0 0 
2904 0 1 0 0 1 1 0 1 0 0 
5276 0 1 0 0 1 1 0 1 0 0 
F9 
LAM1503 0 1 0 1 1 1 0 0 0 0 
1955 0 1 0 1 1 1 0 0 0 0 
3517 0 1 0 1 1 1 0 0 0 0 
F26 
2262 1 1 1 0 0 0 0 0 0 1 
3656 1 1 1 0 0 0 0 0 0 1 
5260 1 1 1 0 0 0 0 0 0 1 
F14 
3100 1 1 0 0 0 0 0 0 1 0 
3388 1 1 0 0 0 0 0 0 1 0 
3651 1 1 0 0 0 0 0 0 1 0 
F15 
KZN605 1 1 0 0 0 0 0 0 0 0 
KZN1435 1 1 0 0 0 0 0 0 0 0 
KZN4207 1 1 0 0 0 0 0 0 0 0 
2576 1 1 0 0 0 0 0 0 0 0 
F11 
4498 0 1 0 0 0 0 1 0 0 0 
5165 0 1 0 0 0 0 1 0 0 0 
 
A zero (0) and a red coloured cell in the field of a specific LSP indicate the absence of that LSP in the 
corresponding isolate, the genomic region is thus present. A one (1) and a green coloured cell in the field of a 
specific LSP indicate the presence of that LSP in the corresponding isolate, the region is thus deleted. An RD 
description marked with an asterisk indicates that the particular RD was identified in the present study, Other 
RDs were previously reported.  
4.3.4. SUMMARY OF THE M. TUBERCULOSIS LAM GENOTYPE  
A previous study has identified specific IS6110 insertion sites in members of PGG2, as well as the 
loss of direct variable repeat (DVR) spacer regions across lineages of PGG2 (Streicher, 2007). Figure 
4.3.11 summarises these lineage defining events and combines it with the findings of the present 
study. The clades, as defined in Section 4.3.1, are indicated with the corresponding IS6110 RFLP 
families. The SNPs defining the different sub-lineages of the LAM genotype can thus be extrapolated 
to the lineages established in Figure 4.3.12. The presence of the identified large sequence 
polymorphisms in the form of RDs are shown on the relationship plot.  
The LAM lineage was found to consist of 6 strain families (F9, F11, F13, F14, F15, F26), that share 
common IS6110 insertions in Rv1754, Rv2352, Rv0835:Rv0836 (Streicher, 2007). According to the 
international designation, F11, F13, F15 and F9 correspond to LAM3, LAM1, LAM4 and LAM11/ZWE, 
respectively, based on their characteristic spoligotype patterns and share the characteristic deletion of 
DVR 21-24 on their spoligotype profile (Brudey et al., 2006; Filliol et al., 2002).  
 




Figure 4.3.12. Relationship plot of the M. tuberculosis LAM genotype. LSPs (RDs) are indicated as red 
arrow blocks on the branches of the RFLP families in which they are present. IS6110 insertion sites, specific 
SNPs, DVR regions lost, and the clades (defined in Section 3) to which each IS6110 RFLP family corresponds 
are indicated.  
4.3.5. NON-LAM EVOLUTION 
The SNPs identified in all the non-LAM M. tuberculosis isolates included in this analysis (thus 
excluding M. canetti and M. africanum isolates) were annotated and the genes in which the SNPs 
occur were assigned to functional categories (Figure 4.3.13). Thirteen percent of the SNPs were in 
intergenic regions. The functional categories most highly represented include ―intermediary 
metabolism and respiration‖ and ―cell wall and cell processes‖. A large number of SNPs were found in 
conserved hypothetical genes, making it challenging to infer the physiological consequences thereof. 
Other functional categories represented, in descending order of representation include ―lipid 
metabolism‖, ―PE/PPE protein families‖, ―information pathways‖, ―regulatory proteins‖, ―virulence, 
detoxification and adaptation‖, and ―insertion sequences and phages‖. This pattern of evolution is 
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similar to that seen in the LAM isolates analysed in Section 4.3.2. It can thus be said that the currently 
circulating strains of different lineages of M. tuberculosis are evolving in the same direction. The 
bacteria are making adjustments to the cell wall, which is the outer barrier that is in direct contact with 
the host and host-immune response. Lipid metabolism is inherently linked with the cell wall and other 
cell processes, hence changes in this functional category are expected to accompany cell wall 
changes. It is anticipated that respiration processes and intermediary metabolism need to adapt in 
response to the changes taking place in the cell wall. As information pathways underlie all cellular 
processes, they also need to adjust to support the other changes that the bacteria undergo. It is 
however unclear whether the adjustments in the cell wall and related processes mediate the rest of 
the evolutionary changes that are observed, or vice versa. The unidirectional evolution shown in this 
study strongly supports the hypothesis of host-pathogen co-evolution (Gagneux, 2012; Gagneux et al., 
2006). 
 
Figure 4.3.13. Functional distribution of genes containing SNPs in non-LAM isolates. All SNPs that were 
identified in the analysed non-LAM M. tuberculosis isolates were functionally annotated.  
4.3.6. SUB-CONCLUSIONS 
The SNP variation summarised in this section (4.3) indicates that the genes involved in the cell wall, 
cell processes, intermediary metabolism and respiration of the LAM genotype are primarily influenced 
during evolution. A similar distribution of SNP variation was observed when the non-redundant SNPs 
of the non-LAM isolates were analysed and functionally annotated. A large proportion of the SNP 
Stellenbosch University  http://scholar.sun.ac.za
88 
 
variants cause non-synonymous changes, which is consistent with what was previously observed in M. 
tuberculosis (Baker et al., 2004). A set of 55 SNPs were identified to be unique to the LAM isolates 
included in this analysis. Different clades within the LAM lineage are defined by subsets of SNPs and 
RDs that are responsible for the topology of the phylogenetic tree presented in Section 4.2.  
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4.4. RDRIO VS NON-RDRIO  
4.4.1. INTRODUCTION 
In order to investigate the functional changes that occurred during the evolution of the RDRio vs. non-
RDRio LAM strains in more detail, two of the LAM isolates included in the phylogenetic and genomic 
analysis were selected. These isolates were cultured, whole cell lysate proteins were extracted from 
these cultures, and the proteins were analysed by mass spectrometry (as described in Chapter 3, 
Section 3.8 – 3.14). These clinical isolates (SAWC 3517 and SAWC 3651) were genotyped using the 
internationally standardised methods of spoligotyping and IS6110 RFLP, (Table 4.4.1), and were 
shown to harbour all of the LAM specific genetic markers. SAWC 3517 is a member of IS6110 family 9 
and is characterised by ∆DVR 21-24, 27-30, 33-36. In contrast, SAWC 3651 presents with an IS6110 
RFLP pattern characteristic of F14 and ∆DVR 15-23 and 33-36 are deleted.  
Table 4.4.1. Clinical isolates used for proteomic analysis 
IS6110 family SAWC number Common name Spoligotype 
9 3517 LAM 11/ZWE 
14 3651 T1, T1-Tusc, T5/Rus 
 
The phylogenetic positions of SAWC 3517 and SAWC 3651 are indicated on the cladogram (Figure 
4.4.1). Isolate SAWC 3517 harbours the 35 SNPs that were found to be unique to the LAM11/ZWE 
(F9) strians, while isolate SAWC 3651 has 90 SNPs uniquely associated with the T1, T1-Tusc, T5/Rus 
(F14) strains (Section 4.3). 




Figure 4.4.1. M. tuberculosis LAM genotype phylogeny, showing the position of SAWC 3517 and SAWC 
3651 
Isolates SAWC 3517 and SAWC 3651 possess additional genomic features that distinguish them from 
each other and other lineages of M. tuberculosis. The large genomic deletions present in the M. 
tuberculosis LAM genotype isolates analysed are summarised in Table 4.3.8. Both SAWC 3517 and 
SAWC 3651 have a number of genomic regions deleted relative to the M. tuberculosis H37Rv genome 
sequence. Both isolates have RD149 deleted, RD174, RDRio, and RD152 are deleted in SAWC 3517, 
while RD115 and a newly identified gene deletion (Rv0145) are deleted in SAWC 3651. A summary of 
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Rv1573  phiRv1 phage protein 
Insertion sequences and 
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Rv1574  phiRv1 phage protein 
Insertion sequences and 
phages 
 
Rv1575  phiRv1 phage protein 
Insertion sequences and 
phages 
 
Rv1576  phiRv1 phage protein 
Insertion sequences and 
phages 
 
Rv1577  phiRv1 phage protein 
Insertion sequences and 
phages 
 
Rv1578c  phiRv1 phage protein Insertion sequences and 


















Lipid metabolism Rv3651 
 
BND = the exact boundaries not determined 
Table 4.4.2. Description of genes in RDs present in SAWC 3517 and/or 3651 continues 
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4.4.2. GENOMIC ANALYSIS  
An extensive genomic comparison of SAWC 3517 and SAWC 3651 was done to exploit other genetic 
features that may underlie the phenotype of each strain. Single nucleotide variants, small genomic 
in/dels and regions of difference (large deletions) were identified in SAWC 3517 and SAWC 3651 with 
the NGS data analysis pipeline, described in Chapter 3, Section 3.5.6, and is presented in this section. 
The SNPs identified in SAWC 3517 and SAWC 3651 are summarised in Table 4.4.3. In total, 819 high 
confidence SNPs were identified in SAWC 3517, relative to the reference genome M. tuberculosis 
H37Rv. Of these, 282 were synonymous, 446 were non-synonymous and 91 were intergenic. Similarly, 
831 high confidence SNPs were identified in SAWC 3651 with respect to the reference genome. Of 
the total, 282 SNPs were synonymous, 457 were non-synonymous and 92 were intergenic. These 
SNPs were annotated and functional categories were assigned to the genes in which the SNPs occur. 
The functional category distribution for the genes in which SNPs found in SAWC 3517 and SAWC 
3651 occur, are also shown in Table 4.4.3. 
Table 4.4.3. Summary of SNPs identified in SAWC 3517 and SAWC 3651 
 
3517 3651 
Functional group All SNPs Syn SNPs 
Non-syn 
SNPs 
All SNPs Syn SNPs 
Non-syn 
SNPs 
Information pathways 50 23 27 52 18 34 
Conserved hypothetical 
proteins 
149 58 91 145 52 93 
Cell wall and cell 
processes 




134 49 85 139 54 85 




30 17 13 27 15 12 
Lipid metabolism 77 37 40 83 37 46 
PE/PPE protein families 90 32 58 91 34 57 
Insertion sequences 
and phages 
10 1 9 14 1 13 
Hypothetical 1 0 1 2 0 2 
Intergenic 91 - - 92 - - 
Total 819 282 446 831 282 457 
 
The SNPs and small in/dels identified in SAWC 3517 and SAWC 3651 were then compared to each 
other. These comparisons are shown in the Venn diagrams is Figure 4.4.2.A and Figure 4.4.2.B, 
respectively. SAWC 3517 and SAWC 3651 share 572 SNPs and 51 small in/dels with respect to M. 
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tuberculosis H37Rv. SAWC 3517 has 247 SNPs that were not identified in SAWC 3651, and SAWC 
3651 has 259 SNPs that were not found in SAWC 3517. Fourteen distinct small in/dels were shown to 
be unique to each strain analysed in this section. Of the total number of SNPs not shared between the 
two isolates, 84 SNPs were identified in SAWC 3517 that were not identified in any other isolate 
included in the phylogeny analysis described in Section 4.2, whilst 48 SNPs were unique to SAWC 
3651. 
 
Figure 4.4.2. Overlapping variants between SAWC 4498 and SAWC 5165. A. SNPs that overlap in position 
and base identity between, or unique to, SAWC 3517 and SAWC 3651, employing M. tuberculosis H37Rv as a 
reference genome. B. In/dels that overlap in length, start- and end position and base identity between, or unique 
to, SAWC 3517 and SAWC 3651, employing M. tuberculosis H37Rv as a reference genome. 
The SNPs identified in only one of the two isolates under investigation in this section, and SNPs 
identified in both of the isolates were functionally annotated. The SNPs (247 in SAWC 3517 and 259 
in SAWC 3651) occurred in genes involved in the cell wall and cell processes and intermediary 
metabolism and respiration. A large number of the SNPs occurred in conserved hypothetical genes. 
The functional distribution for non-overlapping SNPs is shown in Figure 4.4.3.A and –B, respectively 
for SAWC 3517 and SAWC 3651. The SNPs that overlap between SAWC 3517 and SAWC 3651 are 
shown in Figure 4.4.3.C, and the functional distribution is similar to that of the non-overlapping/unique 
SNPs. 
A B 






Figure 4.4.3. Functional distribution of genes containing SNPs identified in SAWC 3517 or SAWC 3651. A. 
SNPs identified only in SAWC 3517, and not in SAWC 3651 were functionally annotated. B. SNPs identified only 
in SAWC 3651 and not in SAWC 3517 were functionally annotated. C. Functionally annotated SNPs identified in 
SAWC 3517 and SAWC 3651.  
The SNPs identified in the two isolates under investigation in this section are summarised in Table 
4.4.4. SNPs identified in only one of either SAWC 3517 or SAWC 3651 and SNPs that were identified 





Stellenbosch University  http://scholar.sun.ac.za
96 
 
Table 4.4.4. SNPs identified in SAWC 3517 and SAWC 3651 
















































































45 29 16 104 9 5 41 30 11 
Cell wall and cell 
processes 




39 25 14 95 5 4 44 25 19 




11 4 7 19 0 2 8 3 5 
Lipid metabolsim 19 11 8 58 1 2 25 17 8 
PE/PPE protein 
families 
32 23 9 8 0 0 33 22 11 
Insertion sequences 
and phages 
2 1 1 58 0 0 6 5 1 
Intergenic 23 - - 68 - - 24 - - 
Total 247 138 86 572 24 20 259 149 86 
Non-syn= non-synonymous, Syn=synonymous 
Small in/dels that were identified in SAWC 3517 but that were not found in SAWC 3651 are listed in 
Table 4.4.5. Small deletions and insertions can have detrimental effects on transcription and 
translation of the genes that they occur in, leading to possibly dysfunctional proteins. In/dels of which 
the sizes are not multiples of three have particularly negative effects on the gene products, as the 
reading frame of the gene is altered. The in/dels identified only in SAWC 3517 range from one to 13 
base pairs and are in genes of varying function, or in intergenic regions. Three of the in/dels identified 
in SAWC 3517 and not in SAWC 3651 were located in PE/PPE gene families.  
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Table 4.4.5. Small in/dels identified in SAWC 3517, not identified in SAWC 3651 
US= upstream, AA= amino acid 
 




























Cell wall and cell 
processes 
3 Insertion 1891 679 680 









Cell wall and cell 
processes 
12 Deletion 4491 1540 1536 
Intergenic - 
Us. of Rv1028A, 
Rv1027c 
- 13 Deletion - - - 








Cell wall and cell 
processes 
1 Insertion 138 112 98 



























1 Insertion 4 342 48 
Intergenic - 
Us. of Rv3474, 
Rv3473c 
- 3 Deletion - - - 
Intergenic (position3964463) - - 1 Deletion - - - 
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In/dels that were identified in SAWC 3651 and not found in SAWC 3517 are summarised in Table 
4.4.6. Fourteen in/dels were found to be unique to SAWC 3651, and range in size from one to 15 base 
pairs. Three of the in/dels were in intergenic regions whilst six were in PE/PPE family genes. As 
discussed previously, the resolution of NGS platforms in repetitive regions, such as PE/PPE genes, is 
questionable. However, the in/dels presented in Table 4.4.4 were identified by GATK in three different 
alignments with independent mapping algorithms, that provides a high confidence for the presence of 
these variants.  
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Table 4.4.6. Small in/dels identified in SAWC 3651, not identified in SAWC 3517 







































PE/PPE families 15 Deletion 825 2205 2200 
Intergenic (position 582458) - - 8 Deletion - - - 
Rv0604 lpqO Lipoprotein 
Cell wall and cell 
processes 
2 Insertion 758 317 256 




PE/PPE families 1 Insertion 1307 444 0 



































1 Insertion 255 129 0 
US= upstream, AA= amino acid
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4.4.2. PROTEOMIC ANALYSIS 
The clinical isolates representative of RDRio (SAWC 3517) and non-RDRio (SAWC 3651) LAM lineages 
were cultured and whole cell lysate proteins were extracted when the cultures reached mid-log growth 
phase. M. tuberculosis H37Rv was cultured in parallel with the clinical isolates and whole cell lysate 
proteins were also extracted from this reference strain. Technical and biological replicates showed 
good correlation and variation between replicates was minimal, heatmaps of protein profiles are 
shown in Appendix F. Quantitative mass spectrometry was done to identify the relative abundance of 
proteins present in these three strains. M. tuberculosis H37Rv was used as the baseline of expressed 
proteins to determine the relative abundance of the corresponding proteins in SAWC 3517 and SAWC 
3651, respectively. Proteins were considered to be up or down-regulated when a fold change of two or 
more was observed for a single protein, with a p-value of ≤ 0.05. 
Table 4.4.7 summarises the number of genomic differences and differentially abundant proteins in 
SAWC 3517 and SAWC 3651. SAWC 3517 and SAWC 3651 have similar numbers of SNPs with 
regards to the reference strain, M. tuberculosis H37Rv. Both strains contain 65 in/dels, of which 14 are 
unique to each. A total of 24 genes are affected by the RDs present in SAWC 3517 and 11 genes are 
affected by RDs present in SAWC 3651. The difference between the SNPs, in/dels and large genomic 
deletions (RDs) found in each strain is discussed in Section 4.3. A total of 2249 proteins were 
identified in SAWC 3517 and 2161 proteins were identified in SAWC 3651. The proteins detected in 
only one of either M. tuberculosis H37Rv and either SAWC 3517 or SAWC 3651, were not included in 
the differential expression analysis. Differential analysis was done if a protein was present in all 4 
replicates of one strain analysed and present in all 4 of the replicates of the strain that it was 
compared to. In SAWC 3517, 186 proteins were up-regulated and 126 were down-regulated, with 
respect to M. tuberculosis H37Rv. Eighty five proteins were up-regulated, and 157 proteins were 
down-regulated in SAWC 3651 (see Table 4.4.7).  
Table 4.4.7. Summary of SNPs and regulated proteins in SAWC 3517 and SAWC 3651 

















SAWC 3517 819 282 446 91 65 24 186 126 
SAWC 3651 831 282 457 91 65 11 85 157 
 
Figure 4.4.4 shows the up- and down-regulated proteins, in functional categories, for SAWC 3517 and 
SAWC 3651. Interestingly, there was no congruence between the differentially abundant proteins 
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identified in SAWC 3517 and SAWC 3651. I.e. none of the proteins overly abundant in one strain were 
also found to be overly abundant in the other and vice versa for under-abundant proteins. A large 
number of proteins that showed the same intensity levels as that observed in the M. tuberculosis 
H37Rv reference strain, was however detected in SAWC 3517 and SAWC 3651. Very few 
hypothetical proteins, transcripts of insertion sequences and phages and PE/PPE proteins were 
identified to be differentially regulated in SAWC 3517 and SAWC 3651. The epidemiological success 
of the RDRio LAM strains has been hypothesised to be partly ascribed to the deletion of certain 
PE/PPE genes. This seems contradictory, as other studies have shown that the deletion of PE/PPE 
genes contributes to high virulence in certain strains (Lazzarini et al., 2008; Manabe et al., 2003; 
Zhang et al., 2007). 
From Figure 4.4.4 it is evident that the number of up-regulated proteins involved in the lipid 
metabolism was very similar for SAWC 3517 and SAWC 3651. However, nearly double the number of 
proteins involved in the lipid metabolism was shown to be down-regulated in SAWC 3517 as 
compared to SAWC 3651. The same distribution was seen for proteins involved in virulence, 
detoxification and adaptation. Approximately twice as many regulatory proteins were up-regulated in 
SAWC 3517 when compared to SAWC 3651. In contrast, the two strains show nearly equal numbers 
of proteins in this functional category that were down-regulated. In SAWC 3517, more than 3 times as 
many proteins involved in the intermediary metabolism and respiration were up-regulated, compared 
to SAWC 3651, whilst more proteins in this functional category were down-regulated in SAWC 3651 
than in SAWC 3517. A comparable distribution of the number of differentially regulated proteins 
involved in the cell wall and cell processes was shown. Proteins with unknown function (conserved 
hypothetical proteins) were shown to be up- and down-regulated in SAWC 3651 and SAWC 3517. 
Since very little is known about the roles of these proteins in the physiology of the pathogen, one 
cannot make any conclusions as to what this difference in regulation of these conserved hypothetical 
proteins between the two strains might mean. More than twice the number of proteins involved in 
information pathways was shown to be up-regulated in SAWC 3517, in comparison with SAWC 3651. 
In contrast, twice as many proteins in this functional category were down-regulated in SAWC 3651, 
compared to SAWC 3517.   
 




Figure 4.4.4. Up and down-regulated proteins in SAWC 3517 and SAWC 3651.  
None of the proteins were detected if the corresponding genes were deleted (RD149 and RD115 in 
SAWC 3651, RD 149, RD174, RDRio in SAWC 3517). Note that when a protein is detected in one 
strain, but not in the other, one cannot confer that that protein is not at all present in the second strain, 
as the detection of very low abundance proteins is limited by the label-free quantitative proteomics 
method that is used. Hence, the protein might be present, but only in very low abundance. 
Nevertheless, not detecting proteins of which the corresponding genes are deleted is reassuring. The 
majority of proteins that were observed in only one of the strains analysed were mostly identifications 
based on the presence of that protein in one or two of the replicates. Those proteins were 
consequently not used for the quantitative comparison. Therefore no comparison was made here as to 
the presence of proteins in one strain compared to the absence in another. Only up- and down-
regulated proteins based on the relative abundances of the identified proteins are compared. However, 
the fact that none of the proteins involved in the deletions present in these two strains were detected, 
serves as a secondary confirmation of the genomic deletions. 
The up- and down-regulated proteins identified in SAWC 3517 and SAWC 3651 were mapped to M. 
tuberculosis biochemical pathways with the open-access online tool, iTUBY, a version of interactive 
pathways explorer (iPATH) 2 (Letunic et al., 2008; Yamada et al., 2011). The primary map used by 
iTUBY summarises the metabolism in biological systems as annotated in the literature to date. 
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Analysis of proteins with iTUBY allows for a general overview of protein functions and their 
interrelatedness.   
The proteins involved in the RDs present in either SAWC 3517 or SAWC 3651, were mapped to the 
metabolic pathways that they are involved in, using iTUBY (see Figure 4.4.5). Note that some 
conserved hypothetical proteins cannot be mapped to biochemical pathways as no possible function 
for the proteins has been determined. If a possible function has been assigned to a conserved 
hypothetical protein based on sequence similarity, the protein will be mapped by iTUBY. The proteins 
involved in RD115 are not present in SAWC 3651 and their absence may have an effect on other 
proteins within the same pathways. The proteins involved in RD115 are shown in Figure 4.4.5.(i). The 
figure legend gives more details as to the sub-categories in which the proteins play a role. Likewise, 
proteins involved in RD174 and RDRio are shown in Figure 4.4.5.(ii) and 4.4.5.(iii), respectively. The 
genes encoding these proteins are deleted in SAWC 3517. Each grey block consists of a number of 
grey ovals that in turn, each represents a gene (Rv number) that is broadly categorised according to 
function, but that has not necessarily been linked to a specific pathway. These categories are 
indicated as A, B, and C in Figure 4.4.5.i, -ii, and –iii.  
 
Figure 4.4.5. Proteins involved in RDs in M. tuberculosis pathways. (i). RD115, A: Transcription, B: 
Posttranslational modification. (ii). RD174, A: Signal transduction mechanisms, B: Inorganic ion transport and 
metabolism. (iii). RD
Rio
, A: Replication, recombination, repair, B: cell motility, C: Energy production and 
conversion. 
Proteins that were identified to be down-regulated in SAWC 3517 were mapped to metabolic 
pathways in the same manner as above, using iTUBY. This map is shown in Figure 4.4.6. Compared 
to other bacteria, M. tuberculosis contains few two-component systems. Nevertheless, these systems 
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play an important role in the early intracellular survival of the pathogen and are also implicated in 
aspects of mycobacterial virulence (Tucker et al., 2007). Proteins involved in two-component systems 
responsible for the maintenance of turgor pressure, initial hypoxic response and proteins involved in 
mineral and organic ion transport were down-regulated in SAWC 3517. The two component system, 
KdpD/KdpE, down-regulated here, has been shown to be an important adaptive mechanism employed 
during host infection, enhancing virulence of the bacteria and promoting survival of the pathogen, 
besides its role as a potassium regulator (Freeman et al., 2013).   
Ether lipids can constitute major parts of the cell membranes of many bacteria, ether lipids may also 
act as antioxidants, but their role in mycobacteria is largely unknown. Proteins involved in ether-lipid 
metabolism, as well as various general energy-related metabolic pathways were down-regulated in 
SAWC 3517. These include pyruvate metabolism, the tri-carboxylic acid (TCA) cycle, oxidative 
phosphorylation and general amino acid metabolisms. Several proteins involved in information storage 
and processing (see legend of Figure 4.4.6) and proteins involved in purine- and pyrimidine 
metabolism were down-regulated in the non-RDRio representative of M. tuberculosis. Other down-
regulated proteins in this strain include various conserved proteins with unknown function (conserved 
hypothetical proteins) and proteins involved in the porphyrin metabolism of M. tuberculosis – possibly 
playing a role in the iron homeostasis of the bacterium and heme degradation in the host (Nambu et 
al., 2013).   
 
Figure 4.4.6. Down-regulated proteins in SAWC 3517. A: Translation, ribosomal structure, B: Transcription, C: 
Replication, recombination, repair, D: Defence mechanisms, E: Signal transduction mechanisms, F: Cell 
wall/membrane, G: Posttranslational modification, H: Intracellular trafficking, I: Energy production and conversion, 
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J: Amino acid transport and metabolism, K: Coenzyme transport, L: Lipid transport and metabolism, M: Inorganic 
ion transport and metabolism.  
The proteins that were identified to be up-regulated in SAWC 3517 are shown in Figure 4.4.7. The up- 
and down regulation of proteins can be caused by genomic alterations such as SNPs, small in/dels 
and RDs, or external stressors. Since the strains in question here were all cultured under the same 
conditions, one could assume that these external factors are the same for all strains and that the 
regulated proteins seen here are mainly due to genomic differences between the strains. Proteins can 
also be up- or down-regulated in response to one another, e.g. the up-regulation of one protein due to 
an underlying genomic feature, leads to the up- or down-regulation of another protein in a related 
pathway, setting in place a cascade of events. Proteins involved in an array of biochemical pathways 
were up-regulated in SAWC 3517. Pathways affected are labelled on the figure and the sub-
categories of general pathways (information storage and processing, cellular processes and signalling, 
and metabolism) are explained in the legend of Figure 4.4.7.  
 
Figure 4.4.7. Up-regulated proteins in SAWC 3517. A: Translation, ribosomal structure, B: Transcription, C: 
Replication, recombination and repair, D: Cell cycle control, cell division, E: Defence mechanisms, F: Signal 
transduction mechanisms, G: Cell wall/membrane, H: Cell motility, I: Posttranslational modification, J: Energy 
production and conversion, K: Carbohydrate transport, L: Amino acid transport and metabolism, M: Coenzyme 
transport, N: Lipid transport and metabolism, O: Inorganic ion transport and metabolism.  
Proteins that were down-regulated in SAWC 3651 were also mapped to biochemical pathways and 
are shown in Figure 4.4.8. Several of the down-regulated proteins have unknown functions. The 
general biochemical pathways are labelled on the figure. Sub-categories of the information storage 
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and processing, cellular processes and signalling and metabolism are labelled A – M and are 
explained in the legend of Figure 4.4.8.  
 
Figure 4.4.8. Down-regulated proteins in SAWC 3651. A: Translation, ribosomal structure, B: Transcription, C: 
Replication, recombination, repair, D: Cell cycle control, cell division, E: Signal transduction mechanisms, F: Cell 
wall/membrane, G: Posttranslational modification, H: Energy production and conversion, I: Carbohydrate 
transport, J: Amino acid transport and metabolism, K: Coenzyme transport, L: Lipid transport and metabolism, M: 
Inorganic ion transport and metabolism.  
Proteins identified in SAWC 3651 that were shown to be up-regulated in comparison with M. 
tuberculosis H37Rv were mapped to the corresponding biochemical pathways using iTUBY. This map 
is shown in Figure 4.4.9 and the general metabolic pathways are labelled on the figure. The sub-
categories of the information storage and processing, cellular processes and signalling and 
metabolism are named A – M and are described in the legend of the figure. Fewer proteins were up-
regulated in SAWC 3651 with respect to with M. tuberculosis H37Rv, than was up-regulated in SAWC 
3517 with respect to M. tuberculosis H37Rv.  




Figure 4.4.9. Up-regulated proteins in SAWC 3651. A: Transcription, B: Defence mechanisms, C: Signal 
transduction mechanisms, D: Cell wall/membrane, E: Posttranslational modification, F: Intracellular trafficking, G: 
Energy production and conversion, H: Amino acid transport and metabolism, I: Coenzyme transport, J: Lipid 
transport and metabolism, K: Inorganic ion transport and metabolism.   
As expected, the association between SNPs and functional groups seen in SAWC 3517 and SAWC 
3651 with respect to the M. tuberculosis H37Rv reference genome, correlates with the differentially 
abundant proteins identified in the same strain to a certain extent, see Figure 4.4.10. However, some 
functional categories that are highly represented in the SNP analysis showed very few to no 
corresponding proteins to be differentially regulated. This was largely restricted to the PE/PPE family 
proteins in both SAWC 3517 and SAWC 3651. A larger percentage of proteins involved in the lipid 
metabolism were shown to be down-regulated in SAWC 3517, and up-regulated in SAWC 3651, 
compared to the percentage of SNPs corresponding to this functional category in both strains. The 
functional category, ―intermediary metabolism and respiration‖ show similar proportions of SNPs in 
both SAWC 3517 and SAWC 3651, whilst 32% of the up-regulated proteins in SAWC 3517 belong to 
this category and 23% in this category were down-regulated. The opposite is seen for the proteins 
involved in intermediary metabolism and respiration in SAWC 3651.  
 
 




Figure 4.4.10. Summary of SNPs, up- and down-regulated proteins from SAWC 3517 and SAWC 3651. A. 
SAWC 3517. B. SAWC 3651  
 
The proteins identified in SAWC 3517 that were quantified as more or less abundantly expressed than 
the corresponding protein in M. tuberculosis H37Rv were considered and the ten proteins with the 
highest fold of up- and down regulation are summarised in Table 4.4.8. Proteins that are up-regulated 
in SAWC 3517 but down-regulated in SAWC 3651 are highlighted in purple, whilst proteins that are 
down-regulated in SAWC 3517 but up-regulated in SAWC 3651 are highlighted in green. This 
colouring scheme is also used in Table 4.4.9. A complete list of all proteins identified to be up- and 
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Table 4.4.8.Decription of 10 highly up- and down-regulated proteins in SAWC 3517 
 
















































Possible adenylate cyclase (ATP 





Rv3874 EsxB 10 kDa culture filtrate antigen (LHP, cfp10) 
Cell wall and cell 
processes 
32.8 0.00514 
































Rv2258c Rv2258c Possible transcriptional regulatory protein Regulatory 387.1 0.000613 
Rv0670 End 
Probable endonuclease iv 
























Probable conserved ATP-binding proteins, ABS 
transporter 
Cell wall and cell 
processes 
17.1 0.00866 
Rv2930 FadD26 Fatty-acid-AMP ligase (synthetase, synthase) lipid metabolism 15.6 0.025218 
Rv2476c Gdh 
Probable NAD-dependent glutamate 












The regulated proteins identified in SAWC 3651 with respect to M. tuberculosis H37Rv were 
considered and the ten proteins with the highest fold of up- and down regulation are summarised in 
Table 4.4.9. Proteins that are up-regulated in SAWC 3651 but down-regulated in SAWC 3517 are 
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highlighted in green, whilst proteins that are down-regulated in SAWC 3651 and up-regulated in 
SAWC 3517 are highlighted in purple.  
Table 4.4.9.Decription of 10 highly up- and down-regulated proteins in SAWC 3651 
 
 






















Rv0379 SecE2 Possible protein transport protein 
Cell wall and cell 
processes 
181.4 0.009525 
Rv3472 Rv3472 Conserved hypothetical protein Conserved hypothetical 65.2 0.039015 





Rv0045c Rv0045c Possible hydrolase lipid metabolism 17.5 0.020074 
Rv2923c Rv2923c Conserved hypothetical protein Conserved hypothetical 16.3 0.002493 
Rv1687c Rv1687c 
Probable conserved ATP-binding protein 
ABC transporter 
Cell wall and cell 
processes 
15.0 1.36E-06 






































Rv1883c Rv1883c Conserved hypothetical protein Conserved hypothetical 209.8 0.005276 











Possible adenylate cyclase (ATP 

























Rv1698 Rv1698 Outer membrane protein 
Cell wall and cell 
processes 
15.4 0.003256 
Rv3213c Rv3213c Possible SOJ/para-related protein 
Cell wall and cell 
processes 
14.8 5.12E-05 
Rv1154c Rv1154c Hypothetical protein Conserved hypothetical 13.6 0.043581 
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All the proteins that were identified in SAWC 3517 and SAWC 3651 and that were shown to be 
differentially abundant were compared. It was shown that 68 proteins were up-regulated in SAWC 
3517 (with respect to M. tuberculosis H37Rv) and down-regulated in SAWC 3651 (also with respect to 
M. tuberculosis H37Rv). A total number of 40 proteins were up-regulated in SAWC 3651 and down-
regulated in SAWC 3517. The functional classification of these proteins are summarised in Table 
4.4.10 and a more comprehensive list of these proteins are included in Appendix D. The remaining 
proteins were either differentially abundant in one strain and identified in similar abundance as the 
corresponding protein in M. tuberculosis H37Rv, or not only identified in one of the respective isolates.  
Table 4.4.10. Functional distribution of proteins that are up-regulated in one isolate and down-
regulated in the other 
Functional category 
Up in SAWC 3517, down 
in SAWC 3651 
Up in SAWC 3651, down in 
SAWC 3517 
Information pathways 5 1 
Conserved hypothetical proteins 16 6 
Cell wall and cell processes 9 5 
Intermediary metabolism and 
respiration 
24 7 
Regulatory proteins 4 3 
Virulence, detoxification and 
adaptation 
3 4 
Lipid metabolism 6 14 
PE/PPE protein families 0 0 
Insertion sequences and phages 0 0 






From this analysis, two operons, as well as the ESX genes identified and that are known to be 
involved in virulence, were selected with the view to elucidate possible mechanisms of gene regulation. 
Some of the differentially abundant proteins mentioned in this discussion are not listed in Table 4.4.8 
or 4.4.9, but are included in Appendix D. 
MOLYBDENUM COFACTOR BIOSYNTHESIS ASSOCIATED PROTEINS 
Proteins involved in molybdenum cofactor (MoCo) biosynthesis and genes in the same genomic 
region as MoCo biosynthesis genes were identified in over-abundance in SAWC 3517. These proteins 
include MoeW (Rv2338c), MoaA (Rv3119), Rv3322c, MoaX (Rv3323c) and MoaC3 (Rv3324c). 
Molybdenum uptake has been implicated in mycobacterial virulence, likely through the function of one 
or a combination of molybdenum cofactor (MoCo) dependent proteins (Williams et al., 2011). MoCo 
allows molybdenum to be bound by enzymes in order to catalyse redox reactions in carbon-, nitrogen- 
and sulphur metabolism. The biosynthesis of MoCo is mediated by various enzymes, including 
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Rv3323c, Rv2338c, Rv3119, Rv3324c (Williams et al., 2011; Zhang and Gladyshev, 2008). 
Unfortunately, very little is known about the regulation of the MoCo biosynthetic pathway in M. 
tuberculosis. Despite the fact that several homologs of the MoCo biosynthetic pathway genes are 
found in M. tuberculosis, certain genes involved in this pathway were shown to be essential for the in 
vitro growth of M. tuberculosis (Lamichhane et al., 2003; Sassetti et al., 2003). M. tuberculosis MoCo 
biosynthesis protein X (MoaX- a MoaD and MoaE fusion protein) mutants were shown to have a 
reduced ability to infect macrophages (Rosas-Magallanes et al., 2007).  Furthermore, MoaX have 
been shown to provide additional MoaD and MoaE activity under certain conditions, and is implicated 
in de novo MoCo biosynthesis in vitro (Williams et al., 2011). The over-abundance of proteins involved 
in the initial steps of MoCo biosynthesis in SAWC 3517, could contribute significantly to the 
hypothesised increased virulence and transmissability of RDRio-LAM strains (Lazzarini et al., 2007, 
2008). This could, in part, explain the epidemiological success of the RDRio lineage globally. In contrast, 
Rv0438c (MoeA2), Rv3322c and Rv3323 (MoaX) were shown to be present in low abundance in 
SAWC 3651 in comparison with M. tuberculosis H37Rv. This suggests that the regulation of the MoCo 
biosynthetic pathway lies within the genomic differences between SAWC 3517 and SAWC 3651. 
Despite extensive mining of the literature and searching numerous databases for indications of protein 
interactions or regulatory mechanisms of the MoCo biosynthesis pathway, no evident explanations 
were found that may aid in the comprehension of the phenomenon observed between the two M. 
tuberculosis clinical isolates representative of the RDRio-LAM and a non-RDRio-LAM lineages analysed 
in this section.  
OXIDATIVE STRESS RESPONSE PROTEINS 
Analysis of the second operon, including Rv2428 and Rv2429, showed that these proteins were down-
regulated in SAWC 3517 and up-regulated in SAWC 3651. Certain mutations in Rv2428 have been 
shown to confer Isoniazid resistance (Sandgren et al., 2009). Rv2428 has been predicted to be in the 
RelA/Rv2583c regulon, while Rv2429 is predicted to be in the SenX3/ Rv0490-RegX3/Rv0491 regulon 
(Dahl et al., 2003; Parish et al., 2003). Rv0491 were shown to be over-abundant in SAWC 3517, and 
under-abundant in SAWC 3651. Rv2428 and Rv2429 are involved in oxidative stress response and 
work together to establish an NADH-dependent peroxidase and peroxynitrite reductase that provides 
cellular protection. The mechanism governing the expression of this operon‘s transcription and 
translation remains to be determined.  
ESX-1 SECRETION SYSTEM PROTEINS 
The M. tuberculosis ESX-1 secretion system acts to secrete virulence factors across the cell envelope 
(Bitter et al., 2009). Attenuated M. bovis BCG vaccine strains have a deletion of a 9.5 kb genomic 
region spanning nine open reading frames of genes primarily involved in the ESX-1 secretion system. 
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This genomic region is termed RD1 and is present in all virulent M. tuberculosis strains and has thus 
been implicated in virulence and pathogenesis of M. tuberculosis (Daugelat et al., 2003; Lewis et al., 
2003). The ESX-1-secretion associated protein, EccA1 has been shown to influence mycolic acid 
synthesis and the mycolic acid composition of the cell envelope, which may correlate with the SNP 
changes which were significantly associated with cell wall processes, and therefore the influence of 
evolution on the cell wall. The deletion of, or mutations in, EccA1 were shown to reduce the mycolic 
acid composition of the envelope and cell wall integrity and also reduced virulence and intracellular 
growth (Joshi et al., 2012). Substrates of the ESX-1 secretion system are mutually dependent on each 
other for secretion (Fortune et al., 2005).  
Several ESX-1 associated proteins were shown to be over abundantly expressed in SAWC 3517, 
compared to M. tuberculosis H37Rv. Predicted ESX-1-secretion-associated proteins EspE, EspF, 
EspG1and EspK (Rv3864, Rv3865, Rv3866 and Rv3879c, respectively) were present in high 
abundance in the RDRio-LAM representative. In addition, EccA (Rv3868) and EccD1 (Rv3877) were 
also overly abundant. EccA is a conserved component of the ESX-1 secretion system, whilst EccD1 is 
predicted to be a transmembrane protein mediating the transport of virulence factors across the 
mycobacterial cell membrane (Abdallah et al., 2007; Bitter et al., 2009). Furthermore, EsxB (Rv3874), 
also known as the mycobacterial antigen CFP10, is correspondingly overly abundant in SAWC 3517. 
This suggests that the general ESX-1 secretion system is up-regulated in the RDRio-LAM 
representative, even though some of the proteins encoded for by ESX-1 secretion genes are not 
detected. The cellular localisation of some of the proteins involved in this secretion system (membrane 
bound proteins) could restrict their detection by means of protein mass spectrometry of the whole cell 
lysate proteins of the cultured isolate. The high abundance of ESX-1 associated proteins correlate with 
the hyper-virulence of RDRio-LAM strains that is implied by the epidemiological dominance that this 
lineage presents with (Gibson et al., 2008; Lazzarini et al., 2008, 2007). In contrast, EspG, EccA1 and 
EspK (Rv3866, Rv3868 and Rv3879, respectively) were shown to be present in low abundance in 
SAWC 3651, in comparison with M. tuberculosis H37Rv.  
4.4.3. SUB-CONCLUSIONS 
It is evident from on-going whole genome and proteomic studies on M. tuberculosis, including the 
present study, that the genomes of circulating M. tuberculosis strains are actively evolving. These 
genomic changes cause significant changes in abundance of a subset of cellular proteins which could 
impact on the physiology of the strain.  
The immense differences in the proteomes of seemingly closely related strains of M. tuberculosis LAM 
genotype isolates are shown in Section 4.4. It is clear that SNPs, small in/dels and the absence or 
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truncation of genes have a significant effect on the expression of not only the corresponding proteins 
but also on other proteins that are functionally related or that may be involved in the same pathways. 
The causal relationship of these genomic changes on the proteome is not obvious. It is thus very 
challenging to attribute proteomic abundance changes to specific genomic events with this whole 
proteome approach. Despite these challenges we were able to show that various virulence associated 
proteins are up-regulated in the RDRio-LAM lineage, however this needs further validation with 
additional functional and experimental work.  
From the data shown in this section, it is apparent that the proteome of SAWC 3517 (the 
representative of the RDRio LAM lineage) is severely affected by the underlying genomic changes that 
it harbours, these include the large genomic deletions, RD149, RD174 and RDRio (the largest genomic 
deletion described to date) (Lazzarini et al., 2008). The functional classification of the results suggests 
that proteins involved in the lipid metabolism and intermediary metabolism and respiration may have a 
critical role to play in the success of the RDRio LAM lineage. Furthermore, it is evident from the 
summary of evolutionary changes shown in Section 4.3, together with what is shown in this section, 
that the genomic- and proteomic features involved in the cell wall and cell processes of the LAM 
genotype in general differ from what is seen in the reference strain, M. tuberculosis H37Rv, possibly 
contributing to the success of this strain family world-wide.  
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CHAPTER 5  
SUMMARY & CONCLUSION      
The current research used whole genome sequencing to describe the genomes of strains 
representative of the different sub-lineages of the LAM genotype from Cape Town, South Africa. In 
addition, proteomic data was analysed to identify different physiological traits associated with two 
different LAM strain families, one of which (RDRio) was shown to cause large outbreaks and is thought 
to be hyper-virulent.  
The customised NGS analysis pipeline established during this study successfully identified the 
mechanism of genetic variation within the previously sequenced M. tuberculosis strain of the LAM 
genotype (F11). This conferred high confidence to the genetic variation detected in other strains that 
had not been previously sequenced. The pipeline also allowed for the identification of micro-
evolutionary events that distinguish strains and strain families from each other, with high confidence. 
The unmatched resolution that WGS provides was exploited with this multi-software approach to call 
genetic variation for the purpose of inferring evolutionary relationships between the isolates analysed 
in the present study.  
Previous studies have shown that SNPs significantly contribute to mycobacterial genome variation and 
have been proved to be suitable to be able to distinguish closely related isolates from each other 
(Gutacker et al., 2002). Based on this principle it was possible to reconstruct the phylogenetic history 
of M. tuberculosis strains representative of the different IS6110 RFLP families and members of the M. 
tuberculosis complex. The resulting phylogenetic tree predicted a clonal population structure 
consisting of distinct lineages. IS6110 RFLP families and spoligotypes were unambiguously 
associated with defined lineages, confirming the robustness of the SNP-generated phylogeny. This 
phylogeny of strains from the Western Cape Province of South Africa proved to be congruent with 
previous evolutionary scenarios for M. tuberculosis isolated from other parts of the world (Baker et al., 
2004; Filliol et al., 2006; Gagneux et al., 2006). This demonstrates that the TB epidemic in this region 
is reflective of the global epidemic and probably arose as the result of these strains being imported 
from both East and West through sea trade.  
The M. tuberculosis strain families in PGG2 contribute significantly to the TB epidemic in Cape Town, 
South Africa and represent more than 50% of all the TB cases in this setting (Streicher, 2007). Strains 
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with a PGG2 classification have also been shown to contribute significantly to the global epidemic and 
are referred to as members of the Euro-American Clade (Gagneux et al., 2006). This detailed analysis 
of the PGG2 LAM genotype is the first to be done on this genotype with the view to understand the 
genetic mechanisms that contribute to the success of this genotype. The present study used whole 
genome sequencing data (SNPs and LSPs) together with previously published markers (i.e. SNP, LSP, 
IS6110 insertion site mapping and spoligotyping) to determine the evolutionary relationships among 
IS6110-RFLP strain families of the LAM genotype of M. tuberculosis. This analysis demonstrated that 
the LAM genotype evolved from a common ancestor characterised by an IS6110 insertion in the DR 
region, the deletion of DVRs 21-24, 33-36,  the PGG2 defining katG463CTG→CGG polymorphism, 
and 55 unique LAM specific SNPs. Thereafter six LAM sub-lineages evolved, namely IS6110 RFLP 
families F9, F11, F13, F14, F15, and F26. Each of the sub-lineages are characterized by a uniqe set 
of SNPs and reflect evolution in genes involved in cell wall, cell processes, intermediary metabolism 
and respiration. The same phenomenon was observed when non-LAM isolates were analysed. This 
suggests that the evolution of M. tuberculosis (in this setting) is unidirectional and the high number of 
non-synonymous changes observed is evident of the positive selective pressures experienced in the 
host by these strains.  
The on-going whole genomic- and proteomic studies on M. tuberculosis, such as the present study, 
have proved that the genomes of circulating M. tuberculosis strains are dynamically evolving. The 
genomic changes that circulating M. tuberculosis strains undergo may cause detectable modifications 
in the phenotypes of these strains, which can be quantitatively measured with highly sensitive protein 
mass spectrometry. The role of these genetic changes in the fluctuating levels of virulence and strain 
fitness remains to be clarified.   
Quantitative proteomics studies are superior to conventional gene expression (transcriptional) studies 
in the sense that they provide insight into the proteins that are truly present at a given point in time. 
This study confirmed that the proteomes of M. tuberculosis isolates of the same lineage (LAM) show 
vast differences that can be ascribed to the underlying genetic variation. SNPs, small in/dels and the 
absence or truncation of genes due to the presence of RDs have an immense effect on the expression 
of the corresponding- and functionally related proteins.   
The functional classification of the regulated proteins in the representative of the RDRio-LAM lineage of 
M. tuberculosis suggests that proteins involved in the MoCo biosynthesis pathway, ESX-1 secretion 
system, and other proteins generally involved in the lipid metabolism and intermediary metabolism and 
respiration may be the key to the pathogenic nature of the RDRio LAM lineage (Lazzarini et al., 2008). 
A combination of the LAM SNP analysis and the LAM RDRio/non-RDRio comparison showed that the 
overall genomic- and proteomic features involved in the cell wall and cell processes of the LAM 
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genotype differ to a large extent from what is seen in the reference strain, M. tuberculosis H37Rv. This 
difference in physiology possibly contributes to the global success of the LAM lineage.  
The proteome is a dynamic, constantly interacting collection of components that provide a holistic view 
of the biology of a living organism.  In contrast, the genome of an organism provides a static view of 
the underlying features of biological characteristics. It is for this reason that combinatorial studies are 
becoming more popular and shows promise to uncover critically important and unanswered questions 
regarding the virulence, pathogenesis, persistence, transmissibility, general evolution and more 
specifically, the evolution of drug resistance in M. tuberculosis. The whole genome sequencing of 
hundreds of M. tuberculosis isolates world-wide, combined with a multitude of genetic typing 
techniques, has not provided an explicit comprehension of the fundamental mechanisms of 
pathogenicity. This emphasises the need for a systems biology approach to correlate genomic data 
with clinical and phenotypic data to better understand the fundamental aspects of M. tuberculosis 
pathogenesis. 
From the current research, proteome homeostasis appears to be more complex than a mere 
representation of the underlying genomic features, as the altered abundance of one protein has the 
ability to set in place a cascade of events, not directly associated with a specific genomic variant. The 
entire interactome drives protein expression so that a polymorphism, deletion or truncation in/of a 
gene may influence the expression of an array of interrelated proteins. Our interpretation is further 
curtailed by a significant knowledge gap in the mechanisms of transcriptional regulation.  
Despite certain shortcomings, this is one of the first studies to combine whole genome- and whole 
proteome data to investigate the biological characteristics of the LAM genotype of M. tuberculosis and 
it provided insightful findings. The current genome wide phylogenetic study is the first of its kind in a 
South African context. The present study is one of the first investigations that address the inter-LAM 
genomic variation as well as the genomic characteristics that separate the LAM genotype from other 
M. tuberculosis strains. Evolutionary studies, such as this one, lay the foundation for phenotypic 
studies, which are instrumental to novel drug- and vaccine development. The aims of this study were 
successfully achieved. 
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CHAPTER 6  
FUTURE STUDIES     
EXPERIMENTAL WORK 
1. Investigate the effects of small genomic in/dels on the evolution of the M. tuberculosis LAM 
genotype by comparing in/dels that are common and unique in different clades of the LAM 
genotype. 
2. Inspect reads that did not map to the M. tuberculosis H37Rv reference genome for genes 
or genomic regions that are present in the strains of interest but absent from the reference 
genome used for the alignment. This will be done by extracting unmapped reads, doing de 
novo assembly on these reads and performing a nucleotide BLAST on the resulting contigs.  
3. PCR verify and determine the exact boundaries of newly identified LSPs that were not 
experimentally verified in the current study.  
4. Determine whether the LSPs identified to be unique or common to clades of the LAM 
genotype are found in a larger mixed M. tuberculosis sample set, consisting of LAM and 
non-LAM isolates.   
5. Construct a comprehensive phylogeny of M. tuberculosis strains from Cape Town, South 
Africa with representatives of all IS6110 RFLP families, including unpublished in-house 
Spoligotyping data, family specific IS6110 insertion sites, known LSPs and verified SNPs.  
6. Confirm a subset of overly abundant proteins implicated in virulence in the RDRio-LAM 
representative strain with Western-blot analysis.  
7. Inspect proteome data in order to identify candidate proteins for future screening of 
possible MoCo biosynthesis regulators in functional studies.   
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RECIPES AND PROTOCOLS 
7H9 LIQUID MEDIA 
4.7g of 7H9 powder in 900 ml dd H₂O 
Add 2 ml of 100% Glycerol 
Add 0.5g of Tween 80 (2.5 ml of 20% Tween) 
Autoclave at 121 °C for 10 minutes. Aseptically add 100ml of ADC or DC (for proteomics experiments), 
Filter sterilise and store at 4 ˚C. 
ALBUMIN DEXTROSE CATALASE (ADC)  
25 g BSA 
10 g Glucose 
375 µl Catalase 
Make up to 500 ml with dH2O, dissolve with magnetic stirrer and filter sterilise before use. Store at 4°C.  
DEXTROSE CATALASE (DC) 
10 g Glucose 
375 µl Catalase 
Make up to 500 ml with dH2O, dissolve with magnetic stirrer and filter sterilise before use. Store at 4°C.  
PROTEIN EXTRACTION BUFFER 
MAKE UP A WORKING STOCK OF PROTEIN INHIBITORS: 
50 µl Protease cocktail in 1 ml ddH2O (filter sterilised) = working stock to be used in recipe for protein 
extraction buffer. 
 
TRIS-HCL PROTEASE INHIBITOR (PROTEIN EXTRACTION) BUFFER: 
 200 ul protease inhibitor cocktail 
 50 µl 1 M Tris 
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 3 µl 20% Tween 80 (filter sterilised) 
 9.47 ml ddH2O 
 Total: 10 ml 
RC-DC ASSAY 
Add 5 µl of DC Reagent S to each 250 µl of DC Reagent A that will be needed for the run. This 
solution is referred to as Reagent A. (Each standard or sample assayed will require 127 µl of 
Reagent A) 
Prepare 3-5 dilutions of a protein standard from 0.2 mg/ml to 1.5 mg/ml protein: 
(Rehydration buffer= Protein extraction buffer left over from protein (whole cell lysate) 
extraction) 
 
BSA dilution (mg/ml) BSA (µl) Rehydration Buffer (µl) 
0 0 25 
0.2 2.5 22.5 
0.5 6.25 18.75 
1.0 12.5 12.5 
1.5 18.75 6.25 
 
BSA stock: 
20 µl BSA + 80 µl H₂O = BSA with concentration of 2 mg/ml (0.002 g) 
 
Pipette 25 µl of standards into clean 1.5 ml Eppendorf tubes (5 tubes for standard curve). 
Pipette 5 µl of clean protein samples and 20 µl of Rehydration buffer into clean tubes, can make 
dilution for protein samples. 
Add 125 µl RC Reagent I into each tube, vortex. Incubate tubes for 1 minute at rt. 
Add 125 µl RC Reagent II into each tube, vortex. Centrifuge the tubes at rt at maximum speed for 
5 minutes. 
Discard the supernatant by inverting the tubes on clean absorbent tissue paper. Allow liquid to 
drain completely from tubes. 
Discard the supernatant by inverting the tubes on clean absorbent tissue paper. Pulse centrifuge 
tubes. Pipette remaining fluid in tubes, without disturbing the pellet. 
Add 127 µl Reagent A (that you prepared from Reagent S and Reagent A) to each tube, vortex. 
Incubate tubes at room temperature for 5 minutes, or until precipitate is completely dissolved. 
Vortex before proceeding to next step. 
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Add 1 ml of DC Reagent B to each tube and vortex immediately. Incubate at room temperature for 
15 minutes. 
After 15 minutes incubation, absorbencies can be read at 595 nm. The absorbencies will be stable 
for at least one hour. 
Draw standard curve on Excel and determine protein sample concentrations. 
Load 60 µg per lane on SDS-page. 
PROTEOMICS SAMPLE PREPERATION, TRYPSYN DIGESTION, DESALTING 
ABBREVIATIONS USED:  
2-DE: Two-dimensional gel electrophoresis  
ABC: Ammonium bicarbonate  
ACN: Acetonitrile  
DTT: DL-Dithiothreitol  
FA: Formic acid  
IAA: Iodoacetamide  
REAGENTS NEEDED:  
Ammonium Bicarbonate: Sigma #09830  
DTT: Sigma #43817  
IAA: Sigma #I1149  
Water: Water LCMS Chromasolv: Sigma #39253 or good MilliQ water  
Acetonitrile: Acetonitrile LCMS Chromasolv: Sigma #34967  
Trypsin: Sequencing grade trypsin: Promega #PRV5111  
SOLUTIONS NEEDED:  
50 mM Ammonium bicarbonate: Dissolve 0.08 g ammonium bicarbonate in 20 ml MilliQ water 
(make fresh before use every time)  
50% Acetonitrile (ACN): 5 ml ACN + 5 ml MilliQ water  
70% Acetonitrile (ACN): 1400 μl ACN + 600 μl MilliQ water  
10 mM DTT: 0.031 g in 20 ml 25 mM ammonium bicarbonate (make fresh before use)  
55 mM IAA: 0.2 g in 20 ml 25 mM ammonium bicarbonate  
 
Trypsin:  
Dissolve a single vial of trypsin (20 μg) in 200 μl of the re-suspension solution provided with the 
trypsin. Divide into aliquots of 20 μl each and store at -80°C. For experimental use: take an aliquot 
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from -80°C and add 180 μl of the 50 mM ammonium bicarbonate for active trypsin. Remember that 
you cannot re-use this trypsin, it must be discarded after use and made just before use. Keep one 
ice.  
STAGE TIP PROTOCOL FOR DESALTING PEPTIDES 
Prepare desalting columns: 
Punch out discs of C18 empore filter with needle 
Place in P200 pipette tip  
Securely wedge disc into tip 
Prepare sample: 
Dry sample to ~30ul to remove all ACN 
Acidify sample by adding 20ul 5% FA (final volume ~50ul) 
Cleanup: (Use 2.5ml combitip) 
Activate column with 50ul MeOH, check for back pressure 
Wash column with 50ul 5% FA 
Run sample through column 2x 
Wash column with 50ul 5% FA 
Elute sample peptides with 50ul 80% ACN, 5% FA 
Dry samples in speedyvac (20-25min) and store at -20˚C until mass spectrometry is done (no 
longer than one month) 
10 X SODIUM TETRA BORIDE (SB) BUFFER  
38.14 g Sodium tetra boride in 1 l Milipore water 
Pour half of the water in a conical flask and put on the magnetic stirrer, add the weighed off SB, rinse 
beaker with some of the water and add to conical flask. Add the rest of the water and allow to dissolve 
whilst stirring.  
4 X LAEMMLI SAMPLE BUFFER 
For 50 ml: 
12 ml 1 M Tris (pH 6.8) 
4g SDS powder 
20 ml Glycerol 
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2.5 ml 0.2% Bromophenol blue  
5 ml β-mercaptoethanol 
14 ml ddWater 
Dissolve on magnetic stirrer, can be stored at room temperature.  
6 X LOADING BUFFER (PH 8) 
30 ml 100% Glycerol 
60 mg bromophenol blue 
0,6 g SDS 
Make up to 100 ml using TE, autoclave at 121 °C for 10 minutes. Store at room temperature 










     Amplicon sizes  





RDmsrA msrA_Rv0138_Forward 5'ACATGGAGATGGATGTGGTG3' 61.96 20 bp 501 bp 853 bp Not real deletion 
msrA_Rv0138_Int_reverse 5'TCTTCTTCCAGATCCACGAC3' 61.29 20 bp    
msrA_Rv0138_Reverse 5'GCATAACTGCTGGTGAAGAC3' 61.34 20 bp    
RDRv0336 Rv0336_Forward 5'AGTCATCCACGTTATCCACAG3' 61.91 21 bp 500 bp 849 bp Not real deletion 
Rv0336_Int_reverse 5'ATCAGGGTCAACGATCAAGTC'3 61.19 22 bp    
Rv0336_Reverse 5'TAACTTCCTGGTCAGTTACCG3' 61.5 23 bp    
RD
Rio
 RDRio_new_fwd  5' ATGACCATTCCTCCAACACC 3' 62.19 20 bp 843 bp 2041 
bp 
 
RDRio_new_int_rev 5' ATGAAATAAGAAGTCCTCCCAG 3' 59.97 22 bp    
RDRio_new_rev 5' GATAGACCGTTTCCTGCCAC 3' 62.91 20 bp    
RD149 RD149_Tosl_fwd 5' CATGTCACCCTGGCCCGACGGGTC 3' 71 24 bp 1170 bp 669 bp  
RD149_intrev 5' ACCGGCGGATTTCTTTGTCGTCGCTGTG 
3' 
69 28 bp    
RD149_Tsol_rev 5' CCAGGCGATCTTCGACCACGGCACAC 3' 70 26 bp    
RD152 RD152_Tsol_fw  5' 
CCGGGTTGAGCAATGCGGATATCAGTGGAC 
3' 
68 30 bp 640 bp 639 bp  
 RD152_Tsol_int_rev 5' TCAAATCCGGTCAGGTACACGGTATTCC 
3' 
69.76 28 bp    
 RD152_Tsol_rev 5' 
TGGGATAGTTCAGGTGGCCATCGTGGGCAT 
3' 
70 30 bp    
 RD152_new_fw 5' GCAACCCATCTGTTCATCTC 3' 61.06 20 bp 321 bp 537 bp  
 RD152_new_int_rev 5' GTATCGGGTTCCTGATCCAC 3' 62.08 21 bp    
 RD152_new_rev 5' TGACCTATACCGACCGACTG '3 62.94 22 bp    
RD174 RD174_fwd 5‘ GCGGTCCTCGTTGTCCTC 3‘ 60.19 18 bp 264 bp 400 bp  
 RD174_int_rev 5‘ ACGGCATCCATTGTGATCTG 3‘ 60.33 20 bp    
 RD174_rev 5‘ TGGCGATGGTCAGAAACTTG 3‘ 60.62 20 bp    
RD115 RD115_F 5‘ CTGGTGGCACGTTCGTATTC 3‘ 59.96 20 bp 240 bp 352 bp  
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 RD115_R1  5‘ GGATCTCGGTGCCCGAAC 3‘ 62.39 18 bp    
 RD115_R2 5‘ GCCATGTCCTGCTCAATGAC 3‘ 60.06 20 bp    
RDwbbL wbbl2_fw 5' TGTCCCTGATGATTACGGTG 3' 61.65 20 bp 751 bp 672 bp Not real deletion 
 wbbL_rev 5' GTGAGCGGAAATGACTTGTG 3' 61.89 20 bp    
 LSP2_R1 5' TGCAGCCGACGAAAGTCGTT 3' 64.93 20 bp    
 
TM= melting temperature
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IDENTIFIED IN/DELS SNPS IN GENES FOR DIFFERENT GROUPS OF ISOLATES 
Table 1  In/dels in SAWC 4498 and SAWC 5165 
Table 2   SNPs unique to all LAM isolates analysed 
Table 3   SNPs defining clade F9 and F13   
Table 4  SNPs defining clade F13  
Table 5  SNPs defining clade F9 
Table 6  SNPs defining clade F26, F14, F15 
Table 7  SNPs defining clade F26 
Table 8  SNPs defining clade F14 
Table 9  SNPs defining clade F15 
Table 10  SNPs defining clade F11 
Table 11  SNPs defining clade F14, F15 
Table 12 Indels overlapping between SAWC 4498 and SAWC 5165 (w.r.t. M. tuberculosis H37Rv) 
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Intergenic us. of Rv0441c - 1 Insertion 
Intergenic us. of Rv0759c 1 Insertion 
Rv0848 cysK2 9 Insertion 
Intergenic us. of Rv1161 - 1 Deletion 
Rv2790c ltp1 1 Insertion 
Rv2896c dprA 1 Deletion 
Rv3196  3 Deletion 






















Rv0064  1 Deletion 
Rv0278c PE_PGRS3 1 Insertion 
Rv1243c PE_PGRS23 1 Deletion 
Rv2490c PE_PGRS43 1 Deletion 
Rv3347c PPE55 1 Deletion 













Intergenic - 1 Insertion 
Intergenic us. of Rv2101 - 3 Deletion 
Intergenic us. of Rv2683 - 1 Insertion 
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Position Gene Gene 
name 












Gene description Functional category 
33457 Rv0030  C T 78 CAC H CAT H SYN hypothetical protein Conserved hypothetical 
74059 Rv0066c icd2 C A 151 AAG K AAA K SYN isocitrate dehydrogenase Intermediary metabolism 
and respiration 
180025 Rv0152c PE2 C A 291 GGG G GAG E NONSYN PE family protein PE/PPE families 
203269 Rv0172 mce1D C T 265 GCG A GTG V NONSYN MCE-family protein Virulence, detoxification 
and adaptation 
207226 Rv0175  T C 138 ATG M ACG T NONSYN MCE-associated membrane 
protein 
Cell wall and cell 
processes 
212353 Rv0181c  C A 220 CGC R CAC H NONSYN conserved hypothetical protein Conserved hypothetical 
472705 Intergenic - T C         
726703 Rv0631c recC C T 535 AGG R ATG M NONSYN exonuclease V gamma chain Information pathways 
764995 Rv0668 rpoC C G 542 GCC A GCG A SYN DNA-directed RNA 
polymerase beta chain 
Information pathways 
796509 Rv0696  G T 331 GGC G TGC C NONSYN membrane sugar transferase Intermediary metabolism 
and respiration 
942479 Intergenic - T C         
1142266 Rv1020 mfd A C 1100 CTA L CTC L SYN transcription-repair coupling 
factor 
Information pathways 
1199547 Rv1075c  G T 275 CCA P CTA L NONSYN conserved exported protein Cell wall and cell 
processes 




1428506 Rv1278  G T 365 GCC A TCC S NONSYN hypothetical protein Conserved hypothetical 
Stellenbosch University  http://scholar.sun.ac.za
Stellenbosch University  http://scholar.sun.ac.za
131 
 
1445474 Intergenic - G A         
1446923 Rv1292 argS T G 182 ATC I AGC S NONSYN arginyl-tRNA synthetase Information pathways 
1480024 Rv1318c  G A 267 TTC F TTA L NONSYN adenylate cyclase Intermediary metabolism 
and respiration 




1692795 Intergenic - G C         
1718761 Rv1524  C T 12 GGC G GGT G SYN glycosyltransferase Intermediary metabolism 
and respiration 
1734994 Rv1534  C T 87 GCC A GCT A SYN transcriptional regulator Regulatory 
1947903 Rv1722  G T 15 GTG V TTG L NONSYN carboxylase lipid metabolism 
1981056 Intergenic - C T         
2207525 Intergenic - C T         
2283030 Rv2037c  A C 231 ATT I ACT T NONSYN conserved membrane protein Cell wall and cell 
processes 
2484255 Rv2216  T G 210 GCT A GCG A SYN conserved hypothetical protein Conserved hypothetical 
2502073 Rv2228c  C A 222 CGG R CGA R SYN conserved hypothetical protein Information pathways 
2621058 Rv2343c dnaG G T 465 CCC P CCT P SYN DNA primase Information pathways 
2736434 Intergenic - C A         
2745889 Rv2446c  C A 84 GCC A ACC T NONSYN conserved membrane protein Cell wall and cell 
processes 
2871048 Rv2551c  C A 49 CTG L CTA L SYN conserved hypothetical protein Conserved hypothetical 
2881455 Rv2561  A G 16 TAC Y TGC C NONSYN conserved hypothetical protein Conserved hypothetical 
2968913 Intergenic - T C         
3077039 Rv2768c PPE43 C T 347 GGC G GTC V NONSYN PPE family protein PE/PPE families 
3101119 Rv2791c  G A 155 CGC R AGC S NONSYN transposase Insertion seqs and phages 
3165074 Rv2854  T C 308 GTG V GCG A NONSYN hypothetical protein Conserved hypothetical 
3175702 Rv2864c  T G 522 ATC I GTC V NONSYN penicillin-binding lipoprotein Cell wall and cell 
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3191027 Rv2881c cdsA G T 199 CTG L TTG L SYN membrane phosphatidate 
cytidylyltransferase 
lipid metabolism 
3243630 Intergenic - G A         
3426795 Rv3062 ligB C G 404 TCC S TCG S SYN ATP-dependent DNA ligase Information pathways 
3429202 Rv3063 cstA T G 654 TAC Y GAC D NONSYN carbon starvation protein A Virulence, detoxification 
and adaptation 
3460986 Rv3092c  G T 250 CCG P CTG L NONSYN conserved membrane protein Cell wall and cell 
processes 
3548641 Rv3179  T C 342 TAT Y CAT H NONSYN conserved hypothetical protein Conserved hypothetical 
3594124 Rv3217c  C A 38 GCC A ACC T NONSYN conserved membrane protein Cell wall and cell 
processes 
3610441 Rv3234c  C A 250 CGT R CAT H NONSYN conserved hypothetical protein lipid metabolism 
3983271 Rv3544c fadE28 T C 292 ATC I CTC L NONSYN acyl-CoA dehydrogenase lipid metabolism 
4075957 Rv3636  C A 69 GCC A GAC D NONSYN transposase Insertion seqs and phages 
4135112 Rv3693  G A 129 ATG M ATA I NONSYN conserved membrane protein Cell wall and cell 
processes 
4163944 Rv3720  A G 70 CAT H CGT R NONSYN fatty-acid synthase lipid metabolism 
4220174 Rv3775 lipE G A 164 GAC D AAC N NONSYN lipase Intermediary metabolism 
and respiration 
4233299 Rv3786c  G T 100 ACC T ATC I NONSYN hypothetical protein Conserved hypothetical 
4340330 Rv3864  T G 21 TTG L GTG V NONSYN conserved hypothetical protein Cell wall and cell 
processes 
4373496 Rv3889c  C C 45 GTG V GTC V SYN hypothetical protein Cell wall and cell 
processes 
4391553 Rv3906c  C A 18 CCG P CCA P SYN conserved hypothetical protein Conserved hypothetical 
Ref = reference, Alt = alternative, AA = amino acid, syn = synonymous, non-syn/NONSYN = non-synonymous 
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Position Gene Gene 
name 












Gene description Functional category 





101727 Rv0092 ctpA G A 382 GGA G GAA E NONSYN cation transporter P-type 
ATPase A 
Cell wall and cell 
processes 
176303 Rv0149  C T 202 CAC H TAC Y NONSYN quinone oxidoreductase Intermediary 
metabolism and 
respiration 
234051 Rv0197  G A 607 CCG P CCA P SYN oxidoreductase Intermediary 
metabolism and 
respiration 
478358 Rv0399c lpqK C A 67 GAG E AAG K NONSYN lipoprotein Cell wall and cell 
processes 




571943 Rv0483 lprQ G A 78 GTG V GTA V SYN lipoprotein Cell wall and cell 
processes 




733798 Rv0638 secE1 G C 21 AGC S ACC T NONSYN preprotein translocase Cell wall and cell 
processes 




1037355 Rv0930 pstA1 T C 119 ACT T ACC T SYN phosphate-transport 
membrane ABC transporter 
Cell wall and cell 
processes 




1281443 Rv1154c  C C 14 AAG K AAC N NONSYN hypothetical protein Conserved 
hypothetical 
1297327 Rv1166 lpqW G A 392 GTG V GTA V SYN lipoprotein Cell wall and cell 
processes 
1297999 Rv1166 lpqW T G 616 TCT S TCG S SYN lipoprotein Cell wall and cell 
processes 
1691799 Rv1500  C T 317 ACC T ATC I NONSYN glycosyltransferase Intermediary 
metabolism and 
respiration 
1709899 Rv1518  A C 86 AAC N CAC H NONSYN conserved hypothetical Conserved 
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1719322 Rv1524  G A 199 CTG L CTA L SYN glycosyltransferase Intermediary 
metabolism and 
respiration 
1736638 Rv1536 ileS C T 40 CGC R CGT R SYN isoleucyl-tRNA synthetase Information pathways 
1847811 Rv1639c  A G 216 CCT P CCG P SYN conserved membrane 
protein 
Cell wall and cell 
processes 
1861274 Rv1650 pheT G A 506 CGC R CAC H NONSYN phenylalanyl-tRNA 
synthetase beta chain 
Information pathways 
2007785 Intergenic - C T         
2126366 Rv1877  G C 155 GTC V CTC L NONSYN conserved membrane 
protein 
Cell wall and cell 
processes 
2213265 Rv1969 mce3D G A 137 CGG R CGA R SYN MCE-family protein Virulence, 
detoxification and 
adaptation 




2527676 Rv2252  G A 230 GGC G AGC S NONSYN conserved hypothetical 
protein 
lipid metabolism 
2599821 Rv2326c  C T 43 GCG A TCG S NONSYN transmembrane ATP-binding 
protein ABC transorter 
Cell wall and cell 
processes 
2664299 Rv2380c mbtE G G 939 ACC T ACG T SYN peptide synthetase lipid metabolism 




2857014 Rv2531c  G T 256 ACC T ACT T SYN amino acid decarboxylase Intermediary 
metabolism and 
respiration 









2946157 Rv2617c  T G 44 AAT N AGT S NONSYN transmembrane protein Cell wall and cell 
processes 
3099269 Rv2790c ltp1 A G 301 TTC F GTC V NONSYN lipid-transfer protein Cell wall and cell 
processes 




3312632 Rv2959c  C A 69 TGG W TGA _ NONSYN methyltransferase/methylase Intermediary 
metabolism and 
respiration 
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3377326 Intergenic - G A         
3874191 Intergenic - T C         




3977226 Rv3538  G A 55 TTG L TTA L SYN dehydrogenase Intermediary 
metabolism and 
respiration 
4042761 Rv3598c lysS G T 60 GAC D GAT D SYN lysyl-tRNA synthetase 1 Information pathways 
4109354 Rv3667 acs A C 521 CTA L CTC L SYN acetyl-CoA synthetase lipid metabolism 




4311871 Rv3838c pheA G T 267 CAC H TAC Y NONSYN prephenate dehydratase Intermediary 
metabolism and 
respiration 
4319652 Intergenic - G A         
4372661 Rv3888c  T G 16 ATC I GTC V NONSYN conserved membrane 
protein 
Cell wall and cell 
processes 








Ref = reference, Alt = alternative, AA = amino acid, syn = synonymous, non-syn/NONSYN = non-synonymous 
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Position Gene Gene 
name 












Gene description Functional category 
170263 Intergenic - G A         
197047 Rv0167 yrbE1A A G 63 ATG M GTG V NONSYN hypothetical membrane protein Virulence, detoxification and 
adaptation 
338012 Rv0279c PE_PGRS4 C A 354 CTG L CTA L SYN PE-PGRS family protein PE/PPE families 
361362 Rv0297 PE_PGRS5 T C 10 ATG M ACG T NONSYN PE-PGRS family protein PE/PPE families 
393780 Rv0327c cyp135A1 T C 89 GAG E GCG A NONSYN cytochrome P450 135A1 Intermediary metabolism 
and respiration 
831206 Rv0739  C T 118 CAG Q TAG _ NONSYN conserved hypothetical protein Conserved hypothetical 
1002044 Rv0897c  A C 124 GAT D GAC D SYN oxidoreductase Intermediary metabolism 
and respiration 
1106649 Rv0989c grcC2 T G 245 TAC Y TGC C NONSYN polyprenyl-diphosphate synthase Intermediary metabolism 
and respiration 
1150143 Intergenic - G T         
1251955 Rv1128c  C A 340 GCG A ACG T NONSYN conserved hypothetical protein Insertion seqs and phages 
1274335 Rv1146 mmpL13b G A 327 TTG L TTA L SYN transmembrane transport protein Cell wall and cell processes 
1364434 Rv1221 sigE C T 8 CGG R TGG W NONSYN alternative RNA polymerase 
sigma factor 
Information pathways 





1692824 Intergenic - A G         
1953648 Rv1727  T C 127 TGG W CGG R NONSYN conserved hypothetical protein Conserved hypothetical 
2133668 Rv1883c  C T 9 GGT G TGT C NONSYN conserved hypothetical protein Conserved hypothetical 
2199684 Rv1949c  G T 117 TTC F TTT F SYN conserved hypothetical protein Conserved hypothetical 
2210740 Rv1967 mce3B A C 47 AAC N ACC T NONSYN MCE-family protein Virulence, detoxification and 
adaptation 
2316912 Rv2061c  G T 58 AAC N AAT N SYN conserved hypothetical protein Conserved hypothetical 
3118976 Rv2813  C G 251 GAC D GAG E NONSYN conserved hypothetical protein Conserved hypothetical 
3244674 Rv2930 fadD26 G A 326 CGG R CGA R SYN fatty-acid-CoA ligase lipid metabolism 
3285945 Rv2942 mmpL7 C G 292 GCC A GCG A SYN transmembrane transport protein Cell wall and cell processes 
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3558749 Intergenic - G T         
3700783 Rv3312A  G T 78 CCC P CCT P SYN secreted protein antigen Cell wall and cell processes 
4068928 Rv3629c  G T 43 CTG L TTG L SYN conserved membrane protein Cell wall and cell processes 
4121030 Intergenic - G A         
4288212 Intergenic - C T         
4345420 Rv3869  G T 128 GTT V TTT F NONSYN conserved membrane protein Cell wall and cell processes 
4398141 Rv3910  G A 515 TCG S TCA S SYN conserved membrane protein Cell wall and cell processes 
4404694 Rv3916c  G T 158 GGC G GGT G SYN conserved hypothetical protein Conserved hypothetical 
Ref = reference, Alt = alternative, AA = amino acid, syn = synonymous, non-syn/NONSYN = non-synonymous 
 
Stellenbosch University  http://scholar.sun.ac.za




Position Gene Gene 
name 












Gene description Functional category 
40162 Rv0037c  C A 347 ATG M ATA I NONSYN conserved membrane 
protein 
Cell wall and cell 
processes 
282188 Rv0235c  G T 143 CGC R TGC C NONSYN conserved membrane 
protein 
Cell wall and cell 
processes 
623021 Rv0532 PE_PGRS6 G T 77 GTG V TTG L NONSYN PE-PGRS family 
protein 
PE/PPE families 





784440 Rv0684 fusA1 G T 652 GCG A GCT A SYN elongation factor G Information pathways 
990533 Rv0890c  T G 688 ACA T ACG T SYN transcriptional 
regulator, luxR-family 
Regulatory 





1132368 Rv1013 pks16 C T 248 ACC T ACT T SYN polyketide synthase lipid metabolism 
1373170 Rv1230c  G G 343 CCG P CGG R NONSYN membrane protein Cell wall and cell 
processes 
1724120 Rv1527c pks5 G T 1430 GAC D GAT D SYN polyketide synthase lipid metabolism 
1755599 Rv1551 plsB1 C T 52 GCC A GTC V NONSYN acyltransferase lipid metabolism 










2019942 Rv1783  A G 229 CAG Q CGG R NONSYN conserved membrane 
protein 
Cell wall and cell 
processes 








2327492 Rv2069 sigC C T 183 CTC L CTT L SYN RNA polymerase 
sigma factor 
Information pathways 
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Cell wall and cell 
processes 
2443188 Rv2180c  G T 9 CAC H CAT H SYN conserved membrane 
protein 
Cell wall and cell 
processes 
3006767 Rv2689c  A G 99 CTT L CGT R NONSYN conserved alanine, 




3089679 Rv2782c pepR G T 228 CCA P CTA L NONSYN zinc protease Intermediary 
metabolism and 
respiration 
3158935 Rv2850c  G G 374 CGC R GGC G NONSYN magnesium chelatase Intermediary 
metabolism and 
respiration 









3514512 Rv3148 nuoD G C 392 GGT G GCT A NONSYN NADH dehydrogenase 




3561155 Rv3193c  G T 673 GCC A GTC V NONSYN conserved membrane 
protein 
Cell wall and cell 
processes 
3847378 Rv3429 PPE59 G C 72 GAC D CAC H NONSYN PPE family protein PE/PPE families 
3847380 Rv3429 PPE59 C A 72 GAC D GAA E NONSYN PPE family protein PE/PPE families 








4288405 Rv3823c mmpL8 G A 1042 GCA A GAA E NONSYN membrane transport 
protein 
Cell wall and cell 
processes 
4359195 Rv3879c  G T 196 GGC G GGT G SYN hypothetical alanine 
and proline rich protein 
Cell wall and cell 
processes 
4377447 Rv3894c  G T 1002 GAC D GAT D SYN conserved membrane 
protein 
Cell wall and cell 
processes 
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4403900 Rv3915  A G 237 ATG M GTG V NONSYN hydrolase Intermediary 
metabolism and 
respiration 
Ref = reference, Alt = alternative, AA = amino acid, syn = synonymous, non-syn/NONSYN = non-synonymous 
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Position Gene Gene 
name 












Gene description Functional category 
8040 Rv0006 gyrA G A 247 GGC G AGC S NONSYN DNA gyrase subunit A Information pathways 
387353 Rv0319 pcp G A 69 GGC G GAC D NONSYN pyrrolidone-carboxylate 
peptidase 
Intermediary metabolism and 
respiration 
403364 Rv0338c  G T 826 CCC P CCT P SYN iron-sulfur-binding 
reductase 
Intermediary metabolism and 
respiration 
403920 Rv0338c  C A 641 CGC R CAC H NONSYN iron-sulfur-binding 
reductase 
Intermediary metabolism and 
respiration 
479632 Rv0400c fadE7 G A 41 ACC T AAC N NONSYN acyl-CoA dehydrogenase lipid metabolism 
535695 Rv0447c ufaA1 C A 271 GGG G GGA G SYN cyclopropane-fatty-acyl-
phospholipid synthase 
lipid metabolism 
558501 Rv0467 icl C T 325 GAC D GAT D SYN isocitrate lyase Intermediary metabolism and 
respiration 
752802 Intergenic - A C         
812808 Rv0717 rpsN1 G A 61 TGG W TAG _ NONSYN 30S ribosomal protein S14 Information pathways 
919393 Rv0825c  G G 54 ACA T AGA R NONSYN conserved hypothetical 
protein 
Conserved hypothetical 
1087279 Rv0974c accD2 T G 23 AAG K GAG E NONSYN acetyl-/propionyl-CoA 
carboxylase beta subunit 
lipid metabolism 
1144664 Rv1023 eno G A 34 CGG R CAG Q NONSYN enolase Intermediary metabolism and 
respiration 
1162274 Rv1039c PPE15 C A 67 GCC A ACC T NONSYN PPE family protein PE/PPE families 
1519847 Rv1353c  C C 47 GGC G CGC R NONSYN transcriptional regulator Regulatory 
1546530 Rv1373  G A 173 GAG E GAA E SYN glycolipid sulfotransferase Intermediary metabolism and 
respiration 
1651306 Rv1463  C T 197 GCC A GCT A SYN ABC transporter ATP-
binding protein 
Cell wall and cell processes 
1797027 Rv1595 nadB C T 408 ACC T ATC I NONSYN L-aspartate oxidase Intermediary metabolism and 
respiration 
1815604 Rv1615  G A 118 GCC A ACC T NONSYN hypothetical membrane 
protein 
Cell wall and cell processes 
2037716 Rv1798  T C 339 CGT R CGC R SYN conserved hypothetical 
protein 
Cell wall and cell processes 
2077253 Rv1832 gcvB G A 459 ACG T ACA T SYN glycine dehydrogenase Intermediary metabolism and 
respiration 
2108838 Intergenic - C T         
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2144617 Rv1897c  G T 89 CCG P CTG L NONSYN conserved hypothetical 
protein 
Conserved hypothetical 
2315669 Rv2059  G A 166 GTC V ATC I NONSYN conserved hypothetical 
protein 
Conserved hypothetical 
2401883 Intergenic - C T         
2518919 Rv2245 kasA G A 269 GGT G AGT S NONSYN 3-oxoacyl-[acyl-carrier 
protein] synthase 1 
lipid metabolism 
2814961 Rv2501c accA1 G T 640 GGC G GGT G SYN acetyl-/propionyl-CoA 
carboxylase alpha subunit 
lipid metabolism 
3004091 Rv2687c  G T 220 CGG R TGG W NONSYN antibiotic-transport 
membrane leucine and 
valine rich protein ABC 
transporter 
Cell wall and cell processes 
3061615 Rv2748c ftsK T G 298 ATG M GTG V NONSYN cell division 
transmembrane protein 
Cell wall and cell processes 
3351926 Rv2994  T C 220 TCG S CCG P NONSYN conserved membrane 
protein 
Cell wall and cell processes 
3423184 Rv3060c  C A 10 ACG T ACA T SYN transcriptional regulator, 
gntR-family 
Regulatory 
3894032 Intergenic - T A         
3973954 Rv3535c  C A 183 GGG G AGG R NONSYN acetaldehyde 
dehydrogenase 
Intermediary metabolism and 
respiration 
4316046 Rv3843c  A C 184 GTC V GCC A NONSYN conserved membrane 
protein 
Cell wall and cell processes 
4363069 Rv3882c  T G 118 ATC I GTC V NONSYN conserved membrane 
protein 
Cell wall and cell processes 
4376098 Intergenic - G A         
4385530 Rv3900c  G G 260 CCA P CGA R NONSYN conserved alanine rich 
protein 
Conserved hypothetical 
4390753 Rv3905c esxF C C 93 TCG S TCC S SYN Esat-6 like protein Cell wall and cell processes 
Ref = reference, Alt = alternative, AA = amino acid, syn = synonymous, non-syn/NONSYN = non-synonymous 
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Gene description Functional category 
12061 Rv0008c  G G 84 GCC A GGC G NONSYN membrane protein Cell wall and cell 
processes 
19185 Rv0016c pbpA T C 350 GCA A GCC A SYN penicillin-binding protein Cell wall and cell 
processes 
52856 Rv0049  C G 9 TCC S TGC C NONSYN conserved hypothetical 
protein 
Conserved hypothetical 
86811 Rv0078  C T 95 GCA A GTA V NONSYN transcriptional regulator Regulatory 
119689 Rv0102  T G 659 ATG M AGG R NONSYN conserved membrane 
protein 
Cell wall and cell 
processes 
191766 Rv0161  C T 387 GCG A GTG V NONSYN oxidoreductase Intermediary metabolism 
and respiration 
227923 Rv0194  T C 349 GTG V GCG A NONSYN drugs-transport 
transmembrane ATP-
binding protein ABC 
transporter 
Cell wall and cell 
processes 
236412 Rv0198c  C T 32 TGG W TGT C NONSYN zinc metalloprotease Intermediary metabolism 
and respiration 
294183 Rv0244c fadE5 C A 484 GGT G GAT D NONSYN acyl-CoA dehydrogenase lipid metabolism 
364984 Rv0302  C T 127 GCG A GTG V NONSYN transcriptional regulator, 
tetR/acrR-family 
Regulatory 




429936 Rv0355c PPE8 G T 1582 CAG Q TAG _ NONSYN PPE family protein PE/PPE families 




527770 Rv0439c  G A 182 GCC A GAC D NONSYN dehydrogenase/reductase Intermediary metabolism 
and respiration 




629571 Rv0537c  G T 54 ACA T ATA I NONSYN membrane protein Cell wall and cell 
processes 
654508 Rv0563 htpX C T 210 GAC D GAT D SYN protease transmembrane 
protein heat shock protein 
Virulence, detoxification 
and adaptation 
661901 Rv0570 nrdZ C T 203 CAA Q TAA _ NONSYN ribonucleoside- Information pathways 
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668666 Rv0575c  C A 360 GCG A GCA A SYN oxidoreductase Intermediary metabolism 
and respiration 
693403 Rv0594 mce2F C T 56 GCC A GTC V NONSYN MCE-family protein Virulence, detoxification 
and adaptation 
696089 Rv0597c  A C 272 GTG V GCG A NONSYN conserved hypothetical 
protein 
Conserved hypothetical 
696362 Rv0597c  C A 181 CGA R CAA Q NONSYN conserved hypothetical 
protein 
Conserved hypothetical 
707548 Rv0613c  C T 656 CCG P CCT P SYN hypothetical protein Conserved hypothetical 
744571 Rv0648  G A 618 GGC G GAC D NONSYN alpha-mannosidase Intermediary metabolism 
and respiration 
779675 Rv0679c  C A 122 GCG A GCA A SYN conserved threonine rich 
protein 
Conserved hypothetical 




913355 Rv0820 phoT T C 210 GCT A GCC A SYN phosphate-transport ATP-
binding protein ABC 
transporter 
Cell wall and cell 
processes 
932523 Rv0836c  T G 137 GAC D GGC G NONSYN hypothetical protein Conserved hypothetical 
951237 Rv0854  C T 19 CTG L TTG L SYN conserved hypothetical 
protein 
Conserved hypothetical 
978545 Rv0879c  G G 71 GCC A GGC G NONSYN conserved membrane 
protein 
Cell wall and cell 
processes 
1001680 Rv0897c  G T 246 CTG L TTG L SYN oxidoreductase Intermediary metabolism 
and respiration 




1133442 Rv1014c pth G A 156 CCG P CAG Q NONSYN peptidyl-tRNA hydrolase Intermediary metabolism 
and respiration 
1154958 Rv1030 kdpB T G 412 ATC I AGC S NONSYN potassium-transporting 
ATPase B chain 
Cell wall and cell 
processes 
1177688 Rv1056  C T 21 CGA R TGA _ NONSYN conserved hypothetical 
protein 
Conserved hypothetical 
1246372 Rv1123c bpoB C A 227 CAG Q CAA Q SYN peroxidase Virulence, detoxification 
and adaptation 
1263722 Intergenic - G T         
1382804 Rv1239c corA T G 80 GAA E GGA G NONSYN magnesium and cobalt Cell wall and cell 
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1384034 Rv1240 mdh C T 274 TAC Y TAT Y SYN malate dehydrogenase Intermediary metabolism 
and respiration 
1394772 Rv1250  C A 198 CCC P CCA P SYN drug-transport membrane 
protein 
Cell wall and cell 
processes 
1399635 Rv1252c lprE T G 90 AAA K AAG K SYN lipoprotein Cell wall and cell 
processes 




1452590 Rv1296 thrB G A 198 GTG V GTA V SYN homoserine kinase Intermediary metabolism 
and respiration 
1599431 Rv1424c  G T 75 CCG P CTG L NONSYN membrane protein Cell wall and cell 
processes 
1628121 Rv1449c tkt G T 693 GCC A GCT A SYN transketolase Intermediary metabolism 
and respiration 
1648024 Rv1461  A G 346 ACC T GCC A NONSYN conserved hypothetical 
protein 
Conserved hypothetical 
1655718 Rv1468c PE_PGRS29 T G 335 CAG Q CGG R NONSYN PE-PGRS family protein PE/PPE families 
1720865 Rv1526c  G T 399 GCC A GTC V NONSYN glycosyltransferase Intermediary metabolism 
and respiration 
1723708 Rv1527c pks5 T G 1568 ACC T GCC A NONSYN polyketide synthase lipid metabolism 
1744607 Rv1542c glbN A C 77 ATG M ACG T NONSYN hemoglobin Intermediary metabolism 
and respiration 
1795283 Rv1594 nadA T C 176 TGT C TGC C SYN quinolinate synthetase Intermediary metabolism 
and respiration 
1823150 Rv1621c cydD G G 42 CCA P GCA A NONSYN transmembrane ATP-




1865421 Intergenic - T C         
1917190 Rv1692  G A 165 GGC G AGC S NONSYN phosphatase Intermediary metabolism 
and respiration 
1925758 Rv1700  G A 59 ATG M ATA I NONSYN conserved hypothetical 
protein 
Information pathways 
1948374 Rv1722  T G 172 TCG S GCG A NONSYN carboxylase lipid metabolism 
2050007 Rv1808 PPE32 G A 29 GCG A GCA A SYN PPE family protein PE/PPE families 
2092031 Rv1842c  C A 19 GGC G AGC S NONSYN conserved membrane 
protein 
Cell wall and cell 
processes 
2107515 Rv1859 modC C T 314 GTC V GTT V SYN molybdenum-transport 
ATP-binding protein ABC 
transporter 
Cell wall and cell 
processes 
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2125239 Intergenic - C T         
2129505 Rv1879  C T 43 GCC A GCT A SYN conserved hypothetical 
protein 
Conserved hypothetical 
2187314 Intergenic - T C         
2209726 Rv1966 mce3A G A 134 GCG A ACG T NONSYN MCE-family protein Virulence, detoxification 
and adaptation 
2309071 Rv2051c ppm1 G G 562 GCC A GGC G NONSYN polyprenol-
monophosphomannose 
synthase 
Cell wall and cell 
processes 
2378805 Rv2119  G A 140 TTG L TTA L SYN conserved hypothetical 
protein 
Conserved hypothetical 
2382238 Rv2123 PPE37 G A 390 GCA A ACA T NONSYN PPE family protein PE/PPE families 
2388969 Rv2127 ansP1 C T 118 ACC T ACT T SYN L-asparagine permease Cell wall and cell 
processes 
2424422 Rv2162c PE_PGRS38 A C 139 GGT G GGC G SYN PE-PGRS family protein PE/PPE families 
2424425 Rv2162c PE_PGRS38 A C 138 GGT G GGC G SYN PE-PGRS family protein PE/PPE families 
2448663 Rv2187 fadD15 G C 168 CCG P CCC P SYN long-chain fatty-acid-CoA 
ligase 
lipid metabolism 
2469415 Rv2205c  C T 350 GGG G GTG V NONSYN conserved hypothetical 
protein 
Conserved hypothetical 




2578942 Intergenic - C G         
2604872 Rv2331A  A C 45 AGG R CGG R SYN hypothetical protein Conserved hypothetical 
2653956 Rv2373c dnaJ2 A C 11 GTG V GCG A NONSYN chaperone protein Virulence, detoxification 
and adaptation 
2715432 Intergenic - G A         
2794377 Rv2486 echA14 A C 10 AGC S CGC R NONSYN enoyl-CoA hydratase lipid metabolism 
2836124 Rv2519 PE26 G A 114 GAG E AAG K NONSYN PE family protein PE/PPE families 
2857169 Rv2531c  G T 205 CGG R TGG W NONSYN amino acid decarboxylase Intermediary metabolism 
and respiration 
2890577 Rv2567  G A 261 GTG V GTA V SYN conserved alanine and 
leucine rich protein 
Conserved hypothetical 
2904696 Intergenic - T C         
2955638 Intergenic - C T         
2957961 Rv2631  C T 130 GAC D GAT D SYN conserved hypothetical 
protein 
Conserved hypothetical 
2974895 Rv2650c  G T 114 CTG L TTG L SYN phiRv2 phage protein Insertion seqs and phages 
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3201547 Rv2892c PPE45 C A 158 GCG A GCA A SYN PPE family protein PE/PPE families 
3208017 Rv2898c  A C 104 GAT D GAC D SYN conserved hypothetical 
protein 
Conserved hypothetical 




3375293 Rv3015c  C A 124 CTG L CTA L SYN conserved hypothetical 
protein 
Conserved hypothetical 
3380083 Rv3021c PPE47 C C 124 GAA E CAA Q NONSYN PPE family protein PE/PPE families 
3397503 Rv3037c  T C 263 CAG Q CCG P NONSYN conserved hypothetical 
protein 
Conserved hypothetical 
3411980 Intergenic - A G         
3417213 Rv3056 dinP T G 170 CTC L CGC R NONSYN DNA-damage-inducible 
protein P 
Information pathways 
3539905 Rv3171c hpx G T 281 CTG L TTG L SYN non-heme haloperoxidase Virulence, detoxification 
and adaptation 
3588423 Rv3211 rhlE T A 209 TTT F TAT Y NONSYN ATP-dependent RNA 
helicase 
Information pathways 
3610134 Rv3233c  C T 80 GCC A TCC S NONSYN conserved hypothetical 
protein 
lipid metabolism 
3627602 Rv3247c tmk G G 154 GCC A GCG A SYN thymidylate kinase Intermediary metabolism 
and respiration 




3746187 Rv3347c PPE55 G T 2333 ACG T ATG M NONSYN PPE family protein PE/PPE families 
3769440 Rv3354  A C 110 GCA A GCC A SYN conserved hypothetical 
protein 
Conserved hypothetical 
3769771 Rv3355c  C C 13 GCC A CCC P NONSYN conserved hypothetical 
protein 
Cell wall and cell 
processes 
3823862 Rv3403c  A C 1 ATG M ACG T NONSYN hypothetical protein Conserved hypothetical 
3842461 Rv3425 PPE57 T A 75 TCT S ACT T NONSYN PPE family protein PE/PPE families 
3843433 Rv3426 PPE58 G T 133 AGA R ATA I NONSYN PPE family protein PE/PPE families 
3858312 Rv3439c  C T 451 GGA G TGA _ NONSYN conserved alanine and 
proline rich protein 
Conserved hypothetical 




3923531 Rv3504 fadE26 A T 354 AAT N ATT I NONSYN acyl-CoA dehydrogenase lipid metabolism 
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3969205 Intergenic - G A         
4046289 Intergenic - C A         
4207533 Rv3762c  C A 448 GCG A GCA A SYN hydrolase Intermediary metabolism 
and respiration 
4219577 Rv3774 echA21 C T 243 GTC V GTT V SYN enoyl-CoA hydratase lipid metabolism 




4233817 Rv3787c  C A 240 TGG W TGA _ NONSYN conserved hypothetical 
protein 
Conserved hypothetical 
4247209 Rv3795 embB A G 232 GCA A GCG A SYN membrane 
indolylacetylinositol 
arabinosyltransferase 
Cell wall and cell 
processes 
4304481 Rv3829c  G T 176 GAC D GAT D SYN dehydrogenase Intermediary metabolism 
and respiration 
4405182 Intergenic - C T         
4409137 Rv3921c  T G 311 CCA P CCG P SYN conserved membrane 
protein 
Cell wall and cell 
processes 
Ref = reference, Alt = alternative, AA = amino acid, syn = synonymous, non-syn/NONSYN = non-synonymous 
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Position Gene Gene 
name 












Gene description Functional category 
4057146 Intergenic - C T         
4096985 Rv3659c  T C 337 GAC D GCC A NONSYN conserved hypothetical 
protein 
Conserved hypothetical 
4101905 Rv3662c  G G 44 GCC A GGC G NONSYN conserved hypothetical 
protein 
Conserved hypothetical 
4156467 Rv3711c dnaQ A C 88 GTC V GCC A NONSYN DNA polymerase III 
epsilon subunit 
Information pathways 
4175390 Rv3728  C T 173 GCG A GTG V NONSYN conserved membrane 
protein 
Cell wall and cell 
processes 
4209511 Rv3763 lpqH G C 155 GAG E GAC D NONSYN 19 kda lipoprotein 
antigen precursor 
Cell wall and cell 
processes 
4325029 Intergenic - T C         
4371779 Rv3888c  C T 310 GTG V TTG L NONSYN conserved membrane 
protein 
Cell wall and cell 
processes 
4384930 Rv3899c  C C 150 CTG L CTC L SYN conserved hypothetical 
protein 
Conserved hypothetical 
4388606 Rv3903c  G T 609 ACC T ACT T SYN hypothetical alanine and 
proline rich protein 
Conserved hypothetical 
4394450 Rv3909  G C 87 GTC V CTC L NONSYN conserved hypothetical 
protein 
Conserved hypothetical 
4397368 Rv3910  A C 258 ATG M CTG L NONSYN conserved membrane 
protein 
Cell wall and cell 
processes 
Ref = reference, Alt = alternative, AA = amino acid, syn = synonymous, non-syn/NONSYN = non-synonymous 
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Gene description Functional category 
88486 Rv0079  G C 95 GAT D CAT H NONSYN hypothetical protein Conserved hypothetical 
111360 Rv0101 nrp T C 454 TCC S CCC P NONSYN peptide synthetase lipid metabolism 
485409 Rv0404 fadD30 C A 478 CCC P CAC H NONSYN fatty-acid-CoA ligase lipid metabolism 
559052 Rv0468 fadB2 A C 53 GAG E GCG A NONSYN 3-hydroxybutyryl-CoA 
dehydrogenase 
lipid metabolism 
637871 Rv0546c  T G 33 GAA E GAG E SYN conserved hypothetical 
protein 
Conserved hypothetical 
751947 Rv0655 mkl T C 144 GTC V GCC A NONSYN ribonucleotide-transport ATP-
binding protein ABC 
transporter 
Cell wall and cell 
processes 
754198 Rv0658c  C A 71 CGC R CAC H NONSYN conserved membrane protein Cell wall and cell 
processes 
817856 Rv0724A  C C 4 CGG R CCG P NONSYN conserved hypothetical 
protein 
Conserved hypothetical 




1083576 Rv0972c fadE12 G A 59 CCC P ACC T NONSYN acyl-CoA dehydrogenase lipid metabolism 
1264381 Rv1135A  A G 23 TAC Y TGC C NONSYN acetyl-CoA acetyltransferase lipid metabolism 
1295418 Rv1165 typA G A 417 CTG L CTA L SYN GTP-binding translation 
elongation factor 
Information pathways 
1325165 Rv1184c  C A 149 CAG Q CAA Q SYN hypothetical exported protein Cell wall and cell 
processes 
1332535 Rv1189 sigI C A 148 GCC A GCA A SYN alternative RNA polymerase 
sigma factor 
Information pathways 
1476056 Intergenic - G A         
1489708 Rv1325c PE_PGRS24 C A 86 GCG A GCA A SYN PE-PGRS family protein PE/PPE families 
1540976 Intergenic - C T         
1791607 Rv1591  C T 13 CCT P CTT L NONSYN transmembrane protein Cell wall and cell 
processes 
1848184 Rv1639c  C A 92 TGG W TAG _ NONSYN conserved membrane protein Cell wall and cell 
processes 
1864767 Rv1651c PE_PGRS30 C C 206 GGG G CGG R NONSYN PE-PGRS family protein PE/PPE families 
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1929252 Rv1703c  T C 157 AAG K ACG T NONSYN catechol-O-methyltransferase Intermediary metabolism 
and respiration 
1968640 Rv1742  T A 156 ATT I ATA I SYN hypothetical protein Hypothetical 
1993334 Rv1760  T C 61 TTG L TCG S NONSYN conserved hypothetical 
protein 
lipid metabolism 
2049666 Intergenic - T G         
2175487 Rv1923 lipD A C 105 AAA K AAC N NONSYN lipase Intermediary metabolism 
and respiration 
2210644 Rv1967 mce3B T C 15 TTC F TCC S NONSYN MCE-family protein Virulence, detoxification 
and adaptation 
2223051 Rv1979c  C C 38 GAG E GAC D NONSYN permease Cell wall and cell 
processes 
2390534 Rv2129c  T G 219 AAC N AGC S NONSYN oxidoreductase Intermediary metabolism 
and respiration 




Cell wall and cell 
processes 
2569403 Rv2298  C A 108 CTG L ATG M NONSYN conserved hypothetical 
protein 
Conserved hypothetical 
2575350 Intergenic - T G         
2581689 Intergenic - A C         
2767371 Rv2464c  C A 99 GCA A ACA T NONSYN DNA glycosylase Information pathways 




2903463 Rv2578c  C A 23 TTG L TTA L SYN conserved hypothetical 
protein 
Conserved hypothetical 
2969308 Intergenic - A C         
3065824 Rv2752c  G T 123 CCG P CTG L NONSYN conserved hypothetical 
protein 
Conserved hypothetical 
3132784 Intergenic - G A         
3169584 Rv2858c aldC C A 380 GCG A GCA A SYN aldehyde dehydrogenase Intermediary metabolism 
and respiration 
3238703 Rv2924c fpg T C 256 GAA E GAC D NONSYN formamidopyrimidine-DNA 
glycosylase 
Information pathways 




3420056 Rv3059 cyp136 G A 189 GTC V ATC I NONSYN cytochrome P450 136 Intermediary metabolism 
and respiration 
3537404 Rv3169  A G 56 AAC N AGC S NONSYN conserved hypothetical Conserved hypothetical 
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3581314 Intergenic - C T         
3588184 Rv3211 rhlE G A 129 GTG V GTA V SYN ATP-dependent RNA helicase Information pathways 
3620280 Rv3240c secA1 G T 84 GAC D GAT D SYN preprotein translocase Cell wall and cell 
processes 
3633957 Rv3254  A C 95 ACG T CCG P NONSYN conserved hypothetical 
protein 
Conserved hypothetical 
3750163 Rv3347c PPE55 A C 1008 TTG L CTG L SYN PPE family protein PE/PPE families 
3938660 Rv3510c  A C 200 TAC Y CAC H NONSYN conserved hypothetical 
protein 
Conserved hypothetical 
3959536 Rv3523 ltp3 G A 3 GGA G GAA E NONSYN lipid carrier protein or keto 
acyl-CoA thiolase 
lipid metabolism 
3998613 Rv3558 PPE64 C T 212 CTC L TTC F NONSYN PPE family protein PE/PPE families 
4072240 Rv3633  G A 150 GCG A GCA A SYN conserved hypothetical 
protein 
Conserved hypothetical 
4099344 Intergenic - T C         
4156279 Rv3711c dnaQ C C 151 GGT G CGT R NONSYN DNA polymerase III epsilon 
subunit 
Information pathways 
4163246 Rv3719  G C 314 AGG R ACG T NONSYN conserved hypothetical 
protein 
Conserved hypothetical 
4177264 Rv3728  C T 798 CGT R TGT C NONSYN conserved membrane protein Cell wall and cell 
processes 
4399385 Rv3910  C T 930 GCG A GTG V NONSYN conserved membrane protein Cell wall and cell 
processes 
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Gene description Functional 
category 
41257 Intergenic - A G         
47699 Rv0043c  G T 134 CGC R CGT R SYN transcriptional regulator, gntR-
family 
Regulatory 
69025 Rv0064  G C 136 GTG V CTG L NONSYN conserved membrane protein Cell wall and 
cell 
processes 
113838 Rv0101 nrp C T 1280 CTT L TTT F NONSYN peptide synthetase lipid 
metabolism 
147655 Rv0120c fusA2 G G 39 CTC L CTG L SYN elongation factor G Information 
pathways 
165665 Rv0138  A G 115 ATC I GTC V NONSYN conserved hypothetical protein Conserved 
hypothetical 
243118 Rv0204c  G T 33 CGC R TGC C NONSYN conserved membrane protein Cell wall and 
cell 
processes 
243535 Rv0205  C T 51 GCG A GTG V NONSYN conserved membrane protein Cell wall and 
cell 
processes 
244719 Rv0206c mmpL3 G T 867 CCG P CTG L NONSYN transmembrane transport protein Cell wall and 
cell 
processes 
244911 Rv0206c mmpL3 G G 803 CCA P CGA R NONSYN transmembrane transport protein Cell wall and 
cell 
processes 
265154 Rv0221  G C 363 TGG W TCG S NONSYN conserved hypothetical protein lipid 
metabolism 
285876 Intergenic - C T         
287904 Rv0237 lpqI T C 240 GTC V GCC A NONSYN lipoprotein Cell wall and 
cell 
processes 
295917 Intergenic - C T         
302660 Intergenic - T C         
326039 Rv0270 fadD2 C T 491 GCC A GCT A SYN fatty-acid-CoA ligase lipid 
metabolism 
338533 Rv0279c PE_PGRS4 C A 181 GGC G AGC S NONSYN PE-PGRS family protein PE/PPE 
families 
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361596 Rv0297 PE_PGRS5 C T 88 GCC A GTC V NONSYN PE-PGRS family protein PE/PPE 
families 
370905 Rv0304c PPE5 G T 620 AAC N AAT N SYN PPE family protein PE/PPE 
families 
370911 Rv0304c PPE5 C C 618 TTG L TTC F NONSYN PPE family protein PE/PPE 
families 
371265 Rv0304c PPE5 C A 500 TCG S TCA S SYN PPE family protein PE/PPE 
families 




429247 Rv0355c PPE8 C A 1811 GGG G GGA G SYN PPE family protein PE/PPE 
families 
453780 Rv0376c  A C 198 ATG M ACG T NONSYN conserved hypothetical protein Conserved 
hypothetical 
457032 Rv0381c  T G 264 CTA L CTG L SYN hypothetical protein Conserved 
hypothetical 
466096 Rv0386  C T 896 CGC R TGC C NONSYN transcriptional regulator, 
luxR/uhpA-family 
Regulatory 
515125 Rv0425c ctpH T C 66 AAC N ACC T NONSYN metal cation transporting P-type 
ATPase 
Cell wall and 
cell 
processes 
533781 Rv0444c  T G 3 GAA E GAG E SYN conserved hypothetical protein Information 
pathways 
544683 Rv0453 PPE11 A G 504 ATG M GTG V NONSYN PPE family protein PE/PPE 
families 




701336 Intergenic - C T         
705595 Rv0610c  C A 105 GCG A GCA A SYN hypothetical protein Conserved 
hypothetical 




784581 Rv0684 fusA1 G C 699 ACG T ACC T SYN elongation factor G Information 
pathways 
814641 Rv0721 rpsE T C 105 GTA V GCA A NONSYN 30S ribosomal protein S5 Information 
pathways 
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848652 Intergenic - A G         
853469 Rv0758 phoR C A 358 GGC G GGA G SYN two component system sensor 
kinase 
Regulatory 
928525 Rv0834c PE_PGRS14 C A 654 AGC S AAC N NONSYN PE-PGRS family protein PE/PPE 
families 




980360 Rv0882  G T 46 GGT G TGT C NONSYN transmembrane protein Cell wall and 
cell 
processes 
986563 Intergenic - C T         
1047683 Rv0938  G T 516 TTG L TTT F NONSYN ATP dependent DNA ligase Information 
pathways 








1090172 Rv0976c  G T 2 CGT R TGT C NONSYN conserved hypothetical protein Conserved 
hypothetical 
1095687 Rv0980c PE_PGRS18 G G 255 ACC T ACG T SYN PE-PGRS family protein PE/PPE 
families 




1157768 Rv1032c trcS A G 63 CTG L CGG R NONSYN two component system sensor 
histidine kinase 
Regulatory 
1163404 Intergenic - C G         
1205269 Intergenic - C T         




1232496 Rv1105  T C 62 TAT Y TAC Y SYN para-nitrobenzyl esterase Intermediary 
metabolism 
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1277731 Rv1148c  G T 6 TGC C TGT C SYN conserved hypothetical protein Insertion 
seqs and 
phages 






1334260 Rv1191  C A 110 GGC G GGA G SYN conserved hypothetical protein Conserved 
hypothetical 















1472337 Intergenic - C T         




1636851 Rv1452c PE_PGRS28 G G 460 ACC T AGC S NONSYN PE-PGRS family protein PE/PPE 
families 
1692205 Rv1501  G A 106 GGC G AGC S NONSYN conserved hypothetical protein Conserved 
hypothetical 
1710070 Rv1518  C G 143 CAA Q GAA E NONSYN conserved hypothetical protein Conserved 
hypothetical 
1778557 Rv1571  C T 7 CTG L TTG L SYN conserved hypothetical protein Conserved 
hypothetical 
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1813255 Rv1614 lgt T A 29 TGC C AGC S NONSYN prolipoprotein diacylglyceryl 
transferases 
Cell wall and 
cell 
processes 
1838153 Rv1633 uvrB G A 360 CGC R CAC H NONSYN excinuclease ABC subunit B Information 
pathways 
1842280 Intergenic - C T         




1862335 Intergenic - A G         
1885073 Rv1662 pks8 A G 1124 ATG M GTG V NONSYN polyketide synthase lipid 
metabolism 
1887410 Rv1663 pks17 C G 300 CCG P CGG R NONSYN polyketide synthase lipid 
metabolism 
2030355 Rv1792 esxM A G 3 TCA S TCG S SYN esat-6 like protein Cell wall and 
cell 
processes 






2038913 Intergenic - T G         
2121063 Rv1870c  C A 123 GGT G GAT D NONSYN conserved hypothetical protein Conserved 
hypothetical 
2184371 Rv1933c fadE18 G T 196 GCC A GTC V NONSYN acyl-CoA dehydrogenase lipid 
metabolism 








2227654 Rv1983 PE_PGRS35 C T 471 CCC P TCC S NONSYN PE-PGRS family protein PE/PPE 
families 
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2249403 Rv2003c  C A 6 CGG R CGA R SYN conserved hypothetical protein Conserved 
hypothetical 
2260339 Intergenic - G T         











Cell wall and 
cell 
processes 
2438090 Rv2176 pknL G A 50 ATG M ATA I NONSYN transmembrane serine/threonine-
protein kinase L 
Regulatory 
2453383 Intergenic - A G         
2461815 Rv2197c  A C 112 TCC S CCC P NONSYN conserved membrane protein Cell wall and 
cell 
processes 
2537602 Rv2264c  A G 250 CTT L CGT R NONSYN conserved proline rich protein Conserved 
hypothetical 
2546359 Rv2273  C T 86 CGC R CGT R SYN conserved membrane protein Cell wall and 
cell 
processes 
















2659711 Rv2379c mbtF G T 792 CCG P CTG L NONSYN peptide synthetase lipid 
metabolism 




2793360 Rv2485c lipQ C A 210 AGC S AAC N NONSYN carboxylesterase Intermediary 
metabolism 
and 
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2835576 Intergenic - G A         
2844689 Rv2524c fas G G 1548 CTC L CTG L SYN fatty-acid synthase lipid 
metabolism 








2932318 Rv2605c tesB2 A G 275 GGT G GGG G SYN acyl-CoA thioesterase II lipid 
metabolism 
2945838 Intergenic - G A         
2964024 Rv2637 dedA G A 147 GTC V ATC I NONSYN transmembrane protein Cell wall and 
cell 
processes 
2976541 Rv2652c  G A 5 GCA A GAA E NONSYN phiRv2 phage protein Insertion 
seqs and 
phages 
3007840 Rv2690c  A C 457 GTG V GCG A NONSYN conserved alanine, valine and 
leucine rich membrane protein 
Cell wall and 
cell 
processes 
3011834 Intergenic - C T         
3051068 Intergenic - C T         
3095606 Rv2787  G A 166 GGG G AGG R NONSYN conserved alanine rich protein Conserved 
hypothetical 
3107859 Rv2799  C T 31 GCG A GTG V NONSYN membrane protein Cell wall and 
cell 
processes 
3130682 Rv2823c  G T 364 GGC G GGT G SYN conserved hypothetical protein Conserved 
hypothetical 
3195557 Rv2886c  G T 292 CAC H CAT H SYN resolvase Insertion 
seqs and 
phages 
3195975 Rv2886c  G T 153 GCG A GTG V NONSYN resolvase Insertion 
seqs and 
phages 
3196434 Rv2887  G A 2 GGT G AGT S NONSYN transcriptional regulator Regulatory 
3284726 Rv2941 fadD28 C G 464 CTC L CTG L SYN fatty-acid-CoA ligase lipid 
metabolism 
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3378404 Rv3018A PE27A G A 4 AGC S AGA R NONSYN PE family protein PE/PPE 
families 
3378419 Intergenic - G C         
3382748 Intergenic - C G         


















3436296 Rv3072c  A C 9 GAT D GAC D SYN conserved hypothetical protein Conserved 
hypothetical 










3495658 Rv3130c  G G 237 CCT P GCT A NONSYN conserved hypothetical protein lipid 
metabolism 




3564790 Rv3195  G A 143 GAC D AAC N NONSYN conserved hypothetical protein Conserved 
hypothetical 
3600717 Rv3224A  T G 28 ATC I AGC S NONSYN conserved hypothetical protein Conserved 
hypothetical 
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3717205 Rv3331 sugI C T 39 CCC P CTC L NONSYN sugar-transport membrane 
protein 
Cell wall and 
cell 
processes 
3722592 Rv3335c  C C 3 GAG E GAC D NONSYN conserved membrane protein Cell wall and 
cell 
processes 
3770768 Intergenic - G T         








3802878 Rv3388 PE_PGRS52 G A 409 GGG G GAG E NONSYN PE-PGRS family protein PE/PPE 
families 
3831558 Intergenic - C G         
3849867 Rv3431c  C A 91 GTG V GTA V SYN transposase Insertion 
seqs and 
phages 






3894176 Rv3477 PE31 T C 28 AAT N AAC N SYN PE family protein PE/PPE 
families 
3968114 Rv3531c  A C 277 AAT N AAC N SYN hypothetical protein Conserved 
hypothetical 
4005862 Rv3564 fadE33 T C 206 TAC Y CAC H NONSYN acyl-CoA dehydrogenase lipid 
metabolism 








4050877 Rv3610c ftsH G G 669 GCC A GCG A SYN membrane-bound ell division 
protein 
Cell wall and 
cell 
processes 
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4076546 Rv3637  G A 21 GTG V GTA V SYN transposase Insertion 
seqs and 
phages 
4084599 Rv3646c topA G A 887 CTG L ATG M NONSYN DNA topoisomerase I Information 
pathways 
4133356 Rv3691  G C 280 GGC G GCC A NONSYN conserved hypothetical protein Conserved 
hypothetical 
4137657 Rv3695  G A 151 CGT R CAT H NONSYN conserved membrane protein Cell wall and 
cell 
processes 
4141036 Rv3698  G T 182 GAT D TAT Y NONSYN conserved hypothetical protein Conserved 
hypothetical 




4148529 Intergenic - T G         
4225647 Rv3779  G A 221 GCG A GCA A SYN conserved alanine and leucine 
rich membrane protein 
Cell wall and 
cell 
processes 
4251087 Rv3797 fadE35 G A 1 ATG M ATA I NONSYN acyl-CoA dehydrogenase lipid 
metabolism 
4266668 Intergenic - C T         
4295631 Rv3825c pks2 C T 1325 GTG V GTT V SYN polyketide synthase lipid 
metabolism 
4297793 Rv3825c pks2 T G 605 ACC T GCC A NONSYN polyketide synthase lipid 
metabolism 
4316114 Rv3843c  G T 161 GCC A GCT A SYN conserved membrane protein Cell wall and 
cell 
processes 
4349688 Rv3871  C T 288 CCC P TCC S NONSYN conserved hypothetical protein Cell wall and 
cell 
processes 
4350446 Rv3871  G C 540 TCG S TCC S SYN conserved hypothetical protein Cell wall and 
cell 
processes 
4361162 Rv3881c  T C 255 CAG Q CCG P NONSYN conserved alanine and glycine 
rich protein 
Cell wall and 
cell 
processes 
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Position Gene Gene 
name 












Gene description Functional category 
196522 Rv0166 fadD5 C T 510 GAC D GAT D SYN fatty-acid-CoA ligase lipid metabolism 
327897 Rv0271c fadE6 C A 189 GTT V ATT I NONSYN acyl-CoA dehydrogenase lipid metabolism 
1040050 Rv0932c pstS2 C A 333 GCG A GCA A SYN periplasmic phosphate-binding 
lipoprotein 
Cell wall and cell 
processes 
2071576 Rv1825  C T 181 CCT P TCT S NONSYN conserved hypothetical protein Conserved hypothetical 




3314629 Rv2962c  C A 165 TGG W TAG _ NONSYN glycosyltransferase Intermediary metabolism 
and respiration 
3454986 Rv3088  C A 216 GCG A GAG E NONSYN conserved hypothetical protein lipid metabolism 
3643630 Rv3263  G A 152 GGC G AGC S NONSYN DNA methylase Information pathways 
3847684 Rv3429 PPE59 G A 174 GGG G AGG R NONSYN PPE family protein PE/PPE families 
3895691 Intergenic - C G - - - - - - - - 
3936761 Intergenic - A G - - - - - - - - 
4136581 Rv3694c  C A 178 GTG V GTA V SYN conserved membrane protein Cell wall and cell 
processes 
4150648 Rv3707c  G T 131 GGC G GGT G SYN conserved hypothetical protein Conserved hypothetical 
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Change Functional group 
125830 Rv0107c ctpI G GA 4712 1633 1571 INSERTION Cell wall and cell 
processes 
131174 Intergenic, upstream of 
Rv0109, upstream of 
Rv0108c 
- T TG      
234496 Rv0197  C CGT 2266 763 762 INSERTION Intermediary 
metabolism and 
respiration 
293704 Intergenic - CT C      
373282 Rv0305c PPE6 TA T 2430 964 0 DELETION PE/PPE families 
424320 Rv0354c PPE7 T TC 375 142 0 INSERTION PE/PPE families 
467508 Rv0388c PPE9 C CG 494 181 180 INSERTION PE/PPE families 
874835 Rv0781 ptrBa C CCG 603 237 0 INSERTION Intermediary 
metabolism and 
respiration 
929995 Rv0834c PE_PGRS14 GCGGCACCCC G 491 883 880 DELETION PE/PPE families 
968426 Rv0872c PE_PGRS15 A AGCCGGGTTG 1819 607 0 INSERTION PE/PPE families 
1010204 Rv0907  C CG 69 533 45 INSERTION Cell wall and cell 
processes 
1061676 Intergenic, upstream of 
Rv0951, upstream of 
Rv0950c 
- GTGC G      
1101832 Rv0986  TA T 30 249 12 DELETION Cell wall and cell 
processes 
1165521 Intergenic, upstream of 
Rv1042c 
- T TA      
1168715 Rv1046c  C CT 514 175 0 INSERTION Hypothetical 
1264980 Intergenic - TCGC T      
1365837 Intergenic, upstream of 
Rv1223 
- C CG      
1527449 Rv1358  G GT 838 1160 300 INSERTION Regulatory 
1753519 Rv1549 fadD11.1 G GC 10 176 20 INSERTION lipid metabolism 
1864078 Rv1651c PE_PGRS30 GC G 1305 1012 550 DELETION PE/PPE families 
1894300 Rv1668c  G GGTCTTGCCGC 1043 373 0 INSERTION Cell wall and cell 
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1944642 Rv1717  CT C 237 117 106 DELETION Conserved 
hypothetical 
2030340 Intergenic, upstream of 
Rv1792 
- AG A      
2094911 Rv1844c gnd1 ACAGCGT A 278 486 484 DELETION Intermediary 
metabolism and 
respiration 
2109523 Intergenic, upstream of 
Rv1862 
- C CG      
2133468 Rv1883c  T TTCGCATGCCGTCACC 225 154 159 INSERTION Conserved 
hypothetical 
2137521 Intergenic - A ACTCCGATCAC     
2207591 Intergenic, upstream of 
Rv1964, upstream of 
Rv1963c 
- T TC      
2208071 Rv1964 yrbE3A TGC T 372 266 129 DELETION Virulence, 
detoxification and 
adaptation 
2357268 Rv2098c PE_PGRS36 TGCC T 766 435 434 DELETION PE/PPE families 
2368564 Intergenic - TA T      
2382085 Rv2123 PPE37 AGT A 1015 474 0 DELETION PE/PPE families 
2523205 Intergenic - G GCGC      
2525722 Rv2250A  CG C 321 140 0 DELETION Intermediary 
metabolism and 
respiration 
2534562 Rv2262c  GGA G 991 361 0 DELETION lipid metabolism 
2796131 Rv2487c PE_PGRS42 G GC 1255 695 432 INSERTION PE/PPE families 
2881597 Rv2561  AG A 189 98 0 DELETION Conserved 
hypothetical 
3131469 Rv2823c  T TTGTCGGCGA 305 810 813 INSERTION Conserved 
hypothetical 
3190145 Rv2879c  TC T 8 190 33 DELETION Conserved 
hypothetical 
3415180 Intergenic, upstream of 
Rv3053c 
- ACACCTAGGGGGTGG A      
3473996 Intergenic, upstream of 
Rv3106, upstream of 
Rv3105c 
- G GA      
3580636 Intergenic, upstream of - CT C      
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Rv3203, upstream of 
Rv3202c 
3590686 Intergenic - G GC      
3844756 Rv3428c  GC G 1215 411 0 DELETION Insertion seqs and 
phages 
3853708 Rv3434c  C CT 221 238 143 INSERTION Cell wall and cell 
processes 
3862472 Intergenic, upstream of 
Rv3443c 
- GA G      
3936661 Rv3508 PE_PGRS54 CCGACGGCGA C 5657 1902 1899 DELETION PE/PPE families 
3998059 Rv3558 PPE64 AGGC A 80 553 552 DELETION PE/PPE families 
4093879 Rv3652 PE_PGRS60 TG T 248 105 0 DELETION PE/PPE families 
4095001 Rv3655c  CG C 300 126 0 DELETION Conserved 
hypothetical 
4197138 Intergenic, upstream of 
Rv3748 
- C CT      
4198611 Intergenic, upstream of 
Rv3751, upstream of 
Rv3750c 
- CG C      
4336090 Intergenic, upstream of 
Rv3860, upstream of 
Rv3859c 
- A AT      
4338595 Intergenic, upstream of 
Rv3863, upstream of 
Rv3862c 
- GC G      
4383144 Rv3897c  C CCGGGG 497 211 0 INSERTION Conserved 
hypothetical 
4400660 Rv3911 sigM AC A 475 223 197 DELETION Information 
pathways 
Ref = reference, Alt = alternative, AA = amino acid, syn = synonymous, non-syn/NONSYN = non-synonymous, pos = position 
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REGULATED PROTEINS IN SAWC 3517 AND SAWC 3651 
Up-regulated in SAWC 3517, down-regulated in 
SAWC 3651 
Up-regulated in SAWC 3651, down-regulated in 
SAWC 3517 
Rv0107c Cell wall and cell processes Rv0313 Conserved hypothetical 
Rv0120c Information pathways Rv0351 Virulence, detoxification and adaptation 
Rv0166 lipid metabolism Rv0394c Cell wall and cell processes 
Rv0169 Virulence, detoxification and adaptation Rv0467 Intermediary metabolism and respiration 
Rv0386 Regulatory Rv0516c Information pathways 
Rv0491 Regulatory Rv0724 Cell wall and cell processes 
Rv0655 Cell wall and cell processes Rv0991c Conserved hypothetical 
Rv0690c Conserved hypothetical Rv1013 lipid metabolism 
Rv0757 Regulatory Rv1094 lipid metabolism 
Rv0758 Regulatory Rv1178 Intermediary metabolism and respiration 
Rv0778 Intermediary metabolism and respiration Rv1185c lipid metabolism 
Rv0932c Cell wall and cell processes Rv1275 Cell wall and cell processes 
Rv0958 Intermediary metabolism and respiration Rv1345 lipid metabolism 
Rv0966c Conserved hypothetical Rv1348 Cell wall and cell processes 
Rv1318c Intermediary metabolism and respiration Rv1685c Conserved hypothetical 
Rv1397c Virulence, detoxification and adaptation Rv1687c Cell wall and cell processes 
Rv1399c Intermediary metabolism and respiration Rv1722 lipid metabolism 
Rv1421 Conserved hypothetical Rv1932 Virulence, detoxification and adaptation 
Rv1427c lipid metabolism Rv2018 Conserved hypothetical 
Rv1523 Intermediary metabolism and respiration Rv2285 lipid metabolism 
Rv1532c Conserved hypothetical Rv2380c lipid metabolism 
Rv1538c Intermediary metabolism and respiration Rv2383c lipid metabolism 
Rv1597 Conserved hypothetical Rv2386c lipid metabolism 
Rv1654 Intermediary metabolism and respiration Rv2428 Virulence, detoxification and adaptation 
Rv1661 lipid metabolism Rv2429 Virulence, detoxification and adaptation 
Rv1700 Information pathways Rv2465c Intermediary metabolism and respiration 
Rv1742 Hypothetical Rv2590 lipid metabolism 
Rv1796 Intermediary metabolism and respiration Rv2627c Conserved hypothetical 
Rv1812c Intermediary metabolism and respiration Rv2711 Regulatory 
Rv1844c Intermediary metabolism and respiration Rv2930 lipid metabolism 
Rv1883c Conserved hypothetical Rv2931 lipid metabolism 
Rv2001 Conserved hypothetical Rv2947c lipid metabolism 
Rv2155c Cell wall and cell processes Rv3093c Intermediary metabolism and respiration 
Rv2161c Intermediary metabolism and respiration Rv3094c Conserved hypothetical 
Rv2557 Conserved hypothetical Rv3161c Intermediary metabolism and respiration 
Rv2568c Conserved hypothetical Rv3547 Intermediary metabolism and respiration 
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Rv2682c Intermediary metabolism and respiration Rv3720 lipid metabolism 
Rv2702 Intermediary metabolism and respiration Rv3765c Regulatory 
Rv2821c Conserved hypothetical Rv3841 Intermediary metabolism and respiration 
Rv2824c Conserved hypothetical Rv3849 Regulatory 
Rv2906c Information pathways 
Rv2956 Conserved hypothetical 
Rv2986c Information pathways 
Rv3077 Intermediary metabolism and respiration 
Rv3106 Intermediary metabolism and respiration 
Rv3203 Intermediary metabolism and respiration 
Rv3213c Cell wall and cell processes 
Rv3232c Intermediary metabolism and respiration 
Rv3237c Conserved hypothetical 
Rv3241c Information pathways 
Rv3279c Intermediary metabolism and respiration 
Rv3303c Intermediary metabolism and respiration 
Rv3320c Virulence, detoxification and adaptation 
Rv3322c Intermediary metabolism and respiration 
Rv3323c Intermediary metabolism and respiration 
Rv3329 Intermediary metabolism and respiration 
Rv3480c lipid metabolism  
Rv3505 lipid metabolism  
Rv3573c lipid metabolism  
Rv3600c Conserved hypothetical 
Rv3603c Conserved hypothetical 
Rv3684 Intermediary metabolism and respiration 
Rv3691 Conserved hypothetical 
Rv3726 Intermediary metabolism and respiration 
Rv3866 Cell wall and cell processes 
Rv3868 Cell wall and cell processes 
Rv3879c Cell wall and cell processes 
Rv3918c Cell wall and cell processes 
 
 








# annotating SNPs for one strain 
# Note that the H37RvAnno.txt and H37RvGeneSeq.fasta files used in this script were downloaded from 










open(MUT, "$vcf") or die "Cannot open $vcf:$!\n"; 
 
while (<MUT>) { 
 
    chomp; 
 
 next if (/^##/); 
     
 if (/^#/) { 
 
 @headers = split(/\t/,$_); 
 
 print join ("\t", ("CHROM", "POS", "LOCUS", "SYMBOL", "REFBASE", "ALTBASE", 




    } 
 
 my ($CHROM, $POS, $ID, $REFBASE, $ALTBASE, $QUAL, $FILTER, $INFO, $FORMAT, 
$STRAIN_1)=split(/\t/,$_); 
 my $annofile="/home/adippenaar/Documents/Bioinformatics/Out_groups_output/H37RvAnno.txt"; 
 my $line=0; 
 my $prevGene; 
 my $prevStrand; 
 my 
$geneseqfile="/home/adippenaar/Documents/Bioinformatics/Out_groups_output/H37RvGeneSeq.fasta"; 
 my $codonsize = 3;     
 open(ANNO, "$annofile") or die "Cannot open $annofile:$!\n"; 
 while (<ANNO>) { 
         if ($line==0) { 
      $line++; 
      next; 
  } 




  chomp; 
  my ($LOCUS, $SYMBOL, $SYNOYM, $LENGHT, $START, $STOP, $STRAND, 
$NAME)=split(/\t/,$_); 
 
  #print "'$STRAND'\n"; 
 
  if ($POS>$START && $POS<$STOP) { 
      
   open(GENESEQ, "$geneseqfile") or die "Cannot open $geneseqfile:$!\n"; 
   my $seq; 
   while (<GENESEQ>) { 
        
       next unless /^>$LOCUS/; 
        
       while (<GENESEQ>) { 
     
    last if /^>/; 
     
    chomp; 
     
    $seq.=$_; 
       } 
        
       last; 
   } 
    
   close GENESEQ; 
    
   my $posingene; 
 
   if ($STRAND eq "+") { 
        
       $posingene = ($POS - $START) + 1; 
   } 
    
   else {$posingene = ($STOP - $POS) + 1; 
          
   } 
    
    
    
   my $codonnr = int(($posingene - 1)/$codonsize + 1); 
    
   #print "'$codonnr'\n"; 
    
   my $firstbase = (($codonnr - 1) * $codonsize) + 1 - 1; 
 
   #print "'$firstbase'\n"; 
      
   my $lastbase = (($codonnr - 1) * $codonsize) + 3 - 1; 
 
   #print "'$lastbase'\n"; 
       
# -1: subst will start to count at 0 
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   my $codon = substr($seq, $firstbase, $codonsize); 
 
   #print "'$seq'\n"; 
    
   #print "'$codon'\n"; 
    
   my $aa = &codon2aa($codon); 
 
   #print "aa is $aa\n"; 
 
   my $offset; 
 
   if (($posingene % $codonsize) == 1) { 
        
       $offset = 1 - 1; 
   } 
 
   elsif (($posingene % $codonsize) == 2) { 
        
       $offset = 2 - 1; 
 
   } 
 
   elsif (($posingene % $codonsize) == 0) { 
 
       $offset = 3 - 1; 
    
   } 
 
   #print "offset value is $offset\n"; 
 
   my $mutcodon = $codon; 
 
   my $mutaa; 
 
   my $change; 
    
 
   if ($STRAND eq "+") {  
 
    substr($mutcodon, $offset, 1) = $ALTBASE; 
 
    #print "altbase is $ALTBASE\n"; 
 
    #print "my mutcodon is $mutcodon\n"; 
 
    $mutaa = &codon2aa($mutcodon); 
 
    if ($mutaa eq $aa) {$change = "SYN"; 
 
    } 
 
    elsif ($mutaa ne $aa) {$change = "NONSYN"; 
 
    } 
              }  




   else  { 
   
        
 
        if ($ALTBASE eq "T") {$ALTBASE = "B"; 
 
        } 
 
        if ($ALTBASE eq "A") {$ALTBASE = "D"; 
 
        } 
 
        if ($ALTBASE eq "C") {$ALTBASE = "E"; 
 
        } 
     
        if ($ALTBASE eq "G") {$ALTBASE = "H"; 
 
        } 
     
    if ($ALTBASE eq "B") {$ALTBASE = "A"; 
 
    }   
         
    if ($ALTBASE eq "D") {$ALTBASE = "T"; 
 
    } 
 
    if ($ALTBASE eq "E") {$ALTBASE = "G"; 
 
    } 
 
    if ($ALTBASE eq "H") {$ALTBASE = "C"; 
 




    substr($mutcodon, $offset, 1) = $ALTBASE; 
 
    #print "altbase is $ALTBASE\n"; 
 
    #print "my mutcodon is $mutcodon\n"; 
 
    $mutaa = &codon2aa($mutcodon); 
 
    if ($mutaa eq $aa) {$change = "SYN"; 
 
    } 
 
    elsif ($mutaa ne $aa) {$change = "NONSYN"; 
 
    } 
 
   } 




#   print join ("\t", ($CHROM, $POS, $LOCUS, $SYMBOL, $REFBASE, $ALTBASE, 
$QUAL, $FILTER, $INFO, $FORMAT, $STRAIN_1, $codonnr, $codon, $aa, $mutcodon, $NAME)), "\n";  
   print join ("\t", ($CHROM, $POS, $LOCUS, $SYMBOL, $REFBASE, $ALTBASE, 
$QUAL, $FILTER, $INFO, $FORMAT, $STRAIN_1, $codonnr, $codon, $aa, $mutcodon, $mutaa, 
$change, $NAME)), "\n";  
 
   last; 
 
  } 
 
  if ($POS<$START){ 
       
      $SYMBOL = "-"; 
 
   my $message="Intergenic"; 
 
   #if($STRAND eq "+") {$message.=".Upstream of $LOCUS"; 
 
   #}  
 
   #if($prevStrand eq "-") {$message.=".Upstream of $prevGene";  
 
   #} 
 
   print join ("\t", ($CHROM, $POS, $message, $SYMBOL, $REFBASE, $ALTBASE, 
$QUAL, $FILTER, $INFO, $FORMAT, $STRAIN_1)), "\n"; 
   last; 
  } 
  $prevGene=$LOCUS; 
  $prevStrand=$STRAND; 
   
   
   
 } 







sub codon2aa { 
     
    my $codon = uc shift; 
     
    if    ( $codon =~ m/GC./ )        { return "A" } # Alanine                                                                                                      
    elsif ( $codon =~ m/TG[TC]/ )     { return "C" } # Cysteine                                                                                                     
    elsif ( $codon =~ m/GA[TC]/ )     { return "D" } # Aspartic Acid                                                                                                
    elsif ( $codon =~ m/GA[AG]/ )     { return "E" } # Glutamic Acid                                                                                                
    elsif ( $codon =~ m/TT[TC]/ )     { return "F" } # Phenylalanine                                                                                                
    elsif ( $codon =~ m/GG./ )        { return "G" } # Glycine                                                                                                      
    elsif ( $codon =~ m/CA[TC]/ )     { return "H" } # Histidine                                                                                                    
    elsif ( $codon =~ m/AT[TCA]/ )    { return "I" } # Isoleucine                                                                                                   
    elsif ( $codon =~ m/AA[AG]/ )     { return "K" } # Lysine                                                                                                       
    elsif ( $codon =~ m/TT[AG]|CT./ ) { return "L" } # Leucine                                                                                                      
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    elsif ( $codon =~ m/ATG/ )        { return "M" } # Methionine                                                                                                   
    elsif ( $codon =~ m/AA[TC]/ )     { return "N" } # Asparagine                                                                                                   
    elsif ( $codon =~ m/CC./ )        { return "P" } # Proline                                                                                                      
    elsif ( $codon =~ m/CA[AG]/ )     { return "Q" } # Glutamine                                                                                                    
    elsif ( $codon =~ m/CG.|AG[AG]/ ) { return "R" } # Arginine                                                                                                     
    elsif ( $codon =~ m/TC.|AG[TC]/ ) { return "S" } # Serine                                                                                                       
    elsif ( $codon =~ m/AC./ )        { return "T" } # Threonine                                                                                                    
    elsif ( $codon =~ m/GT./ )        { return "V" } # Valine                                                                                                       
    elsif ( $codon =~ m/TGG/ )        { return "W" } # Tryptophan                                                                                                   
    elsif ( $codon =~ m/TA[TC]/ )     { return "Y" } # Tyrosine                                                                                                     
    elsif ( $codon =~ m/TA[AG]|TGA/ ) { return "_" } # Stop                                                                                                         
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SCRIPT USED TO ASSIGN FUNCTIONAL GROUPS TO ANNOTATED HIGH 
CONFIDANCE VARIANTS 
#! /usr/bin/perl 
#Note that the functional groups file specified in the usage information of this script was 
compiled from data from the Tuberculist knowledge base. The protein file refers to the protein or 
SNP file with a list of RV numbers that is used as input.  
use strict; 
if ($#ARGV < 1) { 
 die "usage: $0 [functional_groups file] [protein file]\n"; 
} 
my $fgrps =$ARGV[0]; 
my $proteinfile=$ARGV[1]; 
my %grps = (); 
open(F, $fgrps); 
while (<F>) { 
 chomp; 
 next if ($_=~/^Rv_number/); 
 my (@line) = split(/\t/); 





while (<F>) { 
 chomp; 
 next if ($_=~/^CHROM/); 
 my @line = split(/\t/); 
 my $rv_id = $line[2]; 
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 #$rv_id =~s/\"//g; 




Stellenbosch University  http://scholar.sun.ac.za
178 
 
SCRIPT USED TO CREATE SNP STRING FOR PHYLOGENOMIC 
INFERENCE 
#This python script assumes: 
#1. A single chromosome 
#2. Input files with the naming convention 
#   pos_alt_<sample_nr>_<list_identifier>.txt 
#   Entries in these files contain 2 columns: the position of a variant and its 
#   value 
#3. A fasta file (reference sequence) with 1 header line and a column length of 60 
 
#The output of this script is <sample_nr>.txt files, one file for each of the 
#input files. The content of each file is a string of nucleotides, in order  
#of position, for the set of all positions read from the input files. If a 
#value for a certain position is not available for a sample, it contains the  
#value of the the reference allele, as read from the FASTA file.  
 
nr_fasta_header_lines = 1 
col_len = 60 
input_file_prefix = 'pos_alt_'  
 
import sys, os 
 
if len(sys.argv) != 4: 
 print("Usage: python create_phylo_files.py <fasta_file> <input_dir> " + \ 
   "<output_dir>") 
 sys.exit(-1) 
else: 
 fasta_file_name = sys.argv[1] 
 input_dir = sys.argv[2] 
 output_dir = sys.argv[3] 
 
 
#Map containing a map of positions and variants, keyed on sample nr 
sample_map = {} 
#Map containing reference variants, keyed on position 
ref_map = {} 
#Set the column length to 60 
 
input_dir_list = os.listdir(input_dir) 
for file_name in input_dir_list: 
 if file_name[0:8] == input_file_prefix: 
  print('Processing ' + file_name + ' ...') 
 
  #Determine the sample number 
  sample_nr_length = file_name[9:].find('_') 
  sample_nr = file_name[8:9+sample_nr_length] 
     
  #Initialize the variant map for this sample, keyed on position 
  var_map = {} 
 
  #Read the file content and populate the maps 
  in_file = open(os.path.join(input_dir, file_name)) 
  for line in in_file: 
   data = line.strip().split() 
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   pos, var = int(data[0]), data[1] 
   var_map[pos] = var 
   if (pos in ref_map) == False: 
    #Get the reference allele from the fasta file 
    col_nr = str(pos % col_len) 
    row_nr = str((pos / col_len) + nr_fasta_header_lines + 1) 
    if col_nr == '0': 
     col_nr = str(col_len) 
    os.system('head -' + row_nr + ' ' + fasta_file_name + ' | ' + \ 
     'tail -1 > tmp_fasta_line.txt') 
    ref = os.popen('cut -c' + col_nr + \ 
     ' tmp_fasta_line.txt').read().strip().upper() 
    os.system('rm tmp_fasta_line.txt') 
    ref_map[pos] = ref 
  in_file.close() 
  sample_map[sample_nr] = var_map 
 
#Sort the positions 
positions = sorted(ref_map.keys()) 
 
for sample_nr in sample_map.keys(): 
 #Open the output file for this sample 
 print('Writing ' + sample_nr + '.txt ....') 
 out_file = open(os.path.join(output_dir, sample_nr) + '.txt', 'w') 
 debug_file = open(os.path.join(output_dir, sample_nr) + '_debug.txt', 'w') 
 debug_file.write('pos\tref\talt\n') 
 
 #Get the variant map for this sample 
 var_map = sample_map[sample_nr] 
 
 #Write the output file 
 for pos in positions: 
  debug_file.write(str(pos) + '\t') 
  if pos in var_map: 
   var = var_map[pos] 
   debug_file.write('*\t' + var + '\n') 
  else: 
   var = ref_map[pos] 
   debug_file.write(var + '\t*\n') 
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